Characterization of receptors and lysosomes of cells susceptible to infectious bronchitis virus by Lukert, Phil Dean
Retrospective Theses and Dissertations Iowa State University Capstones, Theses andDissertations
1967
Characterization of receptors and lysosomes of
cells susceptible to infectious bronchitis virus
Phil Dean Lukert
Iowa State University
Follow this and additional works at: https://lib.dr.iastate.edu/rtd
Part of the Microbiology Commons
This Dissertation is brought to you for free and open access by the Iowa State University Capstones, Theses and Dissertations at Iowa State University
Digital Repository. It has been accepted for inclusion in Retrospective Theses and Dissertations by an authorized administrator of Iowa State University
Digital Repository. For more information, please contact digirep@iastate.edu.
Recommended Citation
Lukert, Phil Dean, "Characterization of receptors and lysosomes of cells susceptible to infectious bronchitis virus" (1967).
Retrospective Theses and Dissertations. 3407.
https://lib.dr.iastate.edu/rtd/3407
This dissertation has been 
microfilmed exactly as received 68—2839 
LUKERT, D.V.M., Phil Dean, 1931-
CHARACTERIZATION OF RECEPTORS AND LYSOSOMES 
OF CELLS SUSCEPTIBLE TO INFECTIOUS BRONCHITIS 
VIRUS. 
Iowa State University, PhuD,, 1967 
Microbiology 
University Microfilms. Inc., Ann Arbor, Michigan 
CHABACTERIZATION OF RECEPTORS AND LYSOSOMES OF CELLS 
SUSCEPTIBLE TO INFECTIOUS BRONCHITIS VIRUS 
by 
Phil Dean Lukert ^ D V, M , 
A Dissertation Submitted to the 
Graduate Faculty in Partial Fulfillment of 
The Requirements for the Degree of 
DOCTOR OF PHILOSOPHY 
Major Subject : Veterinary Microbiology 
Approved: 
In Charge of Major Work 
Head of Major Department 
Iowa State University 
Of Science and Technology 
Ames, Iowa 
1967 
Signature was redacted for privacy.
Signature was redacted for privacy.
Signature was redacted for privacy.
11 
TABLE OP CONTENTS 
Page 
INTRODUCTION 1 
REVIEW OF THE LITERATURE 3 
Virus Attachment and Virus Receptors 3 
Lysosomes with Relation to Viral Infection 15 
MATERIALS AND METHODS 21 
Viruses 21 
Cell Culture Media and Solutions 22 
Preparation of Cell Cultures 24-
Preparation of Fluorescent Antibody 28 
Attachment of IBV to Cell Monolayers 33 
Thiol Inhibitors of IBV Attachment 40 
Inhibitors of IBV Attachment Pound in Serum 56 
Lysosomal Changes in IBV Infected Cells 73 
RESULTS 78 
Attachment of IBV to Cell Monolayers ?8 
Inhibitors of IBV Attachment Found in Serum 117 
Lysosomal Changes in IBV Infected Cells l60 
DISCUSSION 171 
SUMMA.RÏ 185 
LITERATURE CITED 187 
ACKNOWLEDGMENTS 197 
APPENDIX 198 
1 
INTRODUCTION 
The virus-cell interaction between avian infectious 
bronchitis virus (IBV) and a number of susceptible cell types 
originating from various tissues of the chicken embryo is 
interesting in that each virus-cell system responds different­
ly to infection with this virus. Previous work has shown that 
primary cells cultured from chicken embryo kidney, liver, lung, 
and whole embryos differ as to sensitivity, length of eclipse 
period, cytopathology, and distribution of antigen as detected 
by immunofluorescence (Lukert, 19^ 5; Lukert, 1966b). These 
observations aroused an interest in determining some of the 
reasons for the varied responses of the various cell types to 
IBV. 
Two aspects of IBV-cell interactions were selected for 
study. The first was that of attachment of virus to cells. 
A thorough study of this event might explain the previously 
observed differences in sensitivity of various cell types to 
IBV and would also serve to define the chemical nature of IBV 
receptor sites. The second aspect for study was the distribu­
tion and fate of lysosomes in infected cultures of cells from 
chicken embryo kidney and liver. It was thought that these 
cellular organelles might be implicated in susceptibility to 
IBV and may play a role in viral-induced cytopathic alterations^  
To elucidate differences in the above mentioned virus-cell 
interactions, cells from chicken embryo kidney and liver were 
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chosen for study because of their observed differences in both 
susceptibility to IBV and length of eclipse period. Informa­
tion derived from a study of this nature will provide us with 
greater knowledge of the basic characteristics of IBV as well 
as a better understanding of the virus-cell relationship as 
it pertains to cell, tissue, and host susceptibility. 
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REVIEW OF THE LITERATURE 
Virus Attachment and Virus Receptors 
Attachment 
Virus attachment^  to host cells is usually considered to 
be divided into 2 stages. The initial stage is probably a 
rather nonspecific but reversible stage requiring electrolyte 
and is electrostatic in nature (Levine and Sagik, 195^ ; Tolmach, 
1957)• The second stage of attachment is considered irrevers­
ible and appears to be quite specific (Tolmach, 1957; Hirst, 
1965). In general, animal viruses appear to attach to cells 
less specifically and much more inefficiently than do bacterial 
viruses (Hirst, I965). Studies on the attachment of animal 
viruses are complicated by the fact that not all viral parti­
cles can express themselves as infective units (Taylor and 
Graham, I96I; Joklik and Darnell, I96I) and the possibility 
of subsequent elution of attached virus as in the case of 
vaccinia virus (Smith and Sharp, 196I) and poliovirus (Joklik 
and Darnell, 196l; Penwick and Cooper, 1962). 
The effect of temperature on attachment has not been 
definitely resolved. The attachment of fowl plague and vac-
T^he term "attachment" was selected in preference to "ad­
sorption" in accordance with the view of Tolmach, 1957, as the 
term adsorption has the connotation of physicochemical non-
specificity while viral attachment is notably a specific 
reaction with the cell. 
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cinia viruses (Allison and Valentine, i960), Newcastle disease 
virus (NDV) (Levine and Sagik, 1956) and poliovirus (Bachtold 
et al., 1957) was reported to occur independent of temperature, 
Youngner (1956) and Holland and McLaren (1959) found that 
poliovirus attachment was temperature dependent being favored 
by increased temperature. Philipson and Bengstsson (1962) 
observed that the initial attachment of poliovirus was inde­
pendent of temperature while irreversible attachment was tem­
perature dependent. Bachrach et al. (1957) showed that the 
plating efficiency of foot-and-mouth disease virus was much 
greater, about 10-fold, at 37° and 43° as compared to 29° and 
26°. 
The presence of electrolyte is essential for virus attach­
ment as shown by Levine and Sagik (1956) for NDV. Bachtold 
et al. (1957) demonstrated that the divalent cations, Ca or 
Mg, in concentrations from 10"^  to 10""molar were required 
for poliovirus attachment with 10"^  molar being optimal. 
Allison and Valentine (196O) found that fowl plague attached 
to chicken embryo cell monolayers independent of the valency 
of cations and surprisingly found attachment was depressed 
with high concentrations of divalent and trivalent cations. 
They postulated that the cations reduce the thickness of the 
layer of positively charged ions surrounding viruses and cells 
which normally carry a net negative charge, thus allowing the 
viruses to approach the cell sufficiently close so that short 
range attractive forces can bind them together. 
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The pH of the environment during attachment has a wide 
optimal range and has been shown to have little effect except 
at a pH of 4.0, where attachment is depressed for NDV and fowl 
plague virus (Levine and Sagik, 195^ ; Allison and Valentine, 
i960). At pH 4 the carboxyl groups of virus and cells would 
be ionized and increase the net negative charge, thus reduc­
ing attachment while at pH 5« 5 and above ionization of these 
groups are suppressed and attachment can occur. 
The early findings that attachment is independent of 
temperature, enhanced by electrolyte, especially in the pres­
ence of cations (Allison and Valentine, I96O), and depressed 
at pH 4.0 has lead to the hypothesis that initial attachment 
is electrostatic. Allison and Valentine (I96O) speculated that 
the main interacting groups were likely the amino groups of 
the virus and phosphate groups of the cell. 
While the initial attachment of virus may be electro­
static in nature and somewhat nonspecific, the evidence is 
that the irreversible second stage is probably quite specific 
with definite receptor substances involved for each virus type. 
Hirst (1965) and Green (I966) pointed to the fact that very 
little is actually known about the mechanism of animal virus 
attachment and the receptors involved except in the case of 
myxoviruses which have mucoprotein receptors. Philipson (I963) 
indicated that even though the myxovirus receptors on erythro­
cytes have been rather well characterized, the nature of recep­
tors on host cells are much more complex and less well defined. 
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Myxovlrus receptors 
The biochemical evidence establishing mucoproteins as the 
receptor substance for myxoviruses was first presented by 
Gottschalk (1958) when he showed that the influenza virus enzyme 
was a neuraminidase that split off neuraminic acid sidechains 
from mucoproteins. Using neuraminidase from Vibrio cholerae, 
Stone (1948a) showed that infection of chick embryos with a 
number of myxoviruses could be prevented. A similar finding 
(Stone, 1948b) was observed for influenza viruses in mice. 
Johnson et al. (1964) found a similar reduction of infectivity 
of influenza virus in chicken embryos using neuraminidase de­
rived from Asian influenza virus. Vibrio cholerae, and Clos­
tridium perfringens. They observed that it required more 
enzyme to protect against the PR-8 strain of influenza A virus 
than the Lee-B strain. Haff and Stewart (19^ 5) found a 2.5-
to 4.7-fold inhibition of plaques with influenza viruses when 
chicken embryo cell monolayers were treated with neuraminidase. 
In contrast, neuraminidase 800 times less concentrated than 
that required to alter infectivity modified receptors on 
erythrocytes. They concluded that the receptors on host cells 
were either not fully identical with those of erythrocytes or 
were refractory to neuraminidase treatment. 
Mori et a^ . (1962) demonstrated that the receptors on 
erythrocytes for polyoma virus and influenza viruses were 
similar as they mutually excluded one another and influenza 
virus neuraminidase destroyed polyoma receptors on the erythro-
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cytes. The erythrocyte receptors for both viruses could be 
removed by treatment with neuraminidase and periodate, however, 
these treatments, while destroying host-cell receptors for 
influenza, had no effect on polyoma host-cell receptors for 
infection. Ackermann et a2. (1955) demonstrated that oc-avalno-
p-methozyphenyImethane sulfonic acid (AMPS) impaired attach­
ment of influenza virus to the chorioallantoic membrane. When 
the chorioallantoic membrane was first treated with neuramini­
dase and then AMPS, attachment of virus was con^ letely prevent­
ed, The results of Haff and Stewart (19^ 5) and Mori et al. 
(1962) and Ackermann et al, (1955) show the possible discrep­
ancies encountered when trying to draw analogies between 
receptors on erythrocytes and host cells. Marcus et (1965) 
found that neuraminidase-treated HeLa cells and isolated nuclei 
failed to adsorb virus. They quantitated the molecules of N-
acetylneuraminic acid on the surfaces of the cell and nuclei 
and found that both surfaces contained approximately 10-^  mole-
2 
culeA . 
Further proof that myzovirus receptors are mucoproteins 
with an N-acetylneuraminic acid residue in the sugar moiety 
are the mucoprotein inhibitors of hemagglutination as reviewed 
by Gottschalk (1959). Mucoproteins with sialic acid residues 
other than N-acetylneuraminic acid are ineffective as inhibi­
tors of hemagglutination. 
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Flcomavlrus receptors 
While little is known about the biochemistry of receptors 
for picornaviruses, the need for specific receptors was irrev­
ocably proven when Holland et (1959) showed that infec­
tious ribonucleic acid extracted from poliovirus could infect 
naturally insusceptible nonprimate cells. McLaren et al» 
(1959) had earlier reported that poliovirus did not attach to 
insusceptible cells thus showing a lack of specific receptors 
for the virus. Holland and McLaren (1959) demonstrated that 
disrupted HeLa cells inactivated poliovirus irreversible and 
had the same kinetics as did irreversible attachment of virus 
to whole HeLa cells. Disrupted insusceptible cells did not 
inactivate poliovirus. Quersin-Thiry (I961) confirmed these 
findings and extended the study to NDV, WEE, and vaccinia 
viruses and found that these were also inactivated by suscept­
ible disrupted cells. They found that NDV and WEE inactiva-
tion kinetic curves were interrupted by phases of reactivation. 
The NDV peaks of reactivation could be prevented by meta-
periodate treatment, while the same treatment had no effect 
on poliovirus and WEE virus. Quersin-Thiry and Nihoul (I961) 
extended this study and found that disrupted HeLa cells con-
m 
tained three different inactivating substances. One substance 
combines with poliovirus, is heat labile, and is destroyed 
by trypsin and sonic waves. The second substance combines 
with WEE virus, is resistant to trypsin and sonic waves but is 
destroyed by lipase and heat. The third substance inactivates 
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NDV and Coxsackie B1 and B4 viruses. It is inactivated by 
trypsin and living influenza PR8 viruses, modified by meta-
periodate treatment, and is heat stable. Both groups of work­
ers (Holland and McLaren, 1959) (Quersin-Thiry and Nihoul, 
1961) implicate receptor substances as being the inactivat­
ing substance and feel the receptors for poliovirus are lipo­
protein in nature. The work of Quersin-Thiry and Nihoul 
(1961) however implicates receptors for Coxsackie B1 and B4 
viruses as being similar to myxovirus receptors which are 
mucoprotein substances. 
Holland (I96I) examined the role that receptors might 
play in tissue tropisms of poliovirus. He found that cell-
free homogenates of brain, spinal cord, and intestine of human 
fetuses and adult rhesus monkeys would bind virulent polio­
virus, while homogenates of tissues which do not normally prop­
agate poliovirus did not bind the virus. He also demonstrated 
that tissue cells, normally refractory to poliovirus vivo 
and whose homogenates failed to bind virus, gained receptors 
upon cultivation m vitro and supported poliovirus replication. 
Six molar LiCl and 8M urea, hydrogen bond-disrupting agents, 
prevented virus binding to susceptible whole cells and cell 
homogenates. Several ECHO and Coxsackie viruses also showed 
correlation between virus tissue tropism and ability of tissue 
homogenates to bind virus vitro. Holland (1962) also found 
that treatment of disrupted HeLa cell-poliovirus complexes 
with 6M LiCl and 8M urea would release infective virus, showing 
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That these agents not only prevented attachment but also could 
reverse attachment of virus. 
While the consensus of opinion is that poliovirus does 
not attach to nonsusceptible cells. Warren and Cutchins (1957) 
showed that poliovirus was rapidly removed from the inoculum 
by bovine embryonic cell cultures but did not replicate in 
them. The idea that poliovirus only attaches and replicates 
in primate cells was challenged by the results of Sheffield 
and Churcher (1957). who grew poliovirus in an embryonic rabbit 
kidney (ERK) line, and Mascoll et (1959). who grew polio­
virus in 2 different guinea pig spleen cell lines. Antiserum 
prepared against the ERK cell line was later shown by Brand 
and Syverton (I960) to hemagglutinate human but not rabbit 
erythrocytes indicating that the ERK line might have been 
contaminated with a human cell type. Hsuing and Melnick (1958) 
also demonstrated that poliovirus would attach to primate cells 
that were insusceptible. 
The possible role of thiol groups in virus attachment has 
been shown by a number of workers. Much of the work pointing 
to thiol groups has been done with picornaviruses. Philipson 
and Choppin (196O) and Buckland (196O) independently found that 
the hemagglutinating capacity of ECHO and Coxsackie viruses 
were inactivated using the sulfhydryl compound p-hydroxymer-
curibenzoate (PHMB).^  Philipson and Choppin (I96O) demonstrated 
T^his compound is referred to in most literature as p-
chloromercuribenzoate but is now more correctly referred to as 
p-hydroxymercuribenzoate (Boyer, 195^ ). 
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that the reduced capacity to hemagglutinate erythrocytes was 
due to failure of virus attachment. This was shown by reacti­
vating the PHMB treated virus with reduced glutathione after 
the first exposure to erythrocytes and finding that all the 
virus remained in the supernate. 
Choppin and Philipson (196I) subsequently reported on 
the effect of PHMB on the infectivity of ECHO, Coxsackie, and 
poliovirus. They found all three virus types to be sensitive 
to PHMB but some were more sensitive to PHMB than others. 
They also showed that PHMB inactivated picornaviruses did not 
form a stable attachment to host cells. Allison et al. (1962) 
studied the effect of PHMB and iodoacetamide on the infectivity 
of a wide range of viruses. They showed that 6 of 9 pi coma-
virus types were inactivated by these sulfhydryl compounds. 
The infectivity and hemagglutinating activity of simian entero­
virus SV2 is also destroyed by PHMB (Heberling and Cheever, 
1965). 
Hirst (1961) and Philipson and Choppin (I962) reported 
that poliovirus was inactivated by polysulfides and this 
inactivation was reversed by cysteine, reduced glutathione 
and mercaptoethanol. Their results differed in that Hirst 
(1961) observed that poliovirus attachment to HeLa cells was 
not inhibited, while Philipson and Choppin (1962) found that 
attachment to HeLa cells was inhibited. Hirst (I96I) indicated 
that virus could be reactivated with cysteine even after the 
virus had penetrated sufficiently to be insusceptible to anti­
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body. 
The finding by Pohjanpelto (1959) that polio virus was 
stabilized against heat inactivation by cystine is also indica­
tive of the importance of thiol and disulfide groups in the 
capsid structure of picornaviruses. 
Although inactivation of picornaviruses with sulfhydryl 
reagents apparently inhibits virus attachment to cells, it is 
probably not true for other viruses so inactivated. Vaccinia, 
fowl plague, influenza A, and influenza B viruses inactivated 
with PHMB were found to attach normally to host cells and the 
hemagglutinating activity of the latter 3 was not altered 
(Buckland, 1960; Choppin and Philipson, 1961; and Allison, 
1962). 
Another group of picornaviruses, the encephalomyocarditis 
(EMC) viruses seem to have myxovirus type receptors for attach­
ment, and infection of HeLa cells was prevented with neuramini­
dase (Kodza and Jungeblut, 1958). Buckland (i960) also showed 
that the hemagglutinating activity of these viruses was abol­
ished with PHMB. 
Receptors of other virus groups 
Very little is known about the nature of receptors for 
groups of viruses other than the myxoviruses and picorna­
viruses. Since these two groups have been used as the model 
systems for studying virus attachment, the other virus groups 
have been studied very little and usually only in con^ arison 
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with jnyxoviruses or picornaviruses. 
While many of the adenoviruses hemagglutinate erythro­
cytes from a number of species, nothing is known of the nature 
of these receptors (Tamm and Eggers, I965). Adenovirus type 
7 hemagglutinating activity was prevented with PHMB but Adeno­
virus type 9 and 8VI7 were unaffected (Buckland, I96O). The 
infectivity of 2 adenoviruses tested was reduced by PHMB as 
shown by Allison et a2. (19^ 2). 
Quersin-Thiry and Nihoul (I96I) found that possible 
receptor substances of cellular extracts specific for WEE 
virus, an arbovirus, was susceptible to lipase but resisted 
trypsin and sonic waves. This plus the fact that inhibitors 
of arbovirus hemagglutination found in serums is removed by 
ether extraction (Hirst, I965) leads to the conclusion that 
lipid substances may act as receptors for arboviruses. A 
number of arboviruses were treated with PHMB by Allison et al. 
(1962) and they found the arbovirus A group resisted the treat­
ment while those of the B group and some miscellaneous arbo­
viruses were inactivated. 
The reovirus receptor substances seem to be varied. Eeo-
virus types 1, 2, and 3 all agglutinate human erythrocytes 
but the receptors are unaltered by neuraminidase treatment 
(Tamm and Eggers, I965). Reovirus type 3, however, hemagglut­
inate s bovine erythrocytes and these receptors are destroyed 
by neuraminidase (Gomatos and Tamm, 19^ 2). The hemagglutinat-
ing activity and infectivity of all 3 serotypes of reovirus 
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are inactivated by PHMB (Buckland, I96O; Allison et al., 
1962; Gomatos and Tamm, 1962; and Lerner et , 1963). 
As mentioned under the discussion of myxovirus receptors, 
the polyoma virus erythrocyte receptors are similar to those 
of the myxoviruses and mutually exclude one another (Hartley 
et al., 1959; Mori et a2., I962). The receptors on host 
cells, however, were also shown to resist neuraminidase, thus, 
they are not identical to those on the erythrocyte. The 
hemagglutinating activity and the infectivity of polyoma virus 
is unaltered by sulfhydryl compounds (Tamm and Eggers, 1965). 
Another papovavirus, Shope papilloma virus, was also reported 
to be resistant to PHMB (Schmidt, 1957)• 
Rous sarcoma virus is inactivated by PHMB (Schmidt, 1957) 
and iodoacetamide (Allison et al., 1962). As this property 
may or may not implicate thiol groups as a functional part of 
the virus receptor more work must be done to determine how 
the sulfhydryl compounds inactivate the virus. 
Vaccinia virus is inactivated by mercury (Kaplan, 1959) 
and PHMB (Allison et ^ ., 19^ 2) and can be reactivated by 
thiol compounds indicating that thiol groups are probably 
involved in the inactivating process. Allison (1962) however 
showed that purified preparations of vaccinia virus inactivated 
by PHMB attached to chicken embryo cell monolayers normally. 
This indicates that the inactivation is probably not due to 
alteration of receptor sites on the virus. 
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Attachment of avian Infectious bronchitis virus (IBV) 
Cunningham and Spring (1965) and Lukert (1965) studied 
the effect of time on IBV attachment to primary chicken embryo 
kidney cell monolayers. Both reports showed that maximum 
plaque counts were achieved after a 90-minute attachment period. 
In both instances, the conditions were essentially the same 
except the temperature was 37° in the former study and 25° in 
the latter study. Powers (19^ 5) found that IBV was inactivated 
by PHMB but did not determine if attachment of the virus was 
hindered by this reagent. Biswal et (1966) demonstrated 
that both the hemagglutination of erythrocytes by trypsin-
treated IBV and the infectivity of IBV in chicken embryos were 
inhibited by neuraminidase treatment. 
Lysosomes with Relation to Viral Infection 
Structure and function of lysosomes 
de Duve et al. (1955) first described a cell fraction 
that contained a number of hydrolytic enzymes, all operating 
at an optimum pH of 5- These workers called this cell frac­
tion "lysosomes" before the morphologists had observed their 
structure. Novlkoff et (1956) subsequently examined this 
cell fraction with the electron microscope and found dense 
bodies surrounded by a single membrane along with a high pro­
portion of mitochondria. He suspected that the dense bodies 
were the structures that contained the acid hydrolases de­
scribed by de Duve et al. (1955)• 
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Since this initial observation a large number of acid 
hydrolases have been associated with the lysosome. The sizes 
range from 0.2// to 0,8// and they seem to be involved in 
digestion of material taken into the cell, the removal of 
intracellular material, and autolysis of dead cells. The 
varied functional aspects of these particles account for the 
polymorphism shown by the particles in different cells (de 
Robertis, E.D.P. et , I965). These structures are charac­
terized by the simultaneous release of their enzymes in a 
soluble, fully active form following injury to the membrane 
by a number of agents. Acid phosphatase activity is the usual 
marker enzyme in most cytochemical studies of the lysosome 
(de Duve, C., 1959). 
Lysosomes and viral induced cytopathology 
Allison and Sandelin (1963) were the first to study lyso­
somes in virus-infected cells. They measured the activity of 
5 lysosomal enzymes in lysosomal and supernatant fractions of 
mouse liver and monkey kidney cells infected with mouse hepa­
titis virus and vaccinia virus, respectively. There was a 
release of these enzymes into the supernatant fraction of 
infected cells while no release occurred in uninfected cells. 
They further suggested that release of the lysosomal enzyme 
may contribute to the cytopathic effect caused by these viruses. 
Allison and Mallucci (I965). using a histochemical tech­
nique for acid phosphatase and esterase activity, found that 
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infection of cells with 5 cytopathogenlc viruses; Influenza A, 
NDV, mouse hepatitis. Adenovirus type 5» and vaccinia; caused 
activation and release of lysosomal enzymes. They described 
3 stages of activation. The first was a reversible stage 
characterized by increased permeability of the lysosomal 
membrane without release of enzymes. In the second stage, 
which was irreversible, there was release of lysosomal enzymes 
into the cytoplasm. In the third stage, not usually seen in 
cell cultures, the lysosomal enzymes were no longer detectable, 
either being released from or inactivated in the cells. They 
postulated that the lysosomal enzymes could be responsible 
for cytopathic effects, polykaryocytosis, and malignant cell 
transformation. An 3^  vivo study reported by Allison and 
Sandelln (19^ 3) demonstrated an Increased acid phosphatase 
activity in liver foci Infected with mouse hepatitis virus. 
This enzyme alteration preceded the appearance of histologically 
demonstrable liver cell degeneration. Mallucci and Allison 
(1965) then compared a noncytopathogenlc virus, the MEL strain 
of influenza A, with a cytopathogenlc virus, fowl plague, and 
found no lysosomal enzyme release with MEL strain virus and 
a release of these enzymes within 6 hours of infection with 
fowl plague virus. 
Beeuwkes (1964), using histochemical methods, studied the 
distribution of a number of enzymes in virus infected monkey 
kidney cells. The viruses used were poliovlrus type 1, ECHO 
4 and 9, and Coxsackie B3. One of the enzymes he chose was 
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acid phosphatase, a lysosomal enzyme. He was unable to detect 
any differences between the acid phosphatase activity of 
infected and uninfected cells with any of the viruses. Wolff 
and Bubel (1964), using poliovirus type 1, vesicular stomati­
tis virus (VSV) and vaccinia virus found that poliovirus type 
1 infection produced a release of lysosomal enzymes while the 
other two cytopathogenie viruses did not. They suggested that 
lysosomal enzymes were not released in response to all the 
types of cytopathogenic virus infections. Flanagan (I966) 
supported these findings using KB cells infected with polio­
virus and herpes simplex virus. He found that 5 hydrolytic 
lysosomal enzymes were released 6 hours after poliovirus infec­
tion but no such release was observed with herpes simplex 
virus. McAuslan (1965) studied the deoxyribonuclease (DNAase) 
activity in herpesvirus, adenovirus type 2, and vaccinia 
virus infected cells. In the case of the first 2 viruses, no 
increase of acid DNAase was seen but there was an increase of 
this enzyme in vaccinia infected cells. The increase in acid 
DNAase could be prevented by inhibiting protein synthesis with 
puromycin and actinomycin D, indicating that this increase 
was due to release of existing acid DNAase. 
Lysosomes with relation to viral penetration and uncoating 
Joklik (1964) and Dales and Kajioka (1964) studied, by 
electron microscopy, the penetration and uncoating of vaccinia 
virus by cells. They both found that the virus was taken into 
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phagocytic vacuoles after initial attachment and there the 
virus was reduced to viral cores by removal of its viral 
phospholipid and protein coat. This was followed by a rapid 
transfer of the viral core to the cytoplasmic matrix where 
there was release of the naked viral DNA. Joklik (1964) 
found that in the second stage release of naked viral DNA 
could be prevented by inhibiting cellular protein synthesis. 
This indicates that new enzymes are probably induced by some 
viral protein to perform this task. Both groups of investiga­
tors found acid phosphatase activity associated with the virus 
containing phagocytic vacuoles. Dales and Kajioka (1964) 
felt that lysosomal enzymes were not involved in the active 
uncoating of virus but might perhaps be responsible for the 
slow degradation of heat inactivated virus and virus neutral­
ized with antibody. These inactivated particles were shown 
to be phagocytosed but not uncoated normally. 
Dales and Gomatos (1965) showed that reovirus uncoating 
differed from that of vaccinia virus. After the virus became 
incorporated into the phagocytic vacuole it then became packed 
into dense, membrane bound inclusions, possibly lysosomes, 
where they were digested and the RNA probably freed into the 
cytoplasmic matrix. They felt that in the case of reovirus, 
with its RNAase resistant double stranded RNA, the proteolytic 
enzymes of the lysosome might play a role in the uncoating 
process. 
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Mallucci (1966) treated mouse macrophage cultures with 
chloroquine, a stabilizer of lysosomal membranes, and found 
that these cells produced a much lower yield of mouse hepati­
tis virus than untreated cells. He felt that variations in 
enzymes escaping from the lysosomes were responsible for 
differences in virus uncoating and consequent virus yield. 
David-Ferreira and Manaker (19^ 5) reported that mouse hepati­
tis virus, after being phagocytosed, was observed in dense 
bodies thought to be lysosomes. These findings were similar 
to those reported for vaccinia virus (Dales and Kajioka, 1964). 
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MATERIALS AND METHODS 
Viruses 
Infectious "bronchitis virus 
The Beaudette chicken embryo-adapted strain of IBV was 
used in this study and was kindly supplied by Dr. C. H. 
Cunningham.^  After receipt of this virus it was serially 
passed 33 times in chicken embryo kidney (CEK) cells. This 
33rd passage was frozen and maintained at -60°^  and was used 
as stock virus throughout the study. Under the usual condi­
tions of virus titration in CEK cells, this stock contained 
approximately 10^ '^  plaque-forming units (FPU)/ml. 
Newcastle disease virus 
The B-1 strain of NDV was kindly supplied by Dr. W. A. 
3 Boney. The virus was then serially passed in CEK cells and 
the 3rd passage used as stock for the entire study. The virus 
stock was maintained at -60° and under the usual condition 
of virus titration in CEK cells contained approximately 10^ *® 
PFU/ml. 
D^r. C. H. Cunningham, Michigan State University, East 
Lansing, Michigan. 
2 All temperatures will be in degrees centigrade. 
D^r. W. A. Boney, National Animal Disease Laboratory, 
Ames, Iowa. 
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Cell Culture Media and Solutions 
Cultural medium 
Medium 199 was used for the growth and maintenance of 
cell cultures used in this study. The complete growth medium 
was prepared by combining the following to make 1 liter of 
medium. 
Medium 199^  800 ml 
2 
Tryptose phosphate broth (TPB) 100 ml 
Calf serum 80 ml 
2.8^  NaHCO^  20 ml 
Serum-free maintenance medium was prepared by substituting an 
additional amount of Medium 199 in place of the calf serum. 
All media contained 100 units penicillin G potassium, 100 j^ ig 
3 dihydrostreptomycin, and 50 units Mycostatin per ml. 
Phosphate buffered saline (PBS) 
The following solutions were combined to prepare PBS: 
Solution A: NaCl l6.0 gm 
KCl 0.4 gm 
NagHPO^  
Distilled water 
2.3 gm 
0.4 gm 
1500 ml 
M^edium 199. Hyland Laboratories, Los Angeles, California. 
p 
Tryptose Phosphate Broth, Difco Laboratories, Detroit, 
Michigan. 
A^ntibiotics, E. H. Squibb & Sons, New York, N. Y 
23 
Solution B; MgCl'ôH^ O 0.2 gm 
Distilled water 250 ml 
Solution C; CaCl^  0.2 gm 
Distilled water 250 ml 
All chemicals used were analytical reagent grade. After the 
three solutions were made up they were combined and sterilized 
by filtration through a Millipore^  filter pad with a pore size 
of 0.33 >"• The sterilized PBS was distributed into 1 liter 
volumes and stored at 4°. The final pH of this solution was 
7.4 to 7.5. 
Trypsin 
A 0.25^  trypsin solution used for dispersing cells was 
2 prepared by dissolving 2.5 gm of I-3OO trypsin in 1 liter of 
PBS without Ca and Mg. This solution was filter sterilized 
with a 0.33 // Millipore filter pad. 
Agar-overlay medium 
Agar-overlay medium for plaque assays was prepared as 
follows ; 
2.% agar^  in distilled water 100 ml 
2 X concentrated medium 199 100 ml 
M^illipore Filter Corporation, Bedford, Massachusetts. 
p 
I-3OO trypsin, Nutrition Biochemical Corp., Cleveland, 
Ohio. 
l^onagar No. 2, Consolidated Laboratories, Inc., Chicago 
Heights, Illinois. 
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Tryptose Phosphate Broth (TPB) 30 ml 
2.8# NaHCO^  5.2 ml 
Calf serum 6 ml 
The Medium 199» TPB, NaHGO^ , and serum were mixed and put into 
a 43° water bath. The agar was melted at 100° and then put 
into the 43° water bath. When both solutions had equilibrated 
to 43°, they were mixed and the medium was ready to be dis­
tributed onto the cell culture monolayers. 
Preparation of Cell Cultures 
Chicken embryo kidney (CEK) cell cultures 
Monolayers of CEK cells were prepared from the kidneys of 
l8-day-old chicken embryos. The kidneys were minced and washed 
in PBS. The cells were dispersed with trypsin with trypsiniza-
tion being carried out at ambient temperature for a period of 
60 minutes. Approximately 3 to 4 ml of trypsin were used per 
pair of kidneys. A sterile Teflon-covered magnetic bar and 
magnetic stirrer were used to agitate the tissue-trypsin mixture 
for facilitation of the digestive process. Cells were washed 
free of trypsin by centrifuging at 224 x g at ambient tempera­
ture for 3 to 5 minutes then decanting and resuspending the 
cells in PBS. After 2 cycles of centrifugation with PBS, the 
supernatant fluid was decanted and the packed cells resuspended 
in cultural growth medium. A ratio of 1 ml of packed cells to 
250 ml of medium was used for implanting cultures. Five ml 
of the cell suspension was implanted on 60 x~15 mm plastic 
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tissue culture dishes,^  The cultures were incubated at 37° in 
an atmosphere of 3^  CO2 and air at 85^  relative humidity. 
After hours, the cell sheets were to 100^  confluent and 
were ready for use. If the cell cultures were not used at 
24 hours, they could be held at 4° for as long as 24 hours. 
This prevented cultures from getting overly dense and fibro­
blastic in appearance. Three to 4 hours before the use of 
refrigerated cultures they were returned to the usual 37° 
incubation. All cultures were routinely washed once or twice 
with PBS to remove unattached cells and cell debris before 
being used. Upon microscopic examination, the CEK cultures 
contained many islands of cuboidal epithelial-like cells sur­
rounded by sworls of spindle-shaped fibroblastic cells. 
Chi cken embryo liver (CBLi) cell cultures 
Monolayers of CELi cells were prepared using either 15-
or 16-day-old embryos. The cultures were prepared and handled 
the same as CEK cultures except they were implanted at a ratio 
of 1 ml of packed cells to 200 ml growth medium. At 24 hours 
the cell sheets were 80% to 100^  confluent and were ready for 
use. Microscopic examination of CELi cultures revealed hexag­
onal cells which resembled liver parenchymal cells, while few 
fibroblastic cells were in evidence. Cultures of CELi cells 
F^alcon Plastics, 5500 West 83rd Street, Los Angeles, 
California. 
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could be used either at 24 or 48 hours without loss of epi­
thelial appearance or growth of fibroblastic cells. 
Whole embryo chlcken embryo fibroblast (MCEFi) cell cultures 
Cultures of GEFi cells were prepared using 9-day-old 
embryos. The embryos were decapitated and the appendages 
removed. The remainder of the embryo was minced, trypsinized, 
and washed similar to the CEK cells. The cultures were im­
planted at a ratio of 1 ml packed cells to 300 ml growth medium. 
At 24 hours these cultures were 100^  confluent and ready for 
use. These cultures contained predominantly spindle-shape 
fibroblastic cells with many small islands of epithelial cells 
throughout the culture. For some of the experiments the above 
procedure was modified by removing the abdominal viscera from 
the embryos. The resulting cultures contained practically none 
of the islands of epithelial cells and were almost entirely 
of the spindle-shaped fibroblastic type cells. These culture 
types will be referred to as chicken embryo fibroblast (CEFi) 
cells. 
PK-15 swine kidney cell line^  
This cell line was grown and maintained in medium 199 
p 
with 0.15 gm of L-glutamine /liter added just before use. 
S^upplied by hog cholera project, NADL, Ames, Iowa. 
2 L-glutamine, Difco Laboratories, Detroit, Michigan. 
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The medium for growth contained S% calf serum. Cells were 
serially passed in 250 ml plastic tissue culture bottles.^  
Trypsin (0.25^ ) was used to disperse the cells and the cells 
from 1 bottle were implanted into 5 bottles for routine pas­
sage. For use in experiments cells from 1 bottle were implant­
ed onto 10 of the usual 60 x 15 mm plastic tissue culture dishes. 
Cultures were usually confluent and ready for use in 3 days. 
Plaque assays 
Virus was routinely diluted in serum-free maintenance 
medium 199. Monolayers of CEK cells were inoculated with 
0.5 ml of the selected dilutions of IBV, unless otherwise 
stated. The temperature and time allowed for attachment will 
be described with each experimental procedure. After the 
attachment period the inoculum was removed and the monolayers 
overlayed with 5 ml of the agar medium. The plates were incu­
bated under the usual temperature and atmospheric conditions. 
At 44 to 48 hours postinoculâtion the plates were removed and 
stained with a solution of neutral red (0.01^  neutral red in 
O.15M NaCl) by allowing the stain to diffuse through the agar 
for 3 to 4 hours and then removing the stain solution. The 
plaques were then readily visible and could be easily counted. 
NDV plaques were enumerated at 72 hours. 
F^alcon Plastics, Los Angeles, California. 
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Preparation of Fluorescent Antibody 
Anti-IBV serum 
Five 11-day-old chickens were exposed to an aerosol of 
0.5 ml of Massachusetts strain^  of IBV with a DeVilbiss No. 
40 nebulizer. Three weeks following recovery from signs of 
infectious bronchitis, the chickens were given 1.0 ml IV injec­
tions of virus each week for 4 weeks. The virus suspension 
used contained approximately 10^ '^  chicken embryo infecting 
doses per ml. Two weeks following the last injection the 
birds were exsanguinated. The whole blood was allowed to 
clot in petri dishes and the serum collected. The serum was 
clarified by centrifugation for 30 minutes at l400 x g and 
stored at -20° until used. 
Serum fractionation 
Globulins were obtained from the hyperimmune chicken 
serum by dropwise addition of 1 volume of a saturated solu­
tion of ammonium sulfate at room temperature to 2 volumes of 
the serum at 4°. The serum was kept in an ice bath and con­
stantly agitated with a magnetic stirrer during the addition 
of the ammonium sulfate. Globulins were then sedimented by 
centrifugation for 15 minutes at 2000 x g. The supernatant 
fluid was carefully decanted from the sedimented globulins and 
O^btained from Dr. C. H. Cunningham, Michigan State 
University, East Lansing, Michigan. 
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the precipitate restored to the original serum volume "by 
adding cold 0.85^  NaCl solution. 
This fractionation procedure was repeated two additional 
times but on the last time the precipitate was only restored 
to 1/2 the original serum volume. The redissolved globulins 
were then freed of residual ammonium sulfate by dialysis 
against 0.85^  NaCl (100 volumes saline/volume globulin solu­
tion). Dialysis tubing^ , average pore diameter of 4.8 m//, was 
used for the dialyzing process. To increase agitation of the 
fluid outside the dialysis tubing, a magnetic stirrer was 
used. The sample was dialyzed for 24 hours at 4°C during 
which time the saline was changed three times. Insoluble 
material present in the globulin solution after the dialysis 
was removed by centrifugation for 15 minutes at 2000 x g. 
Protein determination 
The concentration of protein contained in the globulin 
fraction was determined by the biuret spectrophotometric method 
(Gornall et , 19^ 9) at a wavelength of 540 mju utilizing a 
p 
B&L Spectronic 20 spectrophotometer. Two ml of a 1:2 and 
1:4 dilution of the globulin solution in 0.85^  NaCl was mixed 
with 8 ml of the biuret reagent and incubated for 30 minutes 
at ambient temperature before determining the optical density. 
V^isking Company. 
p 
Bausch and Lomb, Incorporated, Rochester, New York. 
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A blank was prepared with 2 ml 0,85^  NaCl and 8 ml of the 
biuret reagent. The optical density of the unknown was 
compared to that of known quantities of purified bovine albu­
min^  for which a standard curve had previously been determined. 
Conjugation of globulins 
The protein concentration of the globulin solution was 
adjusted to 10 mg/ml by dilution with O.QS% NaCl. A carbonate-
bicarbonate buffer, pH 9, was made up by adding 4.4 ml of a 
solution of NagCO^  (5-3 gm/lOO ml water) to 100 ml of a solu­
tion of NaHCO^  (4.2 gm/lOO ml water). The pH was checked on 
a meter and it was sometimes necessary to add some additional 
Na2C0^  solution to arrive at the proper pH. Twenty-five 
thousandths mg of fluorescein isothiocyanate isomer B (FITC) 
mg of protein was dissolved in a sufficient volume of the 
carbonate-bicarbonate buffer to comprise 10% of the combined 
volume of the reactants. The FITC solution was slowly added 
to the globulin solution and the mixture allowed to react for 
16-20 hours while being constantly stirred at 4° using a mag­
netic stirrer (Cherry et al., I960). 
Gel filtration of conjugated globulin 
Separation of free FITC from the FITC-globulin complex 
was accomplished by gravity passage of the mixture through a 
A^rmour Pharmaceutical Co., Kauikakee, Illinois 
p 
Baltimore Biological Laboratory, Baltimore, Maryland 
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Sephadex gel^  column. The Sephadex (G-25, coarse) was washed 
with PBS and maintained as a stock preparation 1:4 in PBS. A 
column was poured measuring 2 by 20 cm and was used for the 
separation of 25-30 ml volumes of the conjugated globulin 
solution. After the gel had settled in the column, the fluid 
level was adjusted to the top surface of the column and the 
sample carefully added. When the last of the sample entered 
the gel, more PBS was carefully added to the column in a suf­
ficient volume to elute the FITC-globulin complex. The uncon­
jugated FITC was left in the upper portion of the column. 
Progress of the conjugated globulin through was readily follow­
ed by its yellow-brown color. 
Adsorption of FITC conjugated globulin 
Portions of the FITC conjugated antibody preparation 
responsible for nonspecific staining were essentially removed 
by adsorption with 20-30 mg of rabbit liver powder (RLP) /mg 
of protein. A slurry of the liver powder in PBS was prepared 
by adding 2.$ ml PBS for each gm of RLP. This allowed for 
hydration of the RLP, thus preventing a marked reduction in 
the volume of the conjugated antibody. The adsorption was 
performed for 16-20 hours at 4° with constant stirring with a 
magnetic stirrer. The bulk of the RLP was removed from the 
conjugated antibody solution by centrifugation at 2,000 x g 
P^harmacia, Ltd., Uppsala, Sweden. 
K^indly supplied by Dr. W. L. Mengeling, NADL, Ames, Iowa. 
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for 30 minutes. The remaining RLP was sedimented by centri-
fugation at 78,000 x g for 1 hour using a #30 rotor in a Spinco 
Model L ultracentrifuge.1 After clarification, the fluorescent 
antibody solution was distributed into 1 dram screw-cap vials 
in aliquots of 0.5 ml. These were stored at -20° until needed. 
These aliquots were diluted 1:4 with PBS before use without 
loss of intensity of bright specific staining. 
Staining and examination of cell cultures 
For fluorescent antibody studies and other histochemical 
techniques, coverslips were added to the petri dishes before 
implanting the cells. At prescribed times following infection 
of the cultures with virus, the cells on coverslips were 
removed and rinsed in PBS. The cells were then fixed in acetone 
at ambient temperature for 3 to 5 minutes. After fixation, 
the coverslips were air dried and then stained with fluorescent 
antibody. The cells were kept in a humidity chamber at 37° 
for 30-^ 5 minutes while staining. They were then washed in 
running water, dried, and mounted in PBS-glycerine (1:1) on a 
microscope slide. The cells were examined for specific fluores-
2 cence using a Leitz ortholux microscope equipped with a dark-
field condenser, BG-12 primary filter, OG-1 barrier filter and 
illuminated by an Osram HBO-200 mercury vapor burner. 
B^eckman Instruments, Inc., Spinco Division, Palo Alto, 
California. 
2 E. Leitz, 468 Park Avenue South, New York, New York. 
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Attachment of IBV to Cell Monolayers 
Effect of temperature, time and pH on attachment 
Since two previous studies had shown maximum attachment 
was achieved in 90 minutes at both ambient temperature and 37° 
(Cunningham and Spring, 1965; Lukert, 1965)» it was felt that 
the effect of temperature on IBV attachment should be examined 
more carefully. 
To determine the effect of temperature on attachment, a 
simple experiment was performed in which 2 dilutions of the 
virus were adsorbed onto monolayers at 3 different tempera-
tuies, i.e., 4°, ambient, and 37°. Triplicate counts were 
made for each temperature and dilution. Each plate was inoc­
ulated with 0.5 ml of either a 10"^ *^  or 10"^  dilution of 
virus and a 90-ffilnute attachment period was allowed. This 
experiment was repeated with the exception that the 4° attach­
ment temperature was omitted and 5 replicate plates instead 
of 3 were inoculated for each temperature. 
Since both previous reports had limited their longest 
attachment period to 2 hours, 2 experiments were conducted 
using extended periods of attachment up to 4 hours. In the 
first experiment 24 plates were inoculated with 0.5 ml of a 
10-5'6 (dilution of virus and allowed to attach at 37°. At 
30-minute intervals 3 plates were removed from the Incubator, 
the inoculum removed, and then overlayed with agar medium. 
This experiment was repeated using 5 plates per time interval 
rather than 3» 
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The possibility that pH as well as temperature might 
influence the attachment of virus was considered. The mainte­
nance medium 199 used as virus diluent having a carbonate-
bicarbonate buffer increases in pH when standing at ambient 
temperature due to loss of GOg to the air. Conversely, the 
pH decreases when the cell-virus attachment was allowed to 
progress at 37° in an atmosphere of 3*0/^  CO2 and air. A phos­
phate buffer and a glycine buffer were made up at pH 6, 7» 8, 
and 9 and used as diluent for the virus. These buffers were 
not influenced greatly by the either addition or loss of COg. 
Standard phosphate buffers were made by first preparing 
stock solutions of M/15 NagHPO^  and M/15 NaHgPO^ . The pH 6 
buffer was made by adding 1 part NagHPO^  to 9 parts NaHgPO/^  
and the pH was checked with a meter. Minor pH adjustments were 
made by addition of either of the appropriate stock solutions. 
For pH's 7. 8, and 9, the ratio of NagHPO^  to NaH^ PO^  was 6:4, 
9.5:0.5. and 9.9:0.1, respectively. 
Sorensen's glycine buffers were miade by first preparing 
a stock solution containing 7-505 gm glycine and 5.85 gm NaCl 
per liter of distilled water. The pH of this stock solution 
was adjusted by the addition of either O.IN HCl or O.IN NaOH 
and the pH determined on a meter. Solutions of the glycine 
buffer were made at pH*s 6, 7. 8 and 9» 
The effect of pH on IBV attachment was determined by 
placing 0.5 ml of a 10~-5 dilution of virus in each buffer at 
pH's 6, 7. 8, and 9 onto 4 replicate GEK cell cultures. A 
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90-minute attachment at 37° was allowed, the inoculxim removed 
and the cells overlayed with agar medium. 
Efficiency of virus attachment 
Since the previous studies on IBV attachment had dis­
regarded unattached virus remaining in the inoculum, experi­
ments were designed to assay for this unattached virus. A 
preliminary esqperiment showed that a great deal of infective 
virus remained unattached after 90 minutes. A series of exper­
iments were designed to determine the efficiency of IBV 
attachment by performing successive 90-minute attachments on 
monolayers. In the first 2 experiments 4 successive 90-
minute attachment periods were carried out in the following 
manner; 
1. Two sets of plates were inoculated, one with O.5 ml 
of a 10"^  and the other with 0.5 ml of a 10"^  dilution of 
stock virus. The virus was allowed to attach to the cells 
for 90 minutes at ambient temperature. 
2. The inocula from each set of plates were removed and 
pooled separately. A sample from each pool was retained at 
4° while the remainder was reinoculated, in 0.5 ml amounts, 
onto another set of plates and a second attachment period of 
90 minutes at ambient temperature was allowed. 
3. After 3 additional cycles of attachment, those samples 
that had been retained from each successive attachment period 
were assayed. 
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The second series of experiments were conducted in a 
manner similar to the first with the exception that only 3 
successive attachment periods were accomplished. In these 
experiments, successive attachment was compared at 3 tempera­
tures, at 37°, ambient, and 4°. A 10~^ *^  dilution of the 
virus was used as inoculum in the first experiment and a 10"^  
dilution used in the second. As a control to determine the 
degree of inactivation of unattached virus at 37°. the follow­
ing experiment was run. Five plates without cells were inoc­
ulated with 0.5 ml of a 10"-^  dilution of virus and held at 
37° for 4.5 hours, which is equivalent to the time involved 
in 3 successive attachment periods. The inocula were then 
removed and assayed for surviving virus. Similarly, virus 
held at 4° for 4.5 hours was assayed. 
Comparison of virus attachment to different cell types 
The following experiment was designed to determine if 
one of the reasons for the differences in sensitivity observed 
with various cell types might be attributed to differences in 
virus attachment. Five cell types were chosen for this study. 
Four cell types were derived from chicken embryo, and were, 
in order of their sensitivity, the CEK, CELi, WCEFi, and CEFi 
cell types. The fifth cell type was a nonsusceptible cell 
type, the PK-15 cell line. Three successive 90-minute attach­
ment periods were conducted at 37° with each of these cell 
types. The dilution of the stock virus was 10"^  and samples 
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from each successive attachment period were inoculated onto 
either 3 or 4 CEK cell cultures to determine the amount of 
unattached virus. This experiment was repeated 2 times. 
Attachment interference 
From the results of the previous experiments, the attach­
ment of IBV appears to cease after 90 minutes while a large 
amount of infective virus remains unattached. A series of 
experiments were run to determine if either some mechanism 
of interference was present or was being established in cell 
cultures that would limit further viral attachment. The 
first series of experiments was conducted to determine how 
efficiently a superinfecting dose of virus would attach to 
monolayer and they were conducted as follows : 
1. Monolayers of CEK cells were infected with an appro­
priate dilution of the stock virus and a 90-minute attachment 
period allowed. 
2. The inoculum was removed, the plates washed once with 
PBS, and half of them were reinoculated with the same dilution 
of virus while the other half were covered with 0.5 Jïû. of 
diluent. 
3. After a second 90-minute attachment period, the inoc­
ulum was removed and the plates overlayed with agar medium. 
In one series of experiments, the attachment period was 
carried out at ambient temperature and in the other series at 
37°. 
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The results of the above series of experiments indicated 
that there was an interference present at 90 minutes which 
limited attachment of a superinfecting dose of virus. To 
determine at what time this interference became evident, a 
series of experiments were designed as follows; 
1. CEK cultures were inoculated with approximately 50 
FPU's of IBV. 
2. At prescribed time intervals the inoculum was removed 
from 8 of the plates and washed once with PBS. Half of the 
plates were inoculated with a second dose of virus, equal 
to the first, while the other half received only diluent. A 
second period of time, equivalent to the first, was allowed 
after which the inoculum was removed and the plates overlayed 
with agar. 
3. The time at which interference begins should then be 
reflected by the prescribed time intervals beyond which plaque 
numbers in the dually exposed cultures failed to be twice 
those of the singly exposed cultures. 
In some experiments these prescribed time intervals were 
15 minutes while in others they were 30 minutes. This type 
of experiment was conducted at both ambient temperature and 37°. 
Ability of ultraviolet-irradiated virus to produce attachment 
interference 
Ultraviolet (UV) inactivated IBV was used in an attempt 
to establish attachment interference. The virus was irradiated 
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by first placing 1 ml of undiluted stock virus in a 60xl5 mm 
plastic petri dish and exposing it to UV irradiation from a 
G15T8 Sylvania germicidal lamp at a distance of 30 mm. A 
preliminary experiment had shown that a 15-second exposure 
inactivated the virus completely. Since complete inactiva-
tion was not desired in this experiment, 1 ml of virus was 
irradiated for 5 seconds and another for 10 seconds. A 0.5 
ml aliquot of each was diluted 1:10 and 0,5 ml inoculated onto 
5 CEK cell cultures while control cultures were inoculated 
with 0.5 ml of diluent. After 90 minutes at 37° the cultures 
were washed once with PBS, inoculated with 0.5 ml of a 10"-^ *^  
dilution of stock virus and were allowed to attach for 90 
minutes at 37°. The remainder of the undiluted and 1:10 
diluted UV-treated virus was assayed to determine the amount 
of virus surviving irradiation. 
Ability of NDV to establish IBV attachment interference 
An experiment designed to determine if NDV could interfere 
with IBV attachment or if IBV could interfere with NDV attach­
ment was conducted as follows. One set of 6 CEK monolayers 
were inoculated with approximately 50 FPU's of NDV and a simi­
lar set with approximately 50 FPU's of IBV. After a 90-
minute attachment period at 37°f the inocula were removed and 
the plates washed once with PBS. Two plates from each set 
received 0.5 ml of diluent alone, while the other 4 plates 
from each set were then reinoculated with doses of heterologous 
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virus that were similar to the first dose, i.e., plates in­
fected initially with IBV were reinfected with NDV and vice 
versa. This experiment was repeated a second time to confirm 
the results and since IBV and NDV plaques are readily distin­
guishable, the number of each was separately determined in 
the dually infected cultures. 
Thiol Inhibitors of IBV Attachment 
Substances inhibitory to IBV attachment were studied and 
evaluated by their incorporation into the virus diluent and 
allowing the virus to attach in the presence of the inhibitor. 
The degree of attachment in the presence of inhibitor was 
compared to a control in which virus was allowed to attach 
with no inhibitor present. 
Before a study of substances that might interfere with 
virus attachment could be evaluated, it was necessary to 
establish the normal variation in average plaque counts which 
might be expected. 
Normal variation In average plaque counts 
These experiments were designed to coa^ are the normal 
variation encountered in a number of equivalent dilutions of 
virus made with varying volumes of virus and diluent. In an 
initial trial, 4 separate 10"-^  dilutions of virus were prepared 
in the following manner: 
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1. First a stock 10"^  dilution of virus was prepared. 
— 5 2. Four separate 10 dilutions were made, 3 by adding 
0.5 ml of the 10~^  dilution to 4.5 ml of diluent and the other 
by adding 2.0 ml of the 10"^  dilution to 18 ml of diluent. 
3. Each 10"^  dilution was assayed on 10 CEK cell cultures 
after an attachment period of 90 minutes at ambient temperature. 
A second experiment, using the same procedures as just 
described, was performed except 8 separate 10"-^  dilutions were 
prepared as follows: 1 with 5 ml virus;45 ml diluent, 4 with 
2 ml virus:18 ml diluent, and 3 with 0.5 ml virus:4.5 ml 
diluent. Seven replicate counts were made on each of the 8 
dilutions of virus. 
1 2 Thiols and sulfhydryl (SH) reagents and their effect on 
IBV attachment 
The work of Powers (1965) which demonstrated that IBV 
was inactivated by PHMB suggests that SH groups are possibly 
involved in the attachment of IBV virus to host cells. To 
investigate this possibility, experiments were conducted using 
thiols and various SH reagents to find what effect they might 
have on IBV attachment. 
C^ompounds containing sulfhydryl groups will be designated 
as thiols. 
2 A substance which can react with sulfhydryl groups will 
be designated as a sulfhydryl reagent. 
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The following group of experiments were conducted using 
the thiol, L-cysteine.^  In these experiments L-cysteine was 
dissolved in the maintenance medium 199 used as virus diluent 
and the virus was allowed to attach in the presence of various 
molarities of L-cysteine. A typical example of an experiment 
to determine the effect of L-cysteine on virus attachment would 
be as follows : 
1. A fresh stock solution of O.IM L-cysteine in virus 
diluent was made before each experiment. 
2. Subsequent dilutions of the L-cysteine were made in 
the diluent until the desired concentrations was reached. The 
pH was adjusted to 7.2 with .IN NaOH when required. 
3. The virus was then diluted to approximately 100 
PFU/0.5 ml either in L-cysteine or diluent alone. Monolayers 
of GEK cells were inoculated with 0.^  ml of virus and the 
difference between plaque counts in the presence and absence 
of L-cysteine were compared. 
4. Viral attachment to the monolayers was carried out 
at 37° for 90 minutes in all experiments with thiols and SH 
reagent s. 
In the first trial to determine the effect of L-cysteine 
on IBV attachment approximately 100 PFU were inoculated onto 
2 2 ? 
each plate in the presence of concentrations of 10" , 10" 
L^-cysteine, Calbiochem, Los Angeles, California. 
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10""^ , 10"^ *^ , and 10""^ M L-cysteine. Five plates were inoc­
ulated per concentration of L-cysteine and the plaque counts 
compared to 8 control plates inoculated without L-cysteine in 
the diluent. A second trial using L-cysteine concentrations 
of 10" , lO"-', and 10" was done using 5 plates for each con­
centration and 5 plates for the control. 
To determine if there was a linear response of plaque 
inhibition to increasec concentration of L-cysteine the follow 
ing experiment was run. Approximately 100 PPU's of IBV were 
' adsorbed in the presence of 2-fold dilutions of L-cysteine 
ranging from 10"^  to lO"^ 'Two experiments were run using 
6 CEK monolayers per concentration in the first and 5 in the 
second. 
The effect of 3 other thiols were checked to determine 
if they had a significant effect on IBV plaque counts. Con­
centrations of 10"^ , 10-3, 10"^ , 10~-5, and 10"^ M reduced 
glutathione^ , and 10"^ , 10"^ , and 10"^ M 2-mercaptoethanol^  and 
1,4-dithiothreitol^  (Cleland's reagent) were used in these 
experiments. These solutions were prepared fresh before each 
experiment and the pH of each concentration was adjusted to 
pH 7.2 with O.IN NaOH where necessary. These experiments 
were run in the same manner as those described for studying 
R^educed glutathione and 1,4-dithiothreitol, Calbiochem, 
Los Angeles, California. 
2 2-mercaptoethanol, Eastman Organic Chemicals, Rochester, 
New York. 
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The effect of L-cysteine on IBV attachment. Replicate plaque 
counts were made on either 4 or 5 CEK monolayers per concen­
tration of thiol and compared to plaque counts on 5 thiol-
free virus control CEK monolayers. 
Since the thiols are reducing agents, it seemed necessary 
to use another non-thiol reducing agent to confirm that plaque 
inhibition was due to the SH groups and not a general property 
of reducing agents. Ascorbic acid was selected as the non-SH 
reducing agent and 100 PFU of IBV was allowed to attach to CEK 
monolayers in the presence of the ascorbic acid. A range of 
10"^ M to lO'-^ M concentration of the ascorbic acid was used 
and 3 CEK monolayers per concentration were inoculated. The 
counts were compared to a control in which attachment was 
carried out in the absence of ascorbic acid. 
To show that cysteine was interfering with attachment and 
not inactivating the virus or interfering with subsequent 
replication of virus, 2 experiments were conducted. 
The first experiment was designed to demonstrate whether 
virus is inactivated by cysteine and was conducted as follows. 
Three ^ -ml sanQjles of IBV containing approximately 100 FPU's/ 
0.5 ml were prepared, one containing no cysteine and the other 
2 containing .OOIM cysteine. One of the cysteine-containing 
samples and the sample containing no cysteine were dialyzed 
against one liter of medium 199 overnight at 4° with constant 
agitation. The third sample, containing cysteine, was held at 
4° overnight. The number of plaques per 0.5 ml of inoculum 
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was then determined as previously described and 5 plates per 
sample were used. This experiment was repeated a second time 
except 4 replicate plates per sample were used rather than 5* 
The second experiment was conducted to demonstrate whether 
more virus remained unattached to cells in the presence of 
cysteine than in its absence. A 10" dilution of stock virus 
was made in 10~^ M cysteine and another similar dilution in 
the absence of cysteine. Five plates were inoculated with 
0.5 ^  each of the cysteine containing virus dilution and 5 
plates with 0.5 ml of virus dilution without cysteine. A 
90-minute attachment period at 37° was allowed and then the 
inocula from each group of plates were removed and pooled 
separately. Each pool was dialyzed overnight against one 
liter of medium 199 at 4° with constant agitation. Three 
CEK monolayers were then inoculated with each pool and plaque 
counts made as previously described. This experiment was 
repeated a second time using a 10"^ *^  dilution of the virus. 
To further verify the need for active thiol groups to 
prevent IBV attachment, the oxidized products of L-cysteine 
and reduced glutathione, L-cystine^  and oxidized glutathione^ , 
were tested. Approximately 100 PFU's of IBV were allowed to 
attach to CEK monolayers in the presence of concentrations 
ranging from 10"^ M to 10*"^ M of both L-cystine and oxidized 
glutathione. Plaque counts were made on 5 CEK cultures and 
L^-cystine and oxidized glutathione, Calbiochem, Los 
Angeles, California. 
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compared to plaque counts made in the absence of the compound 
tested. 
The SH reagents studied in relation to their effect on 
X o 
IBV plaque numbers were PHMB , lodoacetamide , and HgClg. A 
O.OIM stock solution of PHMB was made by dissolving of the 
compound in pH 7.5 glycine buffer. This stock was stored at 
4° and was used throughout the study to make various concentra­
tions of PHMB. lodoacetamide and HgCl2 were made up as fresh 
O.IM solutions in medium 199 before each experiment. These 3 
reagents were incorporated into the diluent, as were the thiols, 
so that virus attachment occurred in the presence of the com­
pound and could be compared to a similar dilution of virus 
which contained no SH reagent and thus served as a control. 
The virus control contained approximately 100 PPU's per 0.5 ml. 
The concentration levels of the 3 SH reagents were varied from 
10""^ M to 10~^ M, and plaque counts performed as previously 
described using either 4 or 5 CEK monolayers per concentra­
tion of reagent. Two trials with each SH reagent were con­
ducted. 
To demonstrate whether the virus is inactivated by the 
PHMB, the following experiment was run. Three samples of IBV, 
containing approximately 100 PPU's/0.5 ml, were made; 2 con-
p^-Hydroxymercuribenzoate» Sigma Chemical Co., 3500 
DeKalb St., St. Louis, Missouri. 
l^odoacetamide, K&K Laboratories, Inc., 177-10 93rd 
Avenue, Jamaica, New York. 
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tained 10~^ M PHMB in medium 199 and 1 contained only medium 
199» One PHMB-containing sample and the non-PHMB-containing 
sample were dialyzed overnight against 1 liter of medium 199 
at 4° with constant agitation. The other PHMB-containing 
sample was held at 4° for the same period of time. After 
dialysis each sample was assayed on 4 CEK monolayers. This 
experiment was repeated a second time using 5 plates to assay 
each sample rather than 4. 
The kinetics of IBV inactivation by PHMB was determined 
using 3 concentrations of the SH reagent and the inactiva­
tion was conducted as follows : 
1. Preparations of virus-PHMB were made up containing 
approximately 10^ '^  PFU*s/ml of IBV and either 10"^ , 10"^ , 
or 10"^ M concentrations of PHMB. The 10"^ M virus-PHMB was 
made up in glycine buffer, pH 7.5* The other virus-PHMB prep­
arations were made up in medium 199* 
2. The virus-PHMB mixtures were held at ambient tempera­
ture and at 30-minute intervals a sample was removed and the 
number of virus survivors determined by the plaque method. The 
first 10-fold dilution made for the plaque titrations was made 
_3 in medium 199 containing 10 M L-cysteine in order to stop the 
action of the PHMB. Two CEK monolayers per dilution were 
inoculated. 
3. A virus control preparation without PHMB was held at 
ambient temperature and a sangle titrated at 30-minute inter­
vals. One CEK monolayer per dilution was used. 
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The Inactivation experiments employing 10~^ M con­
centrations of PHMB were repeated 3 times while those with 
— 2  10" and 10" M PHMB were performed only once. 
An experiment designed to reactivate PHMB inactivated 
virus using L-cysteine was conducted in the following manner. 
1. Four virus-PHMB mixtures containing approximately 
100 PFU*s/0.5 ^  and 10"^ M PHMB were made up and held for 1 
hour at 4°. A control virus preparation without PHMB was 
handled in the same manner. 
2, A fresh solution of .IM L-cysteine was made up and 
appropriate quantities added to 3 of the virus-PHMB mixtures 
to make .02M, .OlM, and .005M L-cysteine. The virus control 
and the remaining virus-PHMB mixture received only an equal 
quantity of virus diluent. 
3- All preparations were dlalyzed against 1 liter of 
medium 199 overnight at 4° with constant agitation to remove 
L-cysteine and free PHMB. 
4. Each preparation was then titrated on 3 CEK mono­
layers to determine the degree of virus reactivation. 
5. The experiment was repeated 2 times. 
An experiment was conducted to determine if the sensi­
tivity of cells was altered if treated with PHMB and L-
cysteine prior to inoculation with IBV monolayer of CEK cells 
were treated for 2 hours at 37° with 1 ml of either 10"^ , 10"^  
- 5  - 2 - 3  - 4  
or 10 M PHMB or 10 ,10 , or 10 M L-cysteine. The cells 
were then washed twice with PBS, Infected with approximately 
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100 FPU's of IBV", and plaque determinations made in the usual 
manner. Plaque counts were made on either 4 or 5 CEK mono­
layers per concentration of PHMB or L-cysteine. Plaque counts 
were made on 5 CEK control cultures handled in a similar 
memner with the exception that they were, not treated with 
either compound. This experiment was repeated 2 times. 
In one experiment, the effect of L-cysteine incorporated 
into the agar overlay was determined. Ten CEK monolayers 
were inoculated with approximately 100 FPU's of IBV and one-
half of them were overlayed with agar medium containing 10~^ M 
L-cysteine while the remainder served as controls. 
Since the results of the previous work show that IBV 
attachment seems to be altered by thiols and SH reagents, the 
following experiment was conducted to see what effect L-
cysteine and PHMB have on NDV attachment. The two compounds 
were tested similarly to the method used to evaluate their 
effect on IBV. Three trials with each compound were made 
using 10"^  and lO^ M^ L-cysteine and 10"^  and 10~^ M PHMB. In 
2 trials approximately 50 PFU's/0.5 ml of NDV were used in 
each concentration of compound while in the third trial about 
200 PPU's/0.5 ml were used. Dithiothreitol was tested in 
one of the trials at a concentration of 10~^ M to determine its 
effect on NDV plaque counts. Plaque counts were at 3 days 
postinoculation with NDV rather than at 2 days in the case of 
IBV. 
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Petermlnat1on of cell-associated, thiol groups 
Because of the finding that thiol groups on the cell 
membrane were apparently active in IBV attachment, it seemed 
plausible that differences in thiol activity might be discern­
ed on the membranes of the cells with different abilities to 
attach IBV. Cytochemical staining for thiol group activity' 
was done on CEK and CELi cells. Quantitative determinations 
of thiol groups were done on CEK, CELi, WCEFi, CEFi, and PK-15 
cells. 
Qualitative determination The cytochemical reagent 
chosen for staining thiol groups of the CEK and CELi cells 
was mercury orange^  [l-( ^--chloromercuriphenylazo ) -naphthol-z] 
as described by Bennett (1951). The stain was prepared by 
making a saturated solution of mercury orange in 80JÊ ethanol. 
To make this saturated solution, 0.01 gm of mercury orange 
was added to 1 liter of 80^  ethanol and allowed to dissolve 
with agitation for 48 hours. There was considerable mercury 
orange that remained undissolved in this solution but it 
settles to the bottom and the mercury orange solution can be 
decanted off just before use. The procedure for fixing and 
staining the CEK and CELi cells was as follows: 
1. Cover glasses with monolayers of either CEK or CELi 
cells were rinsed in PBS and then fixed for 5 minutes in 
acetone. 
M^ercury orange obtained from Sigma Chemical Co., 3500 
DeKalb St., St. Louis 18, Missouri. 
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2. The monolayers were then air dried, hydrated from 
absolute ethanol to Q0% ethanol and placed in the mercury 
orange for staining. The specificity of the staining was 
checked by placing some of the cells in PBS containing O.OOIM 
PHMB for 2 hours prior to staining. The PHMB blocks specific 
staining due to thiol groups. 
3. Monolayers were removed from the stain at 0.5t 1, 2 
and 3 hours. In one trial, some monolayers were stained for 5 
hours. 
4. After removal of the monolayers from the stain they 
were rinsed in 2 changes of 80^  ethanol and dehydrated through 
95^  and absolute ethanol. They were then cleared in xylene 
and mounted on slides in Permount^ )^ 
5. After drying, the cells of the monolayer were exam­
ined for the intensity of staining and for specificity by 
comparing them with PHMB blocked cells. 
Quantitative determination The quantitative method 
used for determining thiol group activity was the method of 
Ellman (1959) employing the reagent 5. 5'-dlthiobi8(2-nitro-
2 benzoic acid) (DTNB) which reacts with thiol groups causing 
yellow color to develop. The intensity of this color reaction 
P^ermount^ ®^  obtained from Fisher Scientific Co., 
Pairlawn, New Jersey. 
2 
DTNB obtained from Aldrich Chemical Co., Inc., 
Milwaukee, Wisconsin. 
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can be measured by absorbance in a spectrophotometer^  at 
4l2 mjjt. The molar concentration of thiol groups can then be 
calculated by the formula: 
where C = molar concentration 
A = absorbance at 4l2 mu 
 ^= extinction coefficient 
= 13,600/M/cm 
D = dilution 
The general procedure for the quantitation was as 
follows : 
1. The DTNB reagent was prepared by dissolving 39.6 mg 
of DTNB in 10 ml phosphate buffer (pH 7.0). 
2. The determination of the thiol groups in an unknown 
cell preparation was made by mixing; 
Unknown cell preparation 3 ml 
Phosphate buffer, pH 8.0 2 ml 
Distilled water 5 ml 
DTNB reagent 0.070 ml 
3. The color was allowed to develop for 2 hours and 
absorbance at 4l2 m>k determined spectrophotometrically. 
Two methods of cell preparation were utilized for meas­
uring thiol group activity of the various cell culture types. 
A^ll spectrophotometrie determinations were performed on 
a B & L Spectronic 20, Bausch & Lomb, Inc., Rochester, New 
York. 
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The first method involved rupturing the cells and measuring 
thiol activity of a sedimented portion and a nonsedimented 
portion. The thiol group activity of CEK and GELi cells in 
culture were compared in this manner. The second method in­
volved the incubation of intact cells with the DTNB reagent 
in physiological saline and following the development of the 
color reaction in the different cell culture types. The 
theory behind this second procedure was that the early color 
reaction that developed should represent the activity of sur­
face thiol groups and any later color development should in­
dicate reactions of the DTNB with thiol groups within the 
cell as the permeability of the cell membrane was altered. 
The thiol activity of CEK, GELi, WGEPi, GEFi, and PK-15 cell 
cultures were studied and compared in this manner. 
The procedure followed for the first method was as fol­
lows : 
1. Gells from a number of CEK and CELi cultures were 
scraped from the surface of the culture vessel with a rubber 
policeman and pooled separately. The cells were sedimented 
at 322 X g for 5 minutes, resuspended in 10 ml of distilled 
water and allowed to lyse overnight (16-22 hours) at ambient 
temperature. The approximate number of cells/culture were 
determined by trypsinizing two cultures and counting the 
number of cells in a hemocytometer. 
2. The lysed preparation was then centrifuged at 
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l400 X g for 10 minutes and the lysate decanted. The pellet 
was then resuspended in 3 ml of distilled water. 
3. The thiol activity of both the lysate and pellet 
were determined as described in the general procedure and 
g 
the molar concentration of thiol groups/10 cells determined. 
After the color had developed the preparations were routinely 
classified by passing them through a 0.33/*Millipore filter. 
Two trials were made with the above procedure. In the 
first trial, cells from 20 CEK and 30 CELi cell cultures were 
used for the determinations. In the second trial, cells from 
28 CEK and 30 CELi cell cultures were used. 
A third trial was made with a modification in the prep­
aration of the cell lysate and pellet. A trypsin-versene 
solution was used to remove the cells from the cultures and 
the cells were disrupted with a Thomas tissue grinder^  with 
a Teflon pestle. The trypsin-versene solution was prepared 
as follows: 
NaCl 8.0 gm 
KCl 0.4 gm 
Dextrose 1.0 gm 
NaHCOj 0.58 gm 
Trypsin 0.5 gm 
Versene 0
 
to
 
gm 
H2O 1000 ml 
Thomas tissue grinder, size B, 0.005-.007 inch clearance 
obtained from Arthur H. Thomas Co., Philadelphia, Pennsylvania. 
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This solution was filtered sterilized with a 0.33^  Millipore 
filter. The cells were separated from the trypsin-versene 
by centrifugation at 322 x g and resuspended in 10 ml dis­
tilled water. This suspension was put into the homogenizer 
and the cells ground until the majority of the cells were 
disrupted as detected by microscopic examination. In this 
trial, the cells from 28 cultures of CEK cells and 29 cultures 
of CELi cells were used for thiol group determinations. 
The procedure for the second method of cell preparation 
for cellular thiol group determination was used on CEK, CELi, 
WCEFi, CEFi and PK-15 cells and was performed as follows: 
1. A working solution of DTNB was prepared by adding 
7.0 ml of the stock DTNB reagent to 800 ml of 0.85^  saline 
and 200 ml of phosphate buffer, pH 8.0. 
2. Two and one-half ml of this solution was added to 
cell cultures previously washed 2 times with PBS. At various 
time intervals, the solution from 2 cultures was removed, 
filtered through a 0.33/ Millipore filter, and the absorbance 
at 4l2 determined spectrophotometrically. 
3. This procedure was followed in 3 separate trials. 
The reagent was allowed to be in contact with the cells at 
ambient temperature in the first trial, 37° in the second, 
and in the third trial a parallel study was made at both tem­
peratures. The first time intervals were at 0.5 and 1 hour 
in all trials and at either 1 or 2-hour intervals up to 5 or 
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6 hours. In the third trial a 20-hour time interval was in­
cluded as well. 
Inhibitors of IBV Attachment Found in Serum 
Demonstration and quantitation of IBV-inhibitors in serum 
In an experiment in which medium 199 with 8^  bovine serum 
was used as virus diluent, it was observed that the plaque 
counts fell far short of the expected value. To investigate 
whether this plaque reduction was due to the presence of 
serum the following experiment was conducted: 
1. A virus preparation containing approximately 100 
PFU's/0.5 ml was made in either serum-free virus diluent or 
virus diluent containing 5^ . 10^  or 20% bovine serum. 
2. Each preparation was inoculated onto 4 or 5 CEK 
monolayers and plaque determinations performed as previously 
described. 
3. A preliminary trial was run to test the inhibitory 
effect of bovine serum #681 at the 20^  level. In a second 
trial the same serum was tested at the 5^ » 10^  and 20^  level. 
In a' similar manner bovine serum pool #951 and a pool of 
fetal calf serum was tested for the presence of inhibitors. 
With the finding of IBV-inhibitors in serum of bovine 
origin it seemed desirable to test serums from other species 
for Inhibitory activity. For this purpose serums from swine, 
chickens and rabbits were tested for activity at the 10^  level. 
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The occurrence of inhibitory activity amongst individuals 
from different species was also determined. Serums from 20 
cattle, 10 rabbits and 4 chickens were tested. The deter­
mination of activity was performed as previously described. 
A method for the quantitation of inhibitory capacity of 
different serums was investigated. Since little difference 
in inhibition was observed between 10^  and 2.0)% levels of 
bovine serum #681, it appeared that an inhibition plateau was 
reached at the 10^  level. The procedure involved attach­
ment of 100 FPU's of IBV in the presence of serum varying 
from to 10^  and determining the degree of inhibition at 
each level to a serum-free virus control. Four separate 
serums were titrated in this manner, either 2 or 3 plates were 
Inoculated with each concentration of serum and plaque deter­
minations made. 
Effect of bovine serum on MDV plaques 
An experiment was conducted to determine if bovine serum 
inhibited NDV as it did IBV. Three trials were conducted to 
establish whether bovine serum inhibited NDV attachment. 
Effect of serum inhibitors applied to cell cultures prior to 
or following IBV attachment 
To test the effect of IBV-inhibitors in bovine serum when 
applied to cells prior to attachment of IBV the following 3 
experiments were conducted. 
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1. In the first experiment, CEK cells were implanted 
with the usual medium 199 containing either 8^  or 20^  bovine 
serum #681. These cultures were then inoculated with approx­
imately 50 FPU's of IBV and comparisons of plaque counts made 
between cells implanted in 8^  serum with those implanted in 
20% serum. Two replicate trials were conducted to make this 
comparison. 
2. In the second experiment, CEK cell cultures were 
implanted with the usual medium but were treated with medium 
containing 4-0^  serum for 2 hours at 37° just prior to inocu­
lation. Plates were washed 2 times with PBS before inocula­
tion. Five CEK cultures were treated in this manner and were 
compared to those of 5 untreated CEK cultures. 
3. The third experiment consisted of implanting CEK 
cell cultures with a non-inhibitory bovine serum #5533 and 
comparing plaque counts in such cultures with those implanted 
with an inhibitory bovine serum pool #1181. Plaque counts 
were made on 4 CEK cultures per treatment. 
The effect of serum on plaque numbers following virus 
attachment was investigated by incorporating bovine serum #681 
into the agar-overlay medium at varied concentrations and com­
paring plaque counts. Since serum was routinely incorporated 
into the agar-overlay medium at a concentration of 2.5^ , the 
first 2 trials compared serum-free agar medium to a 2. 5# 
serum containing agar medium. Further trials conqjared serum-
free, 2.^ %, 5.0^ , and 20% serum-containing agar medium. 
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Characterization of the IBV Inhibitor in bovine serum 
Inhibitory fractions of bovine serum Commercial 
T 23 preparations of bovine albumin , gamma globulin , and fetuin^  
were tested for their inhibitory capacity. The albumin and 
gamma globulin solutions were prepared by dissolving 1 gm of 
the powder in 5 ml of medium 199» Fetuln purified by 2 
different procedures was tested, one had been purified by 
(NH^ )^ S02j, precipitation and the other by alcohol precipitation. 
The fetuln stock solutions were prepared by dissolving O.5 
gm fetuln In 5 ml 0.85^  NaCl. For the test, 1 ml of the 
stock solution of fetuln was added to 4 ml medium 199* Virus 
preparations containing approximately 50 PFU's/0.5 ml were 
prepared in the above solutions and plaque counts compared to 
a control in which the virus inoculum contained no serum com­
ponents. Plaque counts on 8 CEK cultures per solution were 
made in the usual manner. 
A gamma globulin preparation was also prepared from 
bovine serum pool #681 by precipitation with The 
precipitation procedures used was the same as that previously 
described for obtaining gamma globulin for fluorescent antibody 
B^ovine albumin fraction V, Armour Pharmaceutical Co., 
Kankakee, Illinois. 
2 Bovine gamma globulin fraction II, Nutritional Biochem­
ical Corp., Cleveland, Ohio, 
F^etuln, Grand Island Biologies Co., Inc., Grand Island, 
New York. 
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preparation. After the gamma globulin solution was prepared 
and the volume adjusted to the original volume of serum, its 
plaque inhibitory activity was determined by allowing 50 FPU's 
of IBV to attach in the presence of 10^  of the gamma globulin 
solution and comparing plaque counts with those allowed to 
attach in the absence of gamma globulin. 
The activity of the (NH^ )2S0^  precipitated bovine gamma 
globulin #681 was compared to the activity of non-fractionated 
whole bovine serum #681. The method of quantitation of the 
inhibitory activity of the 2 preparations was the same as 
previously described. 
To determine if all of the inhibitory activity of serum 
was removed by precipitation with 1/3 volume saturated 
additional sequential precipitations with 1/2 and then 3/5 
volume saturated (NH^ )280^  ^were conducted. The supernatant 
fluid from the final precipitation was also tested. The 3 
sequentially precipitated serum fractions were tested for IBV 
inhibitory activity at the level of 20^  and ^ 0% while the 
supernatant fluid fraction was tested at the kO% level. 
Destruction and removal of IBV inhibitors in bovine 
serum The susceptibility of viral inhibitors subjected to 
various physical and chemical treatments can sometimes aid in 
determining their nature. Bovine serum #681 was studied as 
to its heat stability at various temperatures as well as its 
susceptibility to neuraminidase, acetone, kaolin adsorption, 
and 1,4-dithiothreitol. 
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Heat stability The heat stability of the inhibi­
tory activity was first determined at 60° and 65°. Since ser­
um was routinely inactivated at 56° for 30 minutes for routine 
cell culture, it was evident that this treatment did not de­
stroy the inhibitory activity. The effect of heat on the in­
hibitor was determined as follows: 
1. A 10% preparation of bovine serum #681 in medium 199 
was prepared and distributed in 10 ml amounts in Pyrex test 
tubes. 
2. These serum preparations were then placed in either 
a 60° or 65° water bath and tubes were removed at prescribed 
time intervals and placed in a 4° water bath. Time intervals 
were 15. 30, 60, 90, and 120 minutes for the 60° temperature 
and 10, 20, and JO minutes for the 65° temperature. A period 
of time was allowed for temperature equilibration and was 3 
minutes in the 60° study and 4 minutes in the 65° study. 
3. After heat treatment the 10^  serum samples were test­
ed for their IBV inhibitory activity in the usual manner. In 
the case of the 60° temperature study, 2 samples were removed 
at each time interval and the activity of each determined sep­
arately. Only 1 sample per time interval was used in the 65° 
temperature study. 
To determine if any inhibitory activity was destroyed by 
the routine 56° treatment of whole serum for 30 minutes, 3 
samples of bovine serum #1181 were treated as follows: One 
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was left imheated, the second was heated at 56° for 30 minutes 
and the third was heated at 65° for 20 minutes. Quantitation 
of their activity was then determined as previously described. 
Neuraminidase^  treatment Treatment of bovine 
serum #681 with neuraminidase was performed as follows; 
1, A 20^  serum solution in medium 199 was prepared and 
5 ml samples were treated with 5» «5# *05» and . OO5 units of 
neuraminidase, respectively, for 40 minutes at 37°. A control 
sample was left untreated, 
2. Each sample was checked for inhibitory activity in 
the usual manner. 
Acetone treatment The acetone extraction pro­
cedure described by Clarke and Casals (1958) was used. The 
procedure was as follows; 
1. The serum was diluted 10-fold with 0.85^  NaCl and 
chilled in a 4° water bath. 
2. Cold acetone (4°) was added to the serum at the rate 
of 12 volumes acetone; 1 volume diluted serum. 
3. Extraction was carried out for 5 minutes with 
periodic shaking and then centrifuged for 5 minutes at 1,400 
X g. 
4. The acetone was aspirated and the precipitate re-
extracted with the same volume of acetone. Vigorous shaking 
N^euraminidase (vibrio cholera), B grade, Calbiochem, 
Los Angeles, California. 
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was necessary to resuspend, the pellet. 
5. After centrifugatlon and removal of the acetone, the 
precipitate was dried with a stream of nitrogen gas. 
6. The dried precipitate was then restored to the orig­
inal serum volume by dissolving in PBS. 
Two samples of bovine serum #681 were extracted in paral­
lel by the above procedure and were tested for inhibitory 
activity in the usual manner. 
Kaolin adsorption The adsorption of serum with 
kaolin was carried out as follows ; 
1. One gm of acid-washed kaolin^  was added to  ^ml of 
serum. 
2. This mixture was held at room temperature for 5 hours 
with occasional shaking to resuspend the kaolin. 
3. The mixture was centrifuged at 1,400 x g and the 
supernatant serum withdrawn and filtered through a 0.^ 5 
Millipore filter. 
One sample of bovine serum #681 was treated in this 
manner and then tested for inhibitory activity. 
1,4-Dithiothreitol (DTT) treatment To test the 
effect of^ DTT on the IBV inhibitor of bovine seru, the (NH2|,)2-
SO/j, precipitated gamma globulin fraction was used. A stock 
solution of IC^ M DTT was prepared in phosphate buffer, pH 8.0. 
K^aolin (acid-washed) obtained from Fisher Scientific 
Co., Fair Lawn, New Jersey. 
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The procedure followed was essentially that of Gunewardena 
and Cooke (1966) and was as follows : 
1. One volume of phosphate buffer, pH 9.0 was added to 
9 volumes gamma globulin solution. DTT was added and allowed 
to react for 1 hour. The final concentration of DTT was 10"" 
— 2  in the first trial and 10" M in the second. 
2. The DTT-treated solution was then alkylated with 
iodoacetamide (final concentration of 10~^ M in both trials) 
and then dialyzed against PBS overnight at 4° with constant 
stirring. In the second trial alkylation was eliminated in 
one sample. 
3. The IBV-inhibitory activity of the DTT-treated gamma 
globulin fractions was tested in the usual manner. 
Physical characterization of IBV-inhibltors in bovine 
serum To gain more knowledge of the physical size of the 
IBV inhibitory substance, serum was examined by ultrafiltra­
tion, rate zonal ultracentrifugation and gel filtration methods. 
Ultrafiltration Serum was filtered through an S&S 
collodion bag^  by applying 15 lb of vacuum to the suction 
vessel. Bovine serum #681 was concentrated to 10 times its 
original volume. The concentrate was restored to the original 
serum and was tested for its inhibitory activity. The filtrate 
was also tested for any inhibitory activity. 
S^&S collodion bag and collodion bag apparatus obtained 
from Carl Schleicher and Schuell Co., Keene, New Hampshire. 
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Rate-zonal centrlfugatlon^  Ammonium sulfate 
precipitated gamma globulin of bovine serum #681 was subjected 
to rate zonal centrifugation as follows : 
1. The gamma globulin was first concentrated 6 times 
using the ultrafiltration apparatus and the amount of protein 
determined by the biuret method. 
2. A sucrose gradient was formed by layering various 
concentrations of sucrose in a 5-nil cellulose nitrate centri­
fuge tube. Sucrose concentration percentages are expressed 
on a weight/volume basis. One-half ml of 59% sucrose was put 
on the bottom of the tube and then 1 ml each of 30%, 25^ , 
20%, and 15% sucrose, respectively, were layered in the tube. 
One-half ml of the gamma globulin solution was layered on top 
of the sucrose. 
3- The preparation was centrifuged in a Spinco Model L 
2 preparative ultracentrifuge using an SW39L rotor. The maxi­
mum centrifugal force was 127,000 x g and the time of centri-
fugation was l6 hours. 
4. Fractions were removed from the top of the tube in 
1/2 ml amounts, diluted 1:10 in medium 199, and dialyzed 
against 1 liter of medium 199 overnight to remove the sucrose. 
B^ate zonal centrifugation kindly performed by Mrs, 
Judith Patterson, NADL, Ames, Iowa. 
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Spinco Model L preparative ultracentrifuge, Spinco 
Division of Beckman Instruments, Inc., Palo Alto, California. 
Each 1:10 dlalyzed sample was tested for IBV inhibitory activ­
ity at 2 different concentrations. The concentrations tested 
represented 10% and 5»55^ t respectively, of the original 
fraction removed from the gradient. 
Gel filtration The precipitated gamma 
globulin of bovine serum #681 was chromâtographed on a Sephadex 
G200^  column using the method described by Thorns s en et al. 
(1966). A 4 X 40 cm column of Sephadex G200 was poured and 
equilibrated with a l.OM NaGl-0.2M Tris [Tris (hydroxymethyl) 
aminomethan^  buffer, pH 8.0. The gamma globulin solution 
was dialyzed against this same buffer for 20 hours at 4°. 
Before the sample was applied 6.0 ml of a 0.1^  solution of 
blue dextran was passed through the column to determine the 
hold-up volume of the column and the eluate volume of the 
sample. Six ml of the gamma globulin was applied to the column 
and 6-ml samples of eluate were collected. Forty samples 
were collected and each sample was checked for protein by 
absorbance at a wavelength of 280 on a Beckman DK2A spec-
trophotometer. The first 26 samples were dialyzed against 
PBS overnight at 4° and the IBV inhibitory activity of each 
fraction tested at the 20^  level. One ml of samples 5-10 and 
0,5 ml of samples 1-26 were pooled and concentrated with an S&S 
S^ephadex G200 obtained from Pharmacia, Uppsala, Sweden. 
2 Beckman DK2A spectrophotometer, Beckman Instruments, Inc., 
2500 Harbor Blvd., Fullerton, California. 
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collodion bag to 1 ml and 0.5 ml, respectively. These con­
centrated samples were tested for IBV inhibitory activity at 
the 10^  level. 
Reversal of IBV-inhibitory activity in bovine serum A 
preliminary test before the sucrose rate zonal centrifugation 
study was run to see if sucrose had any deleterious effect on 
either the virus or cell cultures. The result of this test 
showed that much of the inhibitory effect of 10^  serum was 
lost when virus-serum-sucrose mixtures were allowed to attach 
to cells. When this mixture was dialyzed against PBS to 
remove the sucrose, the inhibitory activity of the serum was 
regained. This finding led to a survey of a number of di- and 
monosaccharides to determine the variety of sugars that could 
reverse the effect of IBV inhibitor. 
The survey consisted of allowing approximately 100 PFU's 
of IBV to attach in the presence of 10^  bovine serum #681 
and 1.5^  of the various sugars. Controls consisted of virus 
attached in 10^  serum alone and serum-free virus attachment. 
The sugars checked were as follows: 
1. Disaccharides - sucrose, lactose, and maltose. 
2. Monosaccharides 
a. Hexoses - D-glucose, L-glucose, D-galactose, 
D-mannose, and D-fructose. 
b. Pentoses - D-xylose, D-ribose, and L-arabinose. 
3. Derivatives of glucose - 2-deoxy-D-glucose, D-
glucosamine, ^ pha-methyl-D-glucoside, and beta-methyl-D-
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glucoslde. 
The effect of pretreatment of CEK cells with D-glucose 
and alpha-methyl-D-glucoside was determined by incubating 
cells in 1.5% solutions of each sugar for 2 hours previous to 
inoculation with 100 FPU's of virus. 
To determine if reversal of IBV-inhibitor was possible 
after the virus and inhibitor were allowed to react together, 
the effect of glucose, alpha-methyl-D-glucoside and galactose 
on IBV-inhibitor were checked in the following way. About 
200 PFU's of IBV were allowed to attach for 90 minutes at 37° 
in the presence of 10^  serum. After this period, 0.1 ml of a 
9% solution of the above sugars was added to the inoculum and 
another period of 90 minutes at 37° allowed. The inoculum was 
withdrawn and plates overlayed in the usual manner. Plaque 
counts on virus control and virus-serum control CEK cultures 
were also done. 
To determine if the IBV-inhibitors found in swine, rabbit, 
and chicken serums was similar to those in bovine serums with 
respect to reversal by sugars the following experiment was 
conducted. Virus was allowed to attach in the presence of 10^  
serum plus 1.5^  alpha-methyl-D-glucoside. Serums from 5 rab­
bits, ^  chickens, and 1 swine serum pool were tested in this 
manner. Since the inhibitory activity of the rabbit serums 
was very high at the 10^  level, 2 rabbit serums were selected 
and the effect of 1.5^  alpha-methyl-D-glucoside was determined 
on 1^ , 3^ t 5^  and 10^  of each serum. 
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Mode of action by IBV-inhibitors in serum While it 
had been felt during the entire study that IBV-inhibitors in 
serum acted by preventing viral attachment, it was difficult 
to prove. With the finding that the IBV-inhibitor could be 
reversed with sugars, it was possible to confirm that viral 
attachment was interfered with. To do this, approximately 100 
FPU's of IBV was allowed to attach to CEK cell monolayers for 
90 minutes at 37° in the presence of 0^  and 10^  bovine serum 
#681. The inocula were removed from each group and pooled 
separately. Glucose was added to each pool to make a final 
concentration of 1.5^ * Five CEK cell cultures were inoculated 
per pool to determine the amount of unattached IBV. 
To determine if thiol groups of the IBV-inhibitors were 
the active groups in preventing IBV attachment, the following 
experiment was conducted. About 100 FPU's of IBV allowed to 
attach in the presence of 0^ , 10^ , and 20^  bovine serum 
#681. The same amount of virus was also allowed to attach in 
the same concentrations of serum except PHMB was added at the 
level of 10~^ *^ M and lO^ M^ concentrations. 
Effect of bovine serum and filtrate of bovine serum on 
IBV cytopathological changes and plaque size When 
bovine serum was incorporated into fluid medium of IBV infected 
cells at the level of 5^  and 10^ , it was observed that cells 
were "spared" from the cytopathic effect (CPE) of IBV compared 
to IBV infected cells in medium free of serum. It was also 
observed that a filtrate of bovine serum filtered through an 
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S&S colloldion bag had the opposite effect and caused an en­
hancement of the CPE of IBV. To demonstrate these observa­
tions CEK cell monolayers on cover glasses were infected with 
either 10^ *^  or 10^ *^  PFU's of IBV. Whole bovine serum and 
the filtrate were incorporated in the medium at the levels of 
1^ , 10^ , and 20^  and cover slips of each treatment were stained 
with fluorescent antibody at 24 and 48 hours. 
The effect of whole bovine serum and the filtrate on 
plaque size was determined by incorporating serum and 2.0% 
filtrate into the agar medium and observing the plaque size 
at 40 hours in comparison to plaques formed under agar medium 
alone. 
Effect of some selected compounds on IBV attachment 
In addition to the thiol inhibitors and inhibitors found in 
serum, a number of other compounds which reportedly affect vi­
ruses other than IBV were tested for their effect on IBV. 
Salicylates The report of Inglot et al. (1966) 
demonstrating that encephalomyocarditis virus attachment was 
inhibited by salicylates led to an investigation of the effect 
of these compounds on IBV attachment. Approximately 100 FPU's 
of IBV were allowed to attach in the presence of acetylsali-
cylate, p-aminosalicylate, and sodium salicylate in concen­
trations of lO"^ , 10"^ , 10"^  and 10"^ *of each compound. 
The pH of these solutions was adjusted to pH 7.2 using .IN 
NaOH or .IN HCl when required. 
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Amantadine hydrochloride^  While Davies et al. 
(1964) reported that the attachment of Influenza A to chicken 
embryo fibroblasts and red blood cells was not interfered with, 
this compound was tested for its effect on IBV attachment. 
The effect of the presence of amantadine hydrochloride on IBV 
plaque numbers during the attachment period was checked at con­
centrations of 100, 50, 25, and 10 ^g/ml. 
Pancreatin The reports (Wallis et , 1966a, 
and Wallis et a2., 1966b) that pancreatin enhanced enterovirus 
and reovirus plaque numbers led to the study of the effect on 
this enzyme preparation on IBV, A stock solution of pancreatin 
2 
was prepared by dissolving 1 buffered pancreatin tablet in 50 
ml of distilled water. Several preliminary trials indicated 
that there was a significant increase in plaque numbers when 
IBV was allowed to attach in the presence of a 1:20 to 1:40 
dilution of the pancreatin stock solution in medium 199- To 
demonstrate this effect and to also investigate the possible 
relationship of pancreatin with enhancement of plaque numbers 
by alpha-methyl-D-glucoside and inhibition by bovine serum the 
following experiment was conducted. One hundred PFU's of IBV 
were allowed to attach to CEK monolayers in the presence of 
1:20, 1:30, and 1:40 dilutions of stock pancreatin. The same 
A^mantadine hydrochloride obtained from E. I. DuPont de 
Nemours & Co., Inc., Wilmington, Delaware. 
B^uffered pancreatin tablets, Oxoid, Colab Laboratories, 
Inc., Chicago Heights, Illinois. 
\ 
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amount of virus was also allowed to attach in those same con­
centrations of pancreatin plus either 1.5^  alpha-methyl-D-glu-
coside or 5% bovine serum. As controls, virus was allowed to 
attach without any treatment, with bovine serum alone, and 
with 1.5^  alpha-methyl-D-glucoside alone. 
Neuraminidase and N-acetylneuraminic acid (NANA) 
The work of Biswal et al. (19^ 6) showed that neuraminidase 
destroyed IBV hemagglutinin receptors on chicken erythrocytes 
and Inhibited IBV infection in the embryonating chicken's egg. 
An experiment was designed to test the effect of neuraminidase^  
on IBV-receptors of CEK cell monolayers. Cell monolayers were 
treated for 1 hour at 37° with 10, 5» and 2.5 units of neur­
aminidase. A unit of activity is equivalent to 1 jug NANA in 
15 minutes at 37° from a glycoprotein substrate obtained from 
human serum. The effect of the neuraminidase treatment of CEK 
cells on IBV and NDV receptors was determined by inoculating 
the monolayers with 50 FPU's of IBV and 100 PFU's of NDV and 
comparing plaque counts with those on untreated cultures. 
The effect of NANA was tested by allowing 50 PFU's of IBV 
and 100 PFU's of NDV to attach to CEK cell monolayers in the 
presence of 1.5^  and 0.75^  NANA. 
N^euraminidase (vibrio cholera), B grade, Calbiochem, 
Los Angeles, California. 
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Lysosomal Changes in IBV Infected Cells 
Acid phosphatase activity was chosen as the marker enzyme 
for lysosomes in this study. The activity of this enzyme dur­
ing the course of IBV infection in CEK and CELi cell cultures 
was determined qualitatively by a histochemical procedure. A 
quantitative procedure to determine the activity of this same 
enzyme was used on IBV-infected CEK cell cultures. 
Histochemical procedure 
The Gomori technique (Duspiva, 1963) modified as suggested 
by Bitensky, 1963, was used for the detection of acid phospha­
tase activity. This technique involved the staining of unfixed 
monolayers of cell cultures since preliminary experiments using 
formalin fixed cells had shown a high degree of inconsistent 
and non-specific staining of the cytoplasm and nuclei. The 
staining of unfixed cells allowed for subsequent acetone fixa­
tion as required for fluorescent antibody staining. 
The entire procedure for the detection of acid phospha­
tase activity fluorescent antibody staining was as follows; 
1. Cell monolayers were washed briefly in 0,85% NaCl and 
then incubated at 37° in a beta-glycerophosphate substrate 
solution made by mixing; 
IM acetate buffer pH 5* 0^  10 ml 
I^M acetate buffer pH 5*0 prepared by mixing 70.5 ml of a 
solution of 136.1 gm sodium acetate/1000 ml with 29-5 ml IN 
acetic acid. 
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5^  aqueous lead nitrate 3 ml 
Distilled water 
?.% aqueous sodium-beta-
glycerophosphate 
20 ml 
10 ml 
A control on the specificity of staining was determined 
by incubating cell monolayers in the above substrate solution 
containing 2 mg NaF, which inhibits acid phosphatase. 
2. After the incubation in the substrate, the cell 
monolayers were removed and rinsed for 10 seconds in \% acetic 
acid and then transferred to 0.85^  NaCl saturated with hydrogen 
sulfide. This solution was prepared by bubbling hydrogen 
sulfide generated from one 5 gm Aitch-Tu-Ess^ ^^  cartridge^  
through 500 ml of 0.8^ % NaCl. The cell monolayers were left 
in this solution for 5 minutes. 
3. The cell monolayers were then washed briefly in 0.85^  
NaCl and fixed for 5 minutes in acetone. 
4. After allowing the cell monolayer to air dry, they 
were stained with the fluorescein conjugated anti-IBV serum 
for 45 minutes at 37° in a high humidity atmosphere. 
5. The cell monolayers were then washed in distilled 
water, allowed to air dry and mounted in a solution of 1 part 
PBS and 1 part glycerol. 
6. Cells stained in the above manner were then examined 
by light, phase, and darkfield microscopy as well as UV 
darkfield microscopy. 
A^itch-Tu-Ess cartridges obtained from Hengar Company, 
Philadelphia, Pennsylvania. 
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The effect of IBV infection on the lysosomes of infected 
CEK and CELi cells was determined by infecting cultures of 
each cell type with 10^ *^  FPU's of IBV. Cell monolayers were 
removed immediately after infection and at 4, 6, 8, 12 and 
18 hours post-infection. They were stained as described above 
with cell monolayers being incubated in the substrate for 15. 
30, 60, 120, and 180 minutes. Two controls were run at each 
time interval; one was a control on specificity of acid phos­
phatase staining and the other was the staining of uninfected 
cell monolayers. 
Qualitative procedure 
The quantitation of acid phosphatase was performed on CEK 
cellular fractions using a Sigma acid phosphatase kit.^  Two 
fractions of cells were prepared, a mitochondrial-lysosomal 
(ML) fraction and a supernatant (soluble) fraction. They 
were prepared as described by Allison and Sandelin, I963, and 
the procedure was as follows; 
1. Cells from 20 CEK cell cultures were scraped from 
the surface of the culture vessel with a rubber policeman. The 
cells were separated from the culture medium with centrifuga-
tion at 224 x g for 5 minutes. They were resuspended in 10 ml 
of cold (4°) O.25M sucrose, centrifuged, and resuspended in 
10 ml of cold hypotonic 0.125M sucrose, 
S^igma acid phosphatase kit, Sigma Chemical Co., 3500 
DeKalb St., St. Louis, Missouri. 
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2. The 0.125M sucrose-cell suspension was then transfer­
red to a Thomas tissue grinder with a Teflon pestle. The 
cells were homogenized at 4° with 20 strokes of the Teflon 
pestle rotating at 2,000 RPM. 
3. The homogenate was centrifuged at 2,000 x g for 15 
minutes at 4° to remove nuclei and cell debris. The remainder 
of the homogenate was then centrifuged at 12,000 x g for 1 
hour at 4°. The soluble fraction was decanted and saved and 
the pellet (ML fraction) suspended in 10 ml of cold 0.125M 
sucrose. Both fractions were then assayed for acid phospha­
tase activity. 
The assay procedure utilizing para-nitrophenylphosphate 
as the substrate was conducted as follows; 
1. Tubes containing 0.5 ml of Sigma stock substrate 
o 
solution and 0.5 ml Sigma acid buffer were warmed in a 37 
water bath. 
2. To each tube 0.2 ml of the cell fraction to be assayed 
was added and then incubated for 30 minutes at 37°. A reagent 
blank was prepared in which 0.2 ml of water was added rather 
than the cell fraction. 
3. After incubation, 5 ml of O.IN NaOH was added to each 
tube to stop the reaction and develop the color. The optical 
density (O.D.) of each sample was read on a spectrophotometer 
at a wavelength of 410 m/ using the reagent blank as a refer­
ence to adjust the O.D. 4l0 to zero. 
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4. A  blank containing 0 , 2  ml of each cell fraction and 
6 ml of O.IN NaOH was also prepared and the O.D. at 4lO mjj. 
determined. A corrected O.D. reading for each sample was 
obtained by subtracting the O.D. value of the sample in step 
4 from the O.D. value of the blank in step 3» 
The quantitation of acid phosphatase activity of the 2 
cell fractions of IBV Infected and uninfected control CEK cell 
cultures was performed at 8 and 16 hours post-infection. The 
cultures were infected with 10^ *^  PPU's of virus. 
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RESULTS 
Attachment of IBV to Cell Monolayers 
Effect of temperature, time, and pH on attachment 
The effect of temperature on attachment of IBV to CEK 
cell monolayers is shown in Table 1. There was no difference 
between attachment of IBV at 4° and ambient temperature but 
at 37° there was a substantial increase in attachment. Titers 
of the virus were increased approximately 5 times thus effec­
tively increasing the log^  ^PPU/ml by 0.7 of a log. 
While extended periods of virus attachment for longer than 
90 minutes did increase the number of PFU's, it was considered 
to be slight (Fig. 1 and Table 40). It should be pointed out 
that the number of PFU's at 90 and 120 minutes was approxi­
mately the same in both trials indicating a plateau with 
another slight increase in PFU's at 150 to ISO minutes. 
There was little effect on attachment of IBV when the pH 
of the environment was varied from 6 to 9 (Table 2). The low 
mean (82 PFU's) of the plaque counts at pH 6 in the first 
trial is 30^  lower than the highest mean plaque count (117 
PFU's) at pH 7 and this amount of variation can normally be 
expected as will be shown later, and was considered to be in­
significant especially since there was no depression of 
plaques at pH 6 in trial 2. 
Fig. 1. Effect of time on the attachment of IBV to CEK cell 
monolayers. 
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o TRIAL 2 
60 120 180 240 
TIME OF ATTACHMENT (MINUTES) 
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Table 1. Results of the effect of temperature on attachment 
of IBV to CEK cell monolayers for 90 minutes 
Attach-
Trial ment Dilution Number of Mean number Log^  g 
number temper- of virus plaques of plaques PPU/m 
ature 
1 40 5 X 10-4 115, 102, 75 97 + 18^  6.6 
40 1 X 10-5 17. 19, 25 20 + 5 6.6 
Ambient 5 X 10-4 102, 87, 105 98 ± 11 6.6 
Ambient 1 X io"5 22, 13, 23 19 + 6 6.6 
37° 5 X 10-4 TNTC^  — — — — 
37° 1 X 10-5 94, 85, 104 94 + 11 7.3 
2 Ambient 5 X 10-4 75. 72. 62, 
66, 73 70 + 5 6.4 
37° 1 X 10-5 4.0, 65, 60, 
61, 57 57 + 9 7.1 
M^ean + 2 standard deviations of the mean (23^ ). 
T^NTC - Plaques too numerous to count. 
Efficiency of attachment 
The experiments conducted to determine the efficiency of 
IBV attachment by performing successive attachments of a virus 
inoculum to CEK cell monolayers showed that attachment was 
very inefficient. Each successive period for attachment re­
vealed that a large amount of virus remained unattached. The 
results in Table 3 show that the inoculum removed from each 
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Table 2. Results of attachment of IBV to CEK cell monolayers 
at various pH's 
Experiment 
number 
Type of 
buffer pH 
Number of 
plaques 
Mean number 
of plaques 
+ 28-
1 Phosphate 6 78, 75, 82, 91 82 ± 7 
Phosphate ? 111 , 116, 111, 128 117 ± 8 
Phosphate 8 99, 113, 108, 127 112 ± 12 
Phosphate 9 111 , 107, 108, 119 111 ± 5 
2 Glycine 6 81, 74, 99, 90 86 1+
 H
 
H
 
Glycine 7 68, 70, 82, 96 79 
(M H +
1 
Glycine 8 56, 68, 72, 81 69 
0
 H +
1 
Glycine 9 66, 64, 77. 89 74 + 12 
attachment period still contained a large relative amount of 
unattached virus. While it is impossible to demonstrate just 
how much of the total virus inoculum is removed with each 
attachment, an indication of the efficiency of attachment can 
be depicted by expressing as a percentage the ratio of the 
virus (FPU's) detected after the first attachment; FPU's 
detected after each of the attachment periods. Thus, the 
ratio would be 1 after the first attachment and would repre­
sent 100^  of the virus. The results of the 2 experiments in 
Table 3 show that this ratio expressed as a percentage was 46^  
and 45^  in the 2 experiments after the 4th successive attach-
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Table 3- Results of attachment of IBV inocula to primary CEK 
cell monolayers in 4 successive attachment periods 
of 90 minutes at ambient temperatures 
Number of 
successive 
attachment 
Mean number of 
unattached PFU's 
detected in inoculum' a 
Exp. 1^  
Ratio of: 
FPU's detected after 
1st attachment 
PFU's detected after 
each attachment 
Exp. 2 Exp. 1 
100# 
Exp. 2 
1st 
2nd 
3rd 
4th 
87 + 14 
62 + 12 
49 + 16 
40 + 14 
82 + 8 
60 + 6 
35 ± 8 
37 + 6 
100# 
71# 
56# 
100# 
73# 
43# 
45# 
®The plaque counts represent the unattached virus in an 
inoculum of a 10"^  dilution of IBV. 
M^eans in Exp. 1 are for 3 counts + 2 standard deviations 
of the mean (2S-). 
M^eans in Exp. 2 are for 5-7 counts + 2.8-. 
ment. 
Table 4 gives the results when the efficiency of IBV 
attachment was conçiared at 37°, ambient and 4° by performing 
3 successive attachments at each temperature. It appears 
from these data that the efficiency of attachment is greater 
at 37° than at ambient temperature and 4°. Only 20# and 30# 
of the virus FPU's detected in the first attachment remained 
after the third attachment while at ambient temperature, 57# 
Table 4. Results of attachment of IBV inocula to primary GEK cell monolayers in 3 
successive attachment periods of 90 minutes at 4°, ambient,.and 37° 
Temper­ Number of 
Mean number of 
unattached FPU's 
Ratio of: 
FPU's detected after 
1st attachment X 100# 
ature successive detected in inoculum FPU's detected after 
attachment each attachment 
Exp. 1^  Exp. 2 b Exp. 1 Exp. 2 
37° 1st 470 + 54 117 ± 22 100# 100# 
2nd 243 ± 5 65 ± 15 51# 56# 
3rd 9 2 + 7  35 ± 7 20# 30# 
ambient 1st 98 + 11 25 + 3 100# 100# 
2nd 6o + 6 20 + 5 61# 80# 
3rd 5 6 + 5  10 + 4 57# 40# 
M^eans are from 2 or 3 counts + 28- and represent unattached virus in an inoc­
ulum of a 10-4.3 dilution of IBV. 
M^eans are from 3 counts + 28- and represent unattached virus in an inoculum of 
a 10-5 dilution of IBV.  ^
Table 4. (Continued) 
Temper­ Number of 
Mean number of 
unattached FPU's 
Ratio of: 
FPU's detected after 
1st attachment X 100# ature successive detected in inoculum PFU's detected after 
attachment each attachment 
Exp. 1®' Exp. 2% Exp. 1 Exp. 2 
4° 1st 97 ± 24 21+5 100# 100# 
2nd 4 2 + 6  15 ± 1 43# 72# 
3rd 7 9 + 3  12 + 1 82# 57# 
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Table 5' Results of exposure of IBV virus for 4.5 hours 
(equivalent to three 90-Biinute attachment periods) 
to 37° and 4 
Exposure 
temperature 
Mean number of 
PFU's remaining 
± 
Ratio of: 
PFU's after 4° exposure „ -, 
PFU's after each exposure  ^
40 71 ± 7^  100# 
37° 14 + 3° 20# 
M^ean of 5 plaque counts. 
M^ean of 4 plaque counts. 
and kO% still remained, and at 4°, QZ% and S7% still remained. 
These data may, however, be misleading, as shown in Table 5t 
because the virus is not only being removed by attachment but 
is also being inactivated by the increased temperature. The 
inactivation at 37° appears to account for the removal of as 
much virus as does the attachment; thus it would be difficult 
to conclude that IBV attaches more efficiently at 37° than at 
lower temperatures. 
Comparison of virus attachment to different cell types 
The results of 3 successive attachments to 5 different 
cell types are shown in Table 6. The CEK cells are the most 
efficient at removal of IBV from an inoculum and have been 
shown to be the most sensitive cell type (Lukert, 1965). 
The PK-I5 is insensitive to IBV, while the sensitivities of 
Table 6. Results of successive attachment of IBV to CEK, CEL1» WCEFi, CEFi, and 
CEK CELi 
Number of Mean PFU's Per cent Mean FPU's Per cent 
successive detected PFU's , detected PFU's , 
Exp. attachment + 2S-^ detected + 2S-* detected 
1 1st 19 ± 4 100 25 + 5 100 
2nd 3 + 2 16 11 + 4 44 
3rd 3 + 2 16 4 + 2 15 
2 1st 49 + 9 100 84 + 7 100 
2nd 14 + 2 14 34 + 5 40 
3rd 6 + 1 6 14 + 5 17 
a 
Means is from 4 plaque counts + 2 standard deviations of the mean (2S-). 
^Per cent PFU's detected is the ratio of; PFU's detected after 1st attacha 
PFU's detected after each attacl 
Fi, and PK-15 cells. Each attachment was for 90 minutes at 37° 
WCEFi CEFi PK-15 
Mean PFU's Per cent Mean PFU's Per cent Mean PFU's Per cent 
detected PFU's , detected PFU's , detected PFU's 
+ 2S-* detected + 2S-^ detected + 2S^* detected 
42 + 2 100 47 + 4 100 45 + 3 100 
19 + 5 45 17 + 4 36 24 + 5 54 
9 + 3 21 8 + 1 17 12 + 6 27 
82 + 4 100 109 + 10 100 103 + 10 100 o? 
48 + 6 58 74 + 10 68 75 + 7 73 
20 + 6 24 27 + 5 25 54 + 10 52 
2S-). 
attachment ^ ioO%. 
attachment 
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CELi, WCEPi, and CEFl lie intermediate between the GEK and 
PK-15 cell types. When the percentage expression of the ratio 
of FPU's detected in the first attachment: FPU's detected in 
each successive attachment is expressed graphically (Fig. 2) 
it can be readily seen that the GEK cells attached IBV more 
efficiently in both experiments while FK-15 cells were the 
least efficient in both cases. Thus, there is a direct cor­
relation between the sensitivity of a cell type to IBV and 
its ability for attachment of the virus. 
Attachment interference 
Table 7 shows that in 7 trials less than 50^  (7^  to 46^ ) 
of a second dose of virus attached to GEK cell monolayers. 
This is strong indication that the first dose of virus estab­
lished an interference preventing the equivalent attachment 
of a second dose of virus. In trial 2, Table 7. the unattached 
virus remaining in the 1st and 2nd dose was determined as 
being 100 + ^ 4 FPU's in the first dose and l6l + FPU's in the 
second dose, thus indicating that the attachment of the second 
dose was being prevented. 
The time of appearance of attachment interference seems 
to be somewhere around 60 minutes after exposure to the first 
dose of virus as shown in Pig. 3 and Table 41. While it was 
difficult to establish a specific time at which attachment 
interference begins, there was a pattern in all trials in 
which there was a time at which the plaque numbers were doubled 
Fig. 2. Per cent of virus detected as unattached FPU's after each of 3 successive 
attachment periods to GEK CELi, WCEFi, CEFi and PK-15 cell monolayers. 
CEK CELLS 
CELi CELLS 
WCEFi CELLS 
CEFi CELLS — 
PK~ 15 CELLS 
EXP 2 
\ 
»» 40-
SUCCESSIVE ATTACHMENT 
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Table ?• Results of the comparison of PFU's on singly and. 
doubly infected CEK cell monolayers 
Number of Percent increase 
doses of virus Mean plaque^  in plaques in 
Trial allowed to attach count + 28- doubly infected 
number to cells®' ~ cultures 
1 1 H
 00
 
+ 13 
2 H
 00
 
± 10 7% 
2 1 168 ± 7 
2 215 ± 14 zz% 
3 1 25 ± 5 
2 34 ± 1 36^ 
4 1 29 ± 5 
2 33 ± 3 1% 
5 1 97 ± 16 
2 142 ± 16 46^ 
6 1 20 ± 5 
2 26 ± 3 30# 
7 1 88 ± 8 
2 112 ± 3 27# 
A^ttachment was at ambient temperature in trials 1-4 and 
37° in trials 5-7. 
M^eans were from 2, 2, 3, 8, 5» 7 and 10 counts, respec­
tively, in trials 1-7. 
Pig. 3* Time of development of IBV attachment interference in CEK cell mono­
layers, Shaded areas indicate the interference observed in each trial. 
250-
-o MEAN COUNT OF SINGLY INFECTED CULTURES X2 
-# OBSERVED MEAN COUNT IN DUALLY INFECTED CULTURES 
TRIAL 4 AMBIENT 
TRIAL" 
I 
VO 
H 
TRIAL 5 
60 90 0 30 
TIME (MINUTES) 
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Table 8. Effect on attachment of an initial exposure of NDV 
and IBV on a second exposure to the heterologous 
virus 
Trial 
number 
Initial 
virus 
exposure 
Second 
virus 
exposure 
Mean 
plaque 
count 
± ^ x^ 
Mean plaque count 
expected in dually 
exposed cultures®-
1 IBV - 22 + 6 
NDV - 36 ± 1 
IBV NDV 57 ± 5 58 
NDV IBV 61 + 5 58 
2 IBV 44 + 1 
NDV 20 + 3 
IBV NDV 26 + 2 (NDV) 20 
1+
 
5 (IBV) 44 
NDV IBV 
+1 00 7 (NDV) 20 
5 0  ± 9  (IBV) 44 
T^otal of mean counts of singly infected IBV and NDV 
cultures. 
or nearly doubled in dually infected cultures and this was 
followed by a decrease in the percent of attachment of a second 
dose of virus. 
Ability of UV-irradiated virus to produce attachment inter­
ference " 
Cultures of CEIL cells treated for 90 minutes with 10°* 
UV-inactivated FPU's of IBV were able to attach virus as 
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readily as untreated cultures. Five cultures previously 
treated with 10-second UV-irradiated IBV had a mean plaque 
count of 13^  + 8 while 5 untreated cultures had a mean count 
of l40 + 16. The UV-irradiated virus used for treatment had 
10 PPU's/ml, thus, only 1 PFU per count on UV-virus-treated 
plates was attributable to the treatment. 
Ability of NDV to establish IBV attachment interference 
The results in Table 8 show that cultures receiving NDV 
first did not interfere with IBV attachment nor did IBV 
interfere with NDV attachment. 
Normal variation of mean plaque counts 
Table 9 shows the variation of mean plaque counts en­
countered in 2 trials. All the means in the first trial over­
lap when 2 standard deviations of the mean are considered and 
all but 1 of the means in trial 2 overlap. Only the means of 
22 + 2.8 and 15 ± 3-2 do not overlap. The lowest mean repre­
sented a reduction of plaques by 31» 8j^  when compared to the 
highest mean, i.e., x 100^  = 31.8^ . For purposes of 
subsequent evaluation of inhibitors of IBV a change in plaque 
counts of 40^  was considered to be significant and changes of 
30^  to 40^  were evaluated more closely before rejecting or 
classifying the substance as non-inhibitory. 
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Table 9. Results of experiment determining the variation in 
mean plaque counts that can be expectêd normally in 
an IBV-CEK cell system 
h 
Trial Dilution Parts 10 virus: Mean plaque 
number number parts diluent count + 28-
1 0.5: 4.5 25 + 4.2 
2 0.5: 4.5 27 ± 3.8 
3 0.5: 4.5 21+5.4 
4 2.0:18.0 22 + 3.4 
1 5.0:45.0 18 + 4.6 
2 2.0:18.0 21+4.6 
3 2.0:18.0 16+4.0 
4 2.0:18.0 •21 + 4.6 
5 2.0:18.0 15 ± 3.2 
6 0.5: 4.5 17 + 2.8 
7 0.5: 4.5 19 ± 4.0 
8 0.5: 4.5 22 + 2.8 
Thlols and SH reagents and their effect on IBV attachment 
The results in Table 10 demonstrate the inhibitory activ­
ity of L-cysteine on IBV plaque counts when the substance is 
present at the time of attachment. Fig. 4 and Table 42 show 
the inhibitory dose response to L-cysteine and doses of about 
10~2*3jj to 10"^ M seem to be optimal and there is a linear 
response of inhibition over an 8-fold decrease in L-cystelne 
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Table 10. Effects of the presence of thiols on the attachment 
of IBV 
Molar ^ change 
concen- in mean 
Trial tration Mean plaque plaque 
Thiol number of thiol count + 28- count 
L~cysteine 1 lO-^M 23 + 5 '75% 
10-2-3M 26 + 5 -72.% 
H o
 1 41 + 10 -56* 
H o
 
43 + 6 -54* 
1 o
 
H 51 ± 5 -45* 
Virus control — — — 93 + 7 — — — 
L-cysteine 2 lO-^M 12 + 2 -77* 
H O 1
 
S*
' 
9 + 1 -83* 
10"\ 25 + 3 -53* 
Virus control — — — 53 + 7 — — — 
Reduced glutathione 1 1 lO'^M 30 + 8 -64* 
1 o
 
H 42 ± 11 -49* 
10 M 69 ± 9 -17* 
H O 1
 
86 ± 4 0* 
Virus control — — — 83 + 9 
2-mercaptoethanol 1 - 10-2% 30 ± 5 -85* 
H O
 1 58 ± 5 -65* J
'
 
1 o 
H 151 ± 19 -23* 
Virus control 197 + 7 
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Table 10. (Continued) 
Thiol 
Trial 
number 
Molar 
concen­
tration 
of thiol 
Mean plaque 
count + 28g 
% change 
in mean 
plaque 
count 
2-mercaptoethanol 2 lO-^ M 4 ± 1 -82# 
H
 
o
 1 6 ± 6 -73% 
H
 O
 1 
17 ± 4 -23# 
1 o
 
H
 24 ± 4 + 9% 
Virus control —  — —  22 ± 3 — — — 
Dithiothreitol 1 lO-^ M 4 ± 1 -99# 
H
 
O
 1 
41 ± 5 • -80# 
1 O H 119 ± 7 -40# 
Virus control 
— — — 197 ± 7 — — — 
Dithiothreitol 2 10-2% 1 ± 1 -99# 
1 o
 
H
 19 ± 3 -81# 
H
 O
 1 00
 
vo
 
± 7 -12# 
H
 
O
 1 
110 ± 3 + 9# 
Virus control — — — 101 1+
 H O
 
— — — 
: = : iizJ -  -  -  -  -  T.  
Pig. 4. Dose response to L-cystelne as detected by the Inhibition of IBV attach­
ment to CEK cell monolayers. 
(O 100 
w 
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concentration. The variation in dose response "between the 2 
trials probably comes from the fact that a new stock solution 
of L-cysteine must be made with each experiment, thus, stand­
ardization was rather difficult. 
It was also shown that the thiols, reduced glutathione, 
2-mercaptoethanol, and DTT, were equally as effective as L-
cysteine in reducing the attachment of IBV (Table 10). A non-
thiol reducing agent (ascorbic acid) was ineffective as an 
inhibitor of IBV (Table 43). The necessity of active thiol 
groups for inhibition of IBV is also shown (Table 43) by the 
fact that L-cystine and oxidized glutathione (disulfide com­
pounds ) are ineffective as inhibitors. 
L-cysteine does not inactivate IBV as shown in Table 11 
because the removal of L-cysteine by dialysis restores the 
activity of virus as demonstrated by its plaque-forming ability. 
The relatively low activity of the L-cysteine in the control 
on L-cysteine inhibition (33^  and 35%) is probably due to the 
oxidation of L-cysteine during the overnight holding period, 
because in all other experiments in which 10"% L-cysteine is 
used as a fresh solution, its Inhibitory activity was greater 
than 60%, 
The results of the experiment to confirm that L-cysteine 
interfered with IBV attachment are shown in Table 12. In 
trials 1, 2, and 3» there was 5^ » 71^ » and 31^ , respectively, 
more virus remaining unattached in inocula containing lO'^ M L-
cystelne than In Its absence. 
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Table 11. Results of experiments to determine if IBV is inac­
tivated by L-cysteine 
% change 
Virus Trial Mean plaque in mean 
treatment number count + 28- plaque count 
Virus + IQ-^ M L-cysteine 1 61 + 7 -16% 
(dialyzed overnight) 
+ 6% 2 52 + 10 
Virus + 10~^ M L-cysteine 1 49 + 7 -33% 
(not dialyzed) 
2 32 + 6 -35% 
Virus alone 1 73 + 12 
(dialyzed overnight) 
2 49 + 4 ~ 
Table 12. Effect of L-cysteine on IBV attachment 
% increase of 
Mean virus detect­
PFU's able in inoc­
Treatment of virus during Trial detected ula containing 
first attachment number in L-cysteine 
Virus + 10"% L-cysteine 1 194 + 22 54# 
(dialyzed overnight after 
71% removal from culture) 2 156 + 6 
3 134 + 18 31% 
Virus alone 1 126+ 5 
(dialyzed overnight after 
removal from culture) 2 40 + 5 
3 102 + 6 — — — 
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All of the SH-reagents (PHMB, lA, and HgClg) were effec­
tive in reducing plaques as shown in Table 13. These compounds 
are very toxic for cells and there is a narrow range of con­
centration in which their activity on the virus can be detected 
and not also affect the cells. Table 14 shows that virus is 
inactivated by PHMB as the removal of unbound PHMB by dialysis 
does not restore virus infectivity. 
The reversal of PHMB-inactivated IBV is shown in Table 15. 
At the concentration of 5 x 10~^ M L-cysteine auid 44^  of 
the PHMB-inactivated virus could be reactivated in the 2 tri­
als. There was no increase in the reactivation of virus by 
increasing the concentration of L-cysteine 2-fold and in one 
trial this increase was much less effective than the lesser 
concentration. 
The kinetics of IBV inactivation by PHMB at concentra­
tions of 10"^ , 10~^  and lo"^  are shown in Fig.5 and Table 44. 
At concentrations of 10"^  and 10"%, the Inactivation appears 
to proceed as a first order reaction during the first 60 min­
utes after which there is a "tailing" effect observed. There 
was little difference in the rate of inactivation between 
2 " 3 
concentrations of lO" and 10 M PHMB, but there was a pro­
portionately larger amount of virus inactivated with the high­
er concentration. There appeared to be a delay of 30 minutes 
—4 before inactivation of IBV with 10 M PHMB became apparent. 
Treatment of cells with PHMB prior to inoculation effec­
tively reduced the sensitivity of CEK cell cultures for IBV. 
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Table 13. Effects of p-hydroxymercurlbenzoate (PHMB), lodo-
acetamide (lA) and HgClg on IBV 
SH-reagent 
Molar 
concen­
tration 
Mean plaque 
count + 2S-^  
— i 
% change in mean 
plaque count 
Trial 1 Trial 2 Trial 1 Trial 2 
PHMB 
Virus control 
lA 
Virus control 
10" ^M 
10-3.3M 
io-\ 
10"^ '\ 
10"% 
10"% 
10"^ '& 
10 -3' 6 M 
10 ^M 
10"^ '& 
10"-^ M 
Toxic 
Toxi c 
2 9 + 3  3 0 + 7  
---  63 + 9 
75 ± 5 75 ± 5 
83 + 9 105 + 3 
Toxic -— 
Toxic 
Toxic 
36 + 5  2 1 + 5  
——— 30+ 4" 
——— 30 + 4 
105 +3 42 + 12 
-65^  
-10^  
-65^  
-71^  
-29^  
-50^  
.29^  
-29^  
a Means determined from 5 counts. 
Concentration of SH-reagent toxic for the cell culture. 
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Table 13. (Continued) 
SH-reagent 
Molar 
concen­
tration 
Mean plaque 
count + 28-
% change in mean 
plaque count 
Trial 1 Trial 2 Trial 1 Trial 2 
HgClg 10"\ 
—4. 3 10 M 
10"^ *^ M 
10-% 
10"^ M 
Virus control 
Toxic Toxic 
Toxic 
— — —  2  +  1  
7 5  ±  12  3 3  + 6  
10 2 + 3  3 9 + 9  
108  + 6  42 +  12  
-31^  
-6^  
-95^  
-21^  
-7^  
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Table 14. Results of experiment demonstrating that PHMB 
inactivates IBV 
Treatment Mean plaque counts^  % inactivation of IBV 
of virus 
Trial 1 Trial 2 Trial 1 Trial 2 
IQ-^ M PHMB for 
1 hour 
(dialyzed 
19 hours) 7 ± 2 3 +2 86^  96^  
lO-^ M PHMB 
for 20 hours 0 0.6+0.5 100^  99>5% 
Virus control 
(dialyzed 
19 hours) 49 + 4 73 +13 
M^eans determined from 5 counts. 
When cells were treated with L-cysteine, there was no effect 
observed. The results in Table I6 show that cell cultures 
treated prior to virus inoculation with 10"^M PHMB were 55% 
and 69% less sensitive to IBV than untreated cell cultures. 
It was also found that incorporation of L-cysteine into 
the agar overlay medium had no significant effect on IBV plaque 
numbers. Plaque counts on 5 CEK cell cultures overlayed with 
10" M L-cysteine containing agar medium had a mean of 86 + 9 
while counts on 5 other CEK cell cultures without L-cysteine 
in the agar medium had a mean of 105 + 4. 
Table 15. Reactivation of PHMB inactivated IBV 
Mean plaque 
count + 2Sj 
Mean 
PFU's 
number of 
inactivated 
% virus 
reactivation^  
Treatment of virus®" Trial 1 Trial 2 Trial 1 Trial 2 Trial 1 Trial 2 
10-^  PHMB + 
L-cysteine 
10"^ M 79 + 12 48 + 7 44 105 41^  19^  
lO-^ M PHMB + 
L-cysteine 
10-2.3M 81 + 9 80 + 5 42 73 43^  
PHMB 48 + 5 24 + 3 75 129 —  — —  
Virus control 123 ± 8 153 ± 23 0 0 —  —  —  —  —  —  
A^ll virus treatment and the virus control were dlalyzed overnight. 
percent virus reactivation determined by the ratio: 
PFU's inactivated by PHMB - FPU's Inactivated by PHMB + L-cystelne  ^
PPU's inactivated by PHMB  ^
Fig. 5» Kinetics of IBV inactivation using 10"^ , 
and lO-^ M PHMB. 
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Table l6. Effect of L-cysteine and PHMB on the sensitivity of 
CEK cell cultures to IBV when treated with these 
compounds for 2 hours prior to inoculation of virus 
Mean plaque®- % change in 
Molar count + 2g^  mean plaque count 
Confound 
concen­
tration Trial 1 Trial 2 Trial 1 Trial 2 
L-cysteine lO-^ M 90 + 19 167 + 25 -34# - 8^  
H
 
o
 i 9 2 + 8  -32* —  — —  
H
 
O
 i 100 + 10 — — —  
-27# —  — —  
PHMB H
 
O
 1 
Toxic Toxic — — — 
— — — 
1 o
 
H
 62 + 13 5 6 + 7  1 0\
 
H
 
O
 1 
118 + 12 114 + 11 -14^  -22# 
Virus control — — — 137 ± 8 181 + 10 —  —  —  — —  —  
M^eans determined from 5 counts. 
The effect of L-cysteine, DTT and PHMB on the infectivity 
of NDV are shown in Table 17. The thiols, L-cysteine and DTT, 
did not reduce the attachment of NDV nor did PHMB at a con­
centration of 10"^ M inactivate the virus. 
Determination of cell associated thiol groups 
Qualitative determination When the staining of CEK 
and CELi cells by mercury orange were coz^ ared, the following 
was observed. After 1 hour of staining the CEK cells were 
stained while the CELi cells showed very little visible stain 
Table 17. Effect of L-cystelne, DTT and PHMB on NDV 
Confound 
Molar 
concen­
tration 
Mean Plaque 
count + 28-
— X 
% change In mean 
plaque count In 
trials 
Trial 1 Trial 2 Trial 3 
L-cystelne 
DTT 
Virus control 
PHMB 
Virus control 
10"2 
10-3 
10"3 
10-3 
10"4 
51 ± 10 
4 9 + 6  
57 + 11 
26 + 4 ——— 
31+6 276 + 19 
3 2 + 8  2 6 3  +  1 7  
.10# 
——— ——— Toxic 
5 3 + 7  250 +17 37 ± 6 
5 7  +  1 1  2 7 6  + 2 5  3 2 + 5  
' % +5# 
-7# '5% +1S% 
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(Fig. 6). After 2 hours both cell types were stained and the 
i n t e n s i t y  o f  s t a i n i n g  w a s  c o n s i d e r e d  t o  b e  e q u a l  ( P i g .  7 ) .  
Both cell types were more intensely stained at 3 hours but 
further staining for up to 5 hours had no observable effect. 
The staining was almost completely blocked when the cells were 
treated with .OOIM PHMB prior to staining. 
Quantitative determination When the lysate and nuclear 
-cell membrane fractions of CEK and CELi cells were compared 
(Table 18), there was little difference in the content of 
thiol groups in trials 1 and 2. In trial 3» however, the 
nuclear-cell membrane and lysate fractions of CELi cells had 
2 and 4 times more thiol activity than did CEK cells. The 
observed difference in trial 3 may only reflect the difference 
in preparation of the cell fractions. 
When the second procedure was applied for the quantita­
tion of thiol groups of 5 different cell types, the results in 
Table 19 were obtained. The thiol group activity of each cell 
type is illustrated graphically in Fig. 8. While the cultures 
were incubating in the DTNB reagent they were examined micro­
scopically and all cell culture types appeared to remain intact 
and attached to the culture vessel during the 6-hour incuba­
tion. At 20 hours, however, the cells had detached from the 
vessel and all cells appeared to be lysed. Because of this 
complete lysis, the thiol activity detected at this time was 
regarded as the total thiol activity of the culture. The 
thiol activity of CEK and CELi cultures was essentially equal 
Pig. 6. Appearance of GELi (left) and CEK (right) cells 
after 1 hour staining with mercury orange. 
Fig. 7. Appearance of CELi (left) and CEK (right) cells 
after 2 hours staining with mercury orange. 
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Table 18. Quantitative determination of thiol groups in a 
lysate fraction and a nuclear-cell membrane frac­
tion of CEK and CELi cells in culture 
Molar concentration of 
Trial Cell SH groups/10 cells 
number type Lysate fraction Nuclear-cell membrane fraction 
1 CEK 1.19 X 
1 o
 
H
 0.286 X 
1 0 
1—1 
CELi 1.63 X H
 
O
 1 0.167 X H
 
0
 1 
2 CEK 1.46 X H
 
O
 1 0.385 X 
1 0
 
H
 
CELi 1.6 X H
 
O
 1 
0.49 X H
 
0
 1 
3 CEK 1.12 X H
 
O
 1 0.475 X H
 0
 1 
CELi 4.42 X H
 
O
 1 
0.96 X H
 
0
 
with this procedure. The thiol activity of the two fibro­
blastic chicken cell types were 2 to 3 times less than the 
epithelial CEK and CELi cell types during the first 6 hours 
of cell-DTNB reagent incubation. At 20 hours, the total ac­
tivity of the fibroblastic cultures was 1.2 to 1.4 times less 
active. The PK-15 cultures, which are epithelial in appear­
ance, had thiol group activity similar to fibroblastic cul­
tures during the first 6 hours but there total activity at 
20 hours slightly exceeded that of the CEK and CELi cultures. 
Table 19. Quantitation of thiol group activity of cultures of CEK, CELl, WCEPl, 
CEPl, and PK-15 by reacting the CTNB reagent with Intact cells In culture 
Molar concentration of SH groups x 10 / 
Reaction cell culture of type; 
time of 
reagent CEK CELl WCEPl CEPl PK-15 
with cells (hours) 37° 22° 37° 22° 37° 22° 37° 22° 37° 22° 
.5 0.27 0.19 0.32 0.19 0.08 0,09 0.08 0.10 0.04 0.04 
1 0.32 0.23 0.44 0.29 0.22 0.12 0.10 O.O9 0.08 O.O6 
2 0.84 0.27 1.08 0.34 0.19 0.32 0.10 —— 
3 1.08 0.45 1.00 0.49 0.50 0.34 0.23 0.41 0.09 
4 0. 46 0 . 50 « —i 0 . 34 mmmmimtam 0 . l6 ^ mm mm mm 
5 1.65 0.58 1.60 0.65 0.75 O.52 O.50 O.32 0.71 O.19 
20 4.74 3.84 4.59 6.00 3.70 3.12 2.68 4.89 
Pig. 8. Thiol activity of CEK, GELi, WCEPi, GEFi and PK-15 cells after incuba­
tion in DTNB reagent for different time intervals. 
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Inhibitors of IBV Attachment Found in Serum 
Demonstration and quantitation of IBV-inhibitors in serum 
Two bovine serum pools and a fetal calf serum pool were 
shown to have high IBV-inhibitory activity when present during 
the viral attachment period (Table 20). Activity was also 
demonstrated in serum pools of swine, chickens and rabbits 
(Table 20) with the highest apparent activity in the rabbit 
serum pool. 
When the IBV-inhibitory activity of individual serums 
from 3 different species of animals were tested, it was found 
that 4 of 20 cattle, 10 of 10 rabbits, and 3 of 4 chickens 
had a high level of activity (Table 21). Again the rabbit 
serums were the most active with 9^  ^or greater inhibitory 
activity with all 10 serums. 
The quantitation of the inhibitory activity of serums 
could be accomplished by allowing 100 PFU's of IBV to attach 
in the presence of varying concentrations of serum. The 
results of the quantitation of 4 different serums (Fig. 9 and 
Table 45) showed that the 2 serum pools, #681 and #1181, 
reached a maximum inhibition at the 6% level and were consid­
ered to be comparable in inhibitory activity. Serum #98 had 
a moderate inhibitory activity at the 10^  level and serum 
#5533 had no real significant activity up to the 10^  level. 
118 
Table 20. Effect of pools of serum from cattle, swine, chick­
ens, and rabbits on the attachment of IBV to CEK 
cell monolayers 
Concen-
Trial tration Mean plaque % change in 
number Serum type of serum count + 28- mean plaque count 
1 Bovine #681 20% 5 + 3 -^ Jfo 
Virus control 72 + 9 
2 Bovine #681 5^  40 + 8 
10% 28 ± 9 
20^  13 ± 7 
Virus control —  —  —  121 + 19 
3 Bovine #951 5^  22 + 3 
\o% 12 + 3 
Virus control —  —  —  115 ± 16 
4 Fetal calf 10^  10 + 5 
20% 5 + 3 
Virus control 
00 ON H
 + 7 
5 Swine 10% 20 + 4 
Chi cken 10% 20 + 2 
Virus control —  —  —  92 + 6 
6 Rabbit 10% 6 + 2 
Virus control — —  —  H
 
ON
 
+ 11 
-67^  
-77^  
-90^  
-9P^  
-95^  
-99^  
-78^  
-78^  
-96^ 
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Table 21. Effect of some individual serums from cattle, chick­
ens, and rabbits on the inhibition of IBV attach­
ment. All serums tested at 10^  concentration 
Species Mean plaque  ^change in 
tested Identification count + 28- mean plaque count 
Bovine 
Virus control 
4698 123 + 30 + 8^ 
4940 4 + 2 -96^  
4958 96 + 10 —16^  
5095 88 + 24 -23# 
5131 99 + 16 -14# 
5394 87 + 9 -23^ 
5397 99 + 12 -14^  
5400 83 ± 7 -28# 
5409 9 + 6 -92# 
5412 117 + 6 4. 2# 
5478 85 + 9 -26# 
5479 6 + 3 -95# 
5506 83 + 16 -28# 
5571 99 + 24 -14# 
5666 74 + 20 -36# 
5672 73 + 5 -37# 
5675 91 + 14 -21# 
5677 23 + 10 -80# 
5679 80 + 20 -30# 
116 + 16 
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Table 21. (Continued) 
Species Mean plaque % change in 
tested Identification count + 28- mean plaque count 
Rabbit 1 2+3 -9^ % 
2 1 ± 2 -99# 
3 2 + 2 -98# 
4  1 + 2  - 9 9 #  
5  1 + 2  - 9 8 #  
Virus control — 100 + l4 
Rabbit 13 4+0 -97# 
14 3 ± 2 -99# 
1 5  6 + 2  - 9 6 #  
1 6  4 + 2  - 9 7 #  
1 7  1 0 + 3  - 9 4 #  
Virus control — 156+12 
Chicken 1 33 ± 2 -67# 
2 17 ± 4 -83# 
3 31 ± 12 -69# 
4 87+9 -13# 
Virus control — 100+14 
Fig. 9. Quantitation of IBV-inhibitory activity of 2 bovine serum pools (#681 
and #1181) and 2 individual bovine serums (#98 and #5533). 
SERUM No. 
681 o 
1181 
98 0-——o 
5533 •"—"• 
fe 60 
t 40 
%SERUM 
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Table 22. Effect of bovine serum on the attachment of NDV to 
CEK cell monolayers 
% change in 
Mean plaque count + 28-^  mean plaque count 
Trial Trial 
Serum 
concentration 1 
20^  31 + 12 32 + 7 ——— +35^  "'3% ——— 
10% 284 + 26 +8^  
Virus control 38 + 4 57 + 12 263 + 21 
M^ean determined from 4 counts. 
Effect of bovine serum on NDV plaques 
Three trials with bovine serum #681 showed that NDV was 
unaffected by the presence of serum at the level of 10% and 
20% during viral attachment (Table 22). 
Effect of serum inhibitors applied to cell cultures prior to 
or following IBV attachment 
Table 23 shows the results of 4 experiments conducted to 
show the effect of IBV-inhibitory serum on the ability of CEK 
cells to attach IBV. When cell cultures were either implanted 
in a high concentration of serum or were treated with a high 
concentration of serum for 2 hours, there was a significant 
decrease in the attachment of IBV to such cultures. Also, 
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Table 23. Effect of exposure of cells to high concentrations 
of IBV-inhibitory serum upon their ability to 
attach IBV 
% change 
Experiment Mean plaque in mean 
number Treatment of cells count + 28- plaque count 
a. Cells implanted in 
fo serum 29 + 7 
b. Cells implanted in 
serum (control) 42 + 6 
a. Cells implanted in 
ZQ% serum JO ± 7 -50% 
b. Cells implanted in 
serum (control) 60 + 6 
a. Cells treated with 
kO% serum for 2 hours 
prior to virus inoc­
ulation 96 + 12 -30% 
b. Cells treated with serum 
free medium for 2 
hours prior to virus 
inoculation 
(control) 137 i  ^ — 
a. Cells implanted in 
8% IBV-inhibitor 
free serum 77 ± 7 +^ 7% 
b. Cells implanted in 
8% IBV-inhibitor 
containing serum 51+8 
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attachment of IBV was increased by 4?^  when CEK cells were 
implanted in a non-inhibitory rather than an inhibitory bovine 
serum. 
There was little or no effect on mean plaque counts when 
serum was incorporated into the agar-overlay medium at 2.5^ ', 
5.0^  and 20^  concentrations as shown in Table 24. There was 
a reduction in the plaque size when serum was present and 
plaque sizes of 0,75 to 1.5 mm in diameter at 40 hours were 
observed with 5^  serum-agar medium while they were 1.5-2.25 mm 
in diameter without serum in the agar. When 20^  serum was 
used in trial 4 (Table 24) the plaques were very minute and 
required an additional 24 hours incubation before they were 
large enough to count with any accuracy. 
Characterization of the lEV-inhibitor in bovine serum 
Inhibitory fractions of bovine serum There was no 
inhibitory activity against IBV found in commercial prepara­
tions of bovine albumin, gamma globulin, or fetuin (Table 25). 
There was, however, high activity observed in a gamma globulin 
preparation of bovine serum #681 (V681) obtained by precipita­
tion with 1/3 volume saturated (Table 25). 
When the inhibitory activity of V681 was compared to that 
of whole bovine serum #681, it was found that they were essen­
tially equal (Fig. 10 and Table 46). The results of sequen­
tial precipitation of bovine serum #681 with 1/3. 1/2 and then 
3/5 volume saturated (NH4J2SO4 given in Table 26. Essen-
Table 24. Effect of bovine serum #681 on mean plaque counts when incorporated into 
the agar-overlay medium 
Concentration Mean plaque counts + 28^  % change in mean plaque 
of serum in in trial:®- count in trial: 
agar medium 
1 2 3 4 1 2 3 4 
Control (0^ ) 28 + 4 88 ± 13 5 4 + 7  H
 O
 
1+
 4 — — — —  —  —  —  —  —  —  — —  
2 . #  20 + 6 99 ± 9 48 + 9 —  —  —  "  -29# +12# -11# 
5.0# —  —  —  •  42 + 7 —  —  —  - -22# — — — — 
20.0# — —  —  —  —  86 + 6 — —  —  —  —  —  —  —  —  -18# 
M^eans were determined from 5 counts. 
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Table 25. Effect of some selected serum fractions on the 
attachment of IBV 
Mean % change 
Goncen- plaque in mean 
tration count plaque 
Serum fraction tested + 28- count 
Bovine albumin 0. 2 gm/ml 25 ± 6 +13^  
Bovine gamma globulin 
(commercial) 0. 2 gm/ml 1+
 4 +55^  
Fetuin precipitated] 0. 02 gm/ml 21 + 3 -
Fetuin (alcohol precipitated) 0. 02 gm/ml 20 + 3 -  9% 
Virus control - -— +
1 CM CM 3 — — — 
Bovine gamma globulin #681 
[(NHij.) gSOij, precipitated) 10^  2 + 1 
-97^  
Virus control 
- •  — 70 + 8 — — — 
tially all of the inhibitor is contained in the first precip­
itate. There was moderate activity in the second precipitate 
at levels of 20 and 30^  while the third precipitate and the 
non-precipitated fraction had no significant inhibitory activ­
ity. 
Destruction and removal of IBV-inhibitors in bovine serum 
Heat stability Results in Table 27 show that the 
inhibitory activity of bovine serum #681 was essentially de­
stroyed at 60° for 90 minutes and at 65° for 10 minutes. When 
unheated serum activity was compared with that of serum heated 
Pig. 10, Quantitation of whole serum #681 and the precipitated 
globulin fraction of serum #681. 
% SERUM 
o WHOLE SERUM Na68l 
e Y GLOBULIN Ma 681 
I ' I 
8 10 
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Table 26. Effect of serum fractions from bovine serum #681 
sequentially precipitated with 
Serum fraction of 
bovine serum #681 
Concen­
tration 
tested 
Mean 
plaque 
count 
± 
# change 
in mean 
plaque 
count 
1/3 volume (NH^ )2S0j^  precipitate 20^  9 + 4 -91# 
30# 8 + 3  -92# 
1/2 volume (NH^ )2S0^  precipitate 20# 6 1 + 7  -42# 
30# 40 + 3 -62# 
3/5 volume (NH2^ )2S02j, precipitate 20# 108 + 5 + 3# 
30# 77 ± 7 -27# 
Virus control — — — 105 + 4 — — — 
Non-precipitated fraction 
Virus control 
110 + 8 
120 + 6 
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Table 27. Effect of 60 and 65 on IBV-lnhibitory activity of 
bovine serum #681, A concentration of 10% serum 
was heated and then tested for IBV inhibition 
Mean plaque % change in mean 
Length of time count + 28- plaque count 
serum heated Temper- . 
in minutes ature Trial 1 Trial 2 Trial 1 Trial 2 
0 —  —  —  12 + 1 10 + 4 -76# -80# 
15 60° 1 8 + 3  21 + 6 -63# -57% 
30 60° 27 + 4 25 + 5 -45# -49# 
60 ON
 
0
 0 33 ± 4 28 + 5 -332 "--43# 
90 60° 38 + 4 41 + 5 -22^ -16# 
120 60° 45 ± 7 43 + 11 - 8^ -12# 
Virus control 49 ± 7 49 + 7 — — —  — —  
0 —  —  —  7 + 5  — -95% —  — —  
10 65° 98 + 13 -— -12% 
20 65° 74 + 16 — -34* —  — —  
30 65° 7 6 + 5  — -32* —  — —  
Virus control 112 + 10 — —  —  —  
at 56° for 30 minutes and 65° for 20 minutes, it was found 
that the 65° treatment destroyed all activity and 56° reduces 
the inhibitory only slightly (Fig. 11 and Table 4?). 
Neuraminidase treatment Treatment of a 20JÉ solu­
tion of bovine serum #681 with as high as 1 unit/ml of neur-
Pig. 11. Comparison of IBV-lnhlbltory activity of unheated serum #681 with that 
of the same serum heated at 56° for 30 minutes and 65° for 20 minutes. 
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aminidase had no effect on reducing its inhibitory activity 
(Table 28). 
Acetone treatment Extraction of serum with ace­
tone did not destroy the serum's inhibitory activity (Table 
28) .  
Kaolin adsorption The inhibitory activity of 
serum could not be removed on kaolin as shown in Table 28. 
DTT treatment Treatment of serum with either 
.OOIM or .OlM DTT destroyed the majority of the IBV-inhib-
itor in bovine serum #681 (Table 28). It was also shown that 
alkylation with iodoacetamide was not necessary after DTT 
treatment to prevent restoration of the inhibitory activity 
after the DTT was removed by dialysis. 
Physical characterization of IBV-inhlbitors in bovine 
serum 
Ultrafiltration When serum was passed through a 
collodion filter with pores less than 5 in diameter the IBV-
inhibitory activity was completely retained by the filter 
(Table 29). These filters allow passage of molecules of 
30,000 molecular weight or less to pass, thus, the IBV-inhib-
itor must be a relatively large molecule. 
Bate-zonal centrlfugation When a 6-fold concen­
trate of y68l was subjected to a sucrose rate-zonal centri-
fugation, the results in Fig. 12 and Table 48 were found. The 
IBV-inhibitory activity was evenly distributed from the 4th 
fraction to the 8th fraction. It had been previously estab-
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Table 28, Results of treatment of IBV-inhibitory bovine serum 
#681 with neuraminidase, acetone, kaolin and dithio-
threitol (DTT) 
Mean % change 
Concentration of: plaque in mean 
count plaque 
Reagent Reagent Serum ± count 
Neuraminidase 5.0 units 20# 3 ± 0 -88# 
Neuraminidase .5 units 20# 4 ± 3 -84# 
N euramini das e .05 units 20# 2 ± 2 -92# 
N euraminidas e .005 units 20# 2 ± 1 -92# 
Untreated serum —  — — —  20# 2 ± 2 -92# 
Virus control 
—  —  — —  
— — — 25 ± 3. — — — — 
Acetone extraction 1 —  —  — —  10# 77 ± 8 -61# 
Acetone extraction 2 —  —  — —  10# 67 ± 13 -67# 
Untreated serum 
—  —  — —  10# 47 ± 3 -76# 
Virus control —  —  —  198 ± 9 — — — 
Kaolin adsorbed 1 gm/5 ml 10# 8 ± 2 -83# 
Untreated serum —  —  — —  10# 5 ± 1 -91# 
Virus control —  —  —  —  
— — —  
48 ± 6 —  —  —  
DTT treated Y&81 
(alkylated) .OOIM 10# 123 ± 7 -26# 
Untreated %8l — — —  10# 23 ± 5 -86# 
Virus control 
— —  
l66 ± 11 —  —  —  —  
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Table 28. (Continued) 
Reagent 
Concentration of: 
Reagent Serum 
Mean 
plaque 
count 
± 
% change 
in mean 
plaque 
count 
DTT treated Y6Q1 
(alkylated) 
DTT treated f68l 
(not alkylated) 
Untreated tSdil 
Virus control 
OlM 
OlM 
10% 
10$ 
10$ 
84 + 12 -12$ 
7 7 + 4  
7 + 2  
96 + 11 
-20$ 
-93$ 
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Table 29. IBV-inhibitory activity of the retained portion and 
the filtrate of bovine serum #681 when filtered 
through a collodion ultrafilter 
Portion of 
ultrafiltered serum 
Concen­
tration 
tested 
Mean plaque 
count + 28g 
% change 
in mean 
plaque count 
Filter-retained portion 20% 1 + 0.6 -92% 
Whole serum 20% 2 + 0.8 
-96% 
Virus control 25 ± 3 — — — — 
Filtrate portion 20% 61 + 6 +11^  
Whole serum 20% 2 ± 0.7 -96^  
Virus control 55 ±7 — — — — 
lished that under these conditions of centrifugation the 75 
globulins were primarily in fractions 3 to 5 and the 195 glob­
ulins in fractions 7 to 9 (Page et al., I967). 
Gel filtration The IBV-inhibitory activity of 
each fraction collected from the Sephadex G-200 column is 
shown in Table 4-9. When this activity is plotted graphically 
in relation to UV-absorbance at 280 (Fig. 13), it can be 
seen that only samples 5-10 and sample 17 appeared to show 
significant levels of IBV inhibition and these samples lie 
near but just off of the peaks of O.D.gso* When samples 1-26 
and 5-10 were pooled and concentrated, their inhibitory activ­
ities were almost equivalent and both had only about 50^  of 
Pig. 12, Distribution of IBV-lnhlbltory activity In fractions collected from a 
sucrose rate-zonal centrlfugatlon. 
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Table 30. IBV-inhibitory activity of concentrated pooled sam­
ples 1-26 and 5-10 from the Sephadex G-200 column 
Concen- Mean plaque % change in 
Samples tested tration count + 2S- mean plaque count 
Pooled samples 1-26 10^  30 + 5 -57^  
Pooled samples 5-10 10^  49 + 8 -43^  
Pooled samples 
0
 H 1 20^  23 + 3 -67^  
/681 10^  2 + 1 -97^  
Virus control — — — 70 + 8 — — — — 
the activity of the original YfeSl (Table 30). Thus, it appears 
that most of the activity in the first 26 samples from the 
column is found in samples 5-10, 
Reversal of IBV-inhibitor activity in bovine serum 
The results of the reversal effect of 15 sugars on the IBV-
inhibitor of bovine serum are presented in Table 31» There 
were 4 sugars that did not significantly reverse the inhib­
itor, i.e., lactose, D-galactose, L-arabinose, and D-glucos-
amine. Eleven of the sugars reversed the inhibitory effect 
by 60% to 176^  with the disaccharides being less active than 
the monosaccharides. The effects of some of the sugars alone 
on virus attachment are shown in Table 32. While the sucrose 
and glucose had no significant effect on mean plaque counts, 
there was a marked increase in plaque counts when the methyl­
ated glucosides were used. 
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Table 31. Effects of several simple sugars on the IBV-inhib­
itory effect of serum. Virus was allowed to 
attach in the presence of 1.5^  sugar and 10% serum 
Mean plaque count 
± 28g 
% of IBV-inhib-
itory activity 
reversed by 
sugars-
Sugar tested Trial 1 Trial 2 Trial 1 Trial 2 
Sucrose 79 ± 20 — 52^  
Lactose 16 + 5 — —  — —  
Maltose +
1 o
 
H
 10 — 72^  
D-glucose 130 ± 24 134 + 17 90^  166# 
L-glucose 
—  — - 90 + 20 —  —  —  108# 
D-galactose +
1 20 22 + 4 27^  18# 
D-mannose 
—  —  - 120 + 12 —  —  —  147# 
D-fructose 107 ± 8 122 + 3 69^  150# 
D-xylose 116 + 3 71 + 11 80^ 83# 
D-ribose 65 + 10 —  —  —  75# 
L-arabinose 56 ± 11 28 + 12 35^  26# 
2-deoxy-D-glucose 
—  — -
120 + 5 —  — —  147# 
D-glucosamine 
—  — - 35 + 8 —  —  —  35# 
d-methyl-D-glucoside 97 + 8 —  117# 
/3 -methyl -D-gluco side 
—  —  - 76 + 16 —  — —  91# 
10^  serum control 9 ± 1 8 + 8 —  —  —  —  — —  
Virus control H 1+
 
12 84 + 8 —  —  —  —  —  —  
P^ercentage determined by the ratio of: 
Mean count with sugar - Mean count serum control lOO^  
Mean count virus control - Mean count serum control  ^
Table 32. Effect of sucrose, glucose, and cL and methylated 
glucosides on attachment of IBV 
Sugar tested 
Concen­
tration 
Mean plaque 
count + 28-
— X 
% change 
in mean 
plaque count 
Sucrose 1.0^  138 ± 7 - 32 
Sucrose 115 ± 6 -202 
Virus control — — — 143 ± 12 —  —  —  
Glucose 1 .#  95 ± 15 +132 
o(-methyl-D-glucoside 1.52 l66 + 6 +982 
-methyl-D-glucoside 1.52 122 + 10 +452 
Virus control —  —  —  84 + 8 —  — —  
ct-methyl-D-glucoside 1.52 109 ± 10 +6o^  
Virus control —  —  —  68 + 9 
When CEK cells were treated with either 1.5% D-glucose 
or alpha-methyl-D-glucoside for 2 hours prior to inoculation 
with IBV, there was a 30% increase in plaque counts in the 
alpha-methyl-D-glucoside treated culture and no increase in 
the glucose treated cells (Table 33). This was considered 
significant since the inoculum came from a single dilution, 
thus reducing the possible variation due to dilution. 
When virus was allowed to attach for 90 minutes in the 
presence of 10^  serum and then either D-glucose, D-galactose 
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Table 33. Effect on IBV attachment by treating CEK cell mono­
layers with either D-glucose or alpha-methyl-D-
glucoside for 2 hours prior to virus inoculation 
Cell treatment 
Concen­
tration 
Mean plaque 
count + 28-
— X 
% change 
in mean 
plaque count 
D-glucose 1-5% 
d-methyl-D-glucoside 1*5^  
Virus control 
72 + 4 
93 ± 6 
7 0 + 5  
+ 3^  
+30^  
or alpha-methyl-D-glucoside was added and another 90minute 
attachment period allowed, there was an effective reversal of 
the inhibitor by D-glucose and the methylated glucose but not 
by D-galactose (Table 34). The reversal was not as complete 
as when virus-serum-sugar mixtures are allowed to attach at the 
same time. 
The IBV-inhibitors of swine, chicken, and rabbit serums 
were similar to those in bovine serums with respect to their 
reversal by alpha-methyl-D-glucoside. The results of their 
reversal are shown in Table 35« In trial 1, it can be seen 
that the levels of inhibitor were so high in rabbit serum 
that 1.5^  alpha-methyl-D-glucoside only reversed the effect 
of 10% serum slightly. In Trial 2, it can be readily seen 
that 2 rabbit serums were reversed significantly only when 1% 
serum was used. 
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Table 3^ . Effect of adding sugars to inocula of IBV contain­
ing 10^  inhibitory bovine serum after an initial 
90-minute attachment 
Sugar added 
Concen­
tration 
Mean plaque 
count + 28-
— X 
% of IBV-
inhibitory 
activity 
reversed^  
by sugar 
Alpha-methyl-D-glucoside 1.5^  
D-glucose 1*5^  
D-galactose 1-5^  
10^  serum control 
Virus control 
122 + 2 
89 + 16 
1 8 + 4  
13 + 4 
210 + 16 
55  ^
39  ^
2.5^  
p^ercentage determined by ratio of: 
Mean count with sugar - Mean count serum control x 100^  
Mean count of virus control - Mean count of serum control 
Mode of action by IBV-inhibitors In serum When virus 
attachment was performed in the presence and absence of serum 
and the unattached virus assay assayed in the presence of 
1 . 5 ^  g l u c o s e ,  w h i c h  r e v e r s e  t h e  i n h i b i t o r ,  t h e r e  w a s  4 3 + 7  
PFU's remaining in inocula containing serum and 18 + 4 PFU's 
in inocula without serum. This indicated that 2.5 times more 
virus remained unattached in the presence than in the absence 
of serum. 
The effect of serum and serum-PHMB mixtures on the attach­
ment of IBV showed that PHMB enhanced the reduction of plaques 
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Table 35- Reversal of the IBV-inhibitor of swine, chicken, 
and rabbit serums by 1.5^  alpha-methyl-D-glucoside 
Mean plaque fo of IBV-
Concen­ count + 2S- inhibitory 
Trial Type of tration X activity^  
number serum of serum alone sugar reversed 
Swine 10% 5 + 3 96 + 16 210# 
Chicken #124 10^  24 + 8 95 + 16 300# 
Chicken #240 \Q% 17 + 2 95 + 13 250# 
Chicken #281 10^  27 + 7 95 + 9 320# 
Rabbit #14 10% 1 + 1 15 + 2 30# 
Rabbit #15 10% 1 + 1 17 + 6 34^ 
Rabbit #l6 10% 2 + 2 17 + 10 33# 
Rabbit #17 H
 
o
 
1 + 1 16 + 8 32# 
Virus control — — — 48 + 6 48 + 6 — — — 
Rabbit #l6 13 ± 3 56 + 3 78# 
8 + 2 29 + 5 35# 
5^ 2 + 2 19 3 26# 
10% 2 + 2 13 + 5 17# 
Rabbit #17 1^ 6 + 3 50 + 5 71# 
4 ± 2 26 + 10 34# 
5^ 4 + 2 21 + 5 27# 
10% 1 + 1 15 + 3 21# 
Virus control — — — 68 + 9 68 9 — — — 
P^ercentage expressed as a ratio of: 
Mean count (serum and sugar) - Mean count (serum alone) ^  lOO^  
Mean count (virus control - Mean count (serum alone) 
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Table 36. Effect of PHMB on the IBV-inhlbitor of bovine serum 
when virus attachment in the presence of bovine 
serum and PHMB-bovine serum mixtures are compared 
Treatment 
Serum 
of virus 
PHMB 
Mean plaque 
count + 2S-
% change in mean 
plaque count 
0 0 121 + 18 — — — — 
0 H
 0
 1 
37 + 3 -69# 
5^ 0 40 + 8 -67# 
H
 0
 1 9 ± 3 -93^ 
10^ 0 28 + 9 -77^ 
1.0% H 0
 1 6 + 2 -95# 
20^ 0 13 + 7 -89# 
zo% 
1 0
 
H
 3 ± 1 -98# 
when added to serum (Table 36). This is not true of cysteine-
PHMB mixtures in which the inhibitory effect of both is 
reduced; thus, the active inhibitory groups of bovine serum 
IBV-inhibitors are probably not thiol groups. 
Effect of bovine serum and filtrate of bovine serum on 
IBV cytopathological changes and plaque size When 10% 
and 20^  whole bovine serum was used in culture medium of cells 
inoculated with 10^ '^  FPU's of virus, there was a sparing 
effect on the infected cells exhibited by the fact that they 
remained attached to the culture vessel for about 24 to 48 
hours longer than infected cells with 1% serum (Figs. 14, I6, 
Pig. 14. (Upper left) Fluorescent antibody staining of CEK 
cells 24 hours postinfection with 10°*5 PFU's of 
IBV. The medium contained Vfo bovine serum. 
Pig. 15. (Upper right) Fluorescent antibody staining of CEK 
cells 24 hours postinfection with 10°'^  FPU's of 
IBV. The medium contained 20^  bovine serum filtrate. 
Pig. 16. (Lower left) Fluorescent antibody staging of CEK 
cells 24 hours postinfection with 10°'^  FPU's of 
IBV. The medium contained 10^  bovine serum. 
Fig. 17. (Lower right) Fluorescent antibody staining of CEK 
cells 24 hours postinfection with 10°*5 FPU's of 
IBV. The medium contained 1.% bovine serum filtrate. 
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171 18 and 19). The spread of viral infection in cultures 
2 4 inoculated with 10 *FPU's was greatly curtailed in the 
presence of 10 and 20^  serum as shown at 48 hours in Pig. 24. 
The serum filtrate exhibited neither the "cell sparing" 
property nor the "anti-spreading" property of whole serum. 
Pigs. 14 and 15 show that when cell cultures were inoculated 
with 10^ *^  FPU's of virus and contained 20^  filtrate, the 
destruction of the monolayer was much more con^ lete at 24 
hours. Virus spread and cell destruction in cultures infected 
2 4 
with 10 * FPU's of virus was much greater at 24 and 48 hours 
as shown in Pigs. 20, 21, 22 and 23. 
Pig. 25 shows 40-hour IBV plaques formed under agar 
medium containing serum filtrate, whole serum, and serum-free 
medium. The plaques range from 2-4 mm with 20^ filtrate, 0 , 7 5  
2 mm with 5% whole serum, and 1-3 mm with only agar medium. 
Effect of some selected compounds on IBV attachment 
Salicylates No effect on IBV attachment was 
observed by the presence of 3 different salicylates as shown 
in Table 50. 
Amantadine hydro chloride When IBV was allowed to 
attach in the presence of concentrations of amantadine hydro­
chloride up to 100 ^ g/ml, there was no significant decrease 
in attachment (Table 50). 
Pancreatin The results in Table 37 show that 
pancreatin alone increased plaque numbers significantly and 
Fig. 18. (Upper left) Fluorescent antibody staging of CEK 
cells 48 hours postinfection with 10°*-5 PFU's of 
IBV, The medium contained 10% bovine serum. 
Fig. 19. 
Fig. 20. 
(Upper right) Fluorescent antibody staining of CEK 
cells 48 hours postinfection with 10"•5 PFU's of 
IBV. The medium contained 20^  bovine serum. 
(Lower left) Fluorescent antibody staining of CEK 
cells 24 hours postinfection with 10^ '5 pFU's of 
IBV. The medium contained 1.% bovine serum filtrate. 
Fig. 21. (Lower right) Fluorescent antibody staining of CEK 
cells 24 hours postinfection with 10 PFU's of 
IBV. The medium contained 20^  bovine serum filtrate. 
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Fig. 22. (Upper left) Fluorescent antibody staging of CEK 
cells 48 hours postinfection with 10^*PFU's of 
IBV. The medium contained bovine serum filtrate. 
Fig. 23. (Upper right) Fluorescent antibody staining of CEK 
cells 48 hours postinfection with 10^ *5 pFU's of 
IBV. The medium contained 20^  bovine serum filtrate. 
Fig. 24. (Lower left) Fluorescent antibody staging of CEK 
cells 48 hours postinfection with 10 PFU's of 
IBV. The medium contained 10^  bovine serum. 
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Fig. 25. Appearance of IBV plaques at 40 hours postinfection 
with agar overlay containing 5% bovine serum, serum-
free medium, and 20^  bovine serum filtrate. Top 
row - 5% serum overlay; middle row - serum-free 
overlay; and bottom row ~ Z0% serum filtrate over­
lay. 
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Table 37. Effect on IBV attachment by panoreatln and 
combinations of pancreatin with either alpha-
met hyl-D-gluco side (AMG) or bovine serum 
Virus attachment Mean plaque % change in mean 
in presence of: count + 28- plaque count 
Pancreatin (1:20) 172 + 12 + 90  ^
Pancreatin (1:30) 161 + 23 + 78  ^
Pancreatin (1:40) . 148 + 14 + 54  ^
Pancreatin (1:20) + 1.5^ AMG C
O
 H
 + 15 +102  ^
Pancreatin (1:30) + 1.5# AMG 170 ± 11 + 88$ 
Pancreatin 
0
 
H
 + H
 1
 
142 ± 8 + 48# 
Pancreatin (1:20) + 5/È serum 16 ± 3 - 83$ 
Pancreatin (1:30) + serum 16 ± 3 - 83$ 
Pancreatin 
0
 
H
 +. serum 15 ± 4 - 84$ 
1.5^ AMG 136 ± 3 + 42$ 
5/^  serum 9 ± 3 - 91$ 
Virus control 96 11 
when both pancreatin and alpha-methyl-D-glucoside were pre­
sent, there seemed to be an even greater increase. When pan­
creatin and serum IBV-inhibitor were present, the inhibitor 
appeared to be only slightly less effective. 
Neuraminidase and NANA Table 38 shows that cell 
monolayers treated with 5 and 10 units of neuraminidase were 
less sensitive to IBV while these same concentrations did not 
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Table 38. Effect on IBV and NDV attachment by either neur­
aminidase treatment of CEK cell monolayers or pres­
ence of N-acetylneuraminic acid (NANA) during virus 
attachment period 
Treatment 
Concen­
tration 
Mean plaque 
count + 28^  
% change in 
mean plaque 
count 
IBV NDV IBV NDV 
Neuraminidase®" 25 units 22 + 4 97 + 3 -86* -63* 
Virus control 153 ± 264 + 1 —  —  —  —  —  — —  —  
Neuraminidase^  10 units 6 + 2 79 + 13 -83* -18* 
5 units H 1+
 4 103 + 15 —60* + 7* 
2.5 units 22 + 4 115 + 8 -37* +20* 
Virus control 35 ± 7 96 + 13 — — 
NANA^  1.5^  9 ± 3 — -96* —  —  — —  
Virus control 152 ± 15 - •  — —  —  —  —  —  —  — —  
NANA^  1.5^  0.25 + 0.5 31 ± 6 -98* -67* 
0.75% +
1 0 H 1 45 + 11 -96* 
-53* 
Virus control 27 + 5 95 ± 3 — — —  —  — — — — 
•^Cells were treated for 1 hour at 37° just prior to inoc­
ulation. 
1^ rus was allowed to attach in the presence of NANA. 
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significantly decrease NDV plaques; however, treatment with 
25 units was effective against both viruses. When NANA was 
present during attachment of both IBV and NDV, there was a 
significant decrease in attachment of both viruses with IBV 
apparently being inhibited to the greatest extent (Table 38). 
Lysosomal Changes in IBV Infected Cells 
Histochemical procedure 
When unfixed uninfected CEK and CELi cells were stained 
for acid phosphatase activity, the staining was confined to 
cytoplasmic foci with no diffuse staining observed. In CEK 
cells, lysosomes began to stain at 1 hour with more and more 
becoming evident until at 3 hours maximum staining was ob­
served with all cells showing specific acid phosphatase stain­
ing. Figs. 26, 27, and 28 show uninfected CEK cells stained 
for 1, 2, and 3 hours. The photographs were taken with dark-
field illumination, thus, the stained lysosomes appear as 
bright foci. The uninfected CELi cells exhibited a different 
staining pattern in that it required 2 hours of staining to 
detect lysosomes and by 3 hours the lysosomal staining was 
maximal (Pigs. 29, 30, 31 and 32). The CELi cells also dif­
fered in that not all cells exhibited the same degree of acid 
phosphatase activity as did the CEK cells when stained max­
imally. 
Infected cells of both CEK and CELi cell types exhibited 
the same acid phosphatase staining pattern for up to 12 hours 
Fig. 26, (Upper left) Uninfected CEK cells incubated for 
1 hour in ^ -glycerophosphate substrate. Acid phos­
phatase activity is detected as bright granules when 
observed by dark field illumination. 
Fig. 27. (Upper right) Uninfected CEK cells incubated for 
2 hours in ^ -glycerophosphate substrate. Dark field 
illumination. 
Fig. 28, (Lower left) Uninfected CEK cells incubated for 3 
hours in 0-glycerophosphate substrate. Dark field 
illumination. 
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Fig. 29. (Upper left) Uninfected GELi cells incubated for 2 
hours in ^ -glycerophosphate substrate. Dark field 
illumination and 72X magnification. 
Fig. 30. (Upper right) Uninfected CELi cells incubated for 
2 hours in ^ -glycerophosphate substrate. Bright 
field illumination and 48OX magnification. 
Fig. 31. (Lower left) Uninfected CELi cells incubated for 
3 hours in ^ -glycerophosphate substrate. Dark 
field illumination and 72X magnification. 
Fig. 32. (Lower right) Uninfected CELi cells incubated for 
3 hours in (J-glycerophosphate substrate. Bright 
field illumination and 48OX magnification. 
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postinfection that was observed in uninfected cells. Pigs. 
33» 3^ . 35» and 36 show CEK cell 8 and 12 hours after IBV 
infection that were stained for acid phosphatase for 2 hours 
and then stained with fluorescent antibody. There is no 
direct relationship between infected cells as detected by 
fluorescence and cells showing acid phosphatase activity. Not 
until 18 hours postinfection was there observable deviation 
from normal acid phosphatase staining and these deviations 
were detectable in infected cells showing very advanced cyto-
pathological changes. These dying cells were stained after 
shorter incubation in the substrate and there was no diffuse 
cytoplasmic staining, indicating release of the enzyme from 
lysosomes. This type of staining was especially evident in 
the large virus induced syncytia as shown in Figs. 37 and 38. 
The same staining pattern was observed with the infected GELi 
cells. The cytopathic effect of IBV in GELi cells differs in 
that cells do not die and release from the vessel as rapidly 
and viral induced syncytia are much smaller than in CEK cells. 
Figs. 39 and 40 show a small GELi syncytium 18 hours postin­
fection stained for acid phosphatase for 2 hours and then 
stained with fluorescent antibody. It can be readily seen 
that this syncytium does not exhibit any marked acid phospha­
tase activity. 
Fig, 33' (Upper left) Infected CEK cells 8 hours postinfec­
tion. The cells were incubated for 2 hours in |3-
glycerophosphate substrate and stained with fluores­
cent antibody to show infected cells (30OX magnifi­
cation) . 
Fig. 3^ . (Upper right) Same field as Fig. 33 with dark field 
illumination to show acid phosphatase activity. 
Fig. 35» (lower left) Infected CEK cells 12 hours post­
infection, The cells were incubated for 3 hours in 
(''-glycerophosphate substrate and stained with fluo­
rescent antibody to show infected cells (300X mag­
nification) . 
Fig. 36. (Lower right) Same field as Fig. 3^  with dark field 
illumination to show acid phosphatase activity. 
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Pig. 37* (Upper left) Infected CEK cells 18 hours postinfec 
tion. The cells were incubated for 2 hours in p-
glycerophosphate substrate. Bright field illumina­
tion and 12OX magnification. 
Fig, 38. (Upper right) Syncytium observed in Fig. 37 with 
48OX magnification showing both localized and diffuse 
acid phosphatase staining of the cytoplasm. 
Pig. 39» (Lower left) Infected CELi syncytium 18 hours post­
infection. The cells were incubated for 2 hours in 
-^glycerophosphate substrate and stained with fluo­
rescent antibody (480X magnification). 
Pig. 40. (Lower right) The same syncytium as Pig. 39 with 
bright field illumination showing absence of acid 
phosphatase activity. 
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Table 39. Acid phosphatase activity of soluble (S) and mito­
chondrial -lysosomal (ML) fractions of CEK cells 
infected with IBV as compared to uninfected cells 
Acid phosphatase activity of: 
Sigma units activity^ / 
Hours after infection O.D. 10 mg protein 
of CEK cell with 
10°0 FPU'S of IBV S ML S ML 
8 hour (uninfected) .18 .12 2.0 4.3 
8 hour (infected) .15 .11 1.2 2.3 
16 hour (uninfected) .09 .12 0.6 2.3 
16 hour (infected) .07 .10 0.8 3.1 
O^ne Sigma unit of acid phosphatase liberates 1 ^M of 
p-Nitrophenol per hour at pH 5 and 38°. 
P^rotein determinations of each fraction were made by 
the biuret procedure (Gornall et al., 19^ 9). 
Qualitative procedure 
The results of acid phosphatase assays of the soluble and 
ML fractions of IBV infected CEK cells confirmed the histo-
chemical results and are shown in Table 39. There was no 
significant release of acid phosphatase activity from the ML 
fraction of CEK cells infected for either 8 or 16 hours. 
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DISCUSSION 
The results of this study concerning the attachment of IBV 
to susceptible cell monolayers clearly reveals the complexity 
of this initial step of viral infection and replication. At 
least two factors affecting viral attachment, attachment inter­
ference and serum IBV-inhibitors, were shown to be present in 
the virus-cell systems studied. These, and possibly other 
factors, make the attachment of IBV to cells a very inefficient 
process. A third factor that might well be considered is that 
the cell systems as prepared in this study of IBV-cell inter­
actions are difficult to standardize. The CEK cell cultures, 
the most IBV-sensitive cell type, do not contain a completely 
homogeneous cell population and some nonsusceptible cells are 
present in each culture. It was also shown that the chemical 
nature of IBV receptors is quite complex. At least 3 separate, 
seemingly unrelated, chemical groups may be involved: (1) 
thiol groups, (2) neuraminidase sensitive groups, and (3) 
serum IBV-inhibitor sensitive groups. The prevention of IBV 
attachment with relatively simple compounds such as cysteine 
and NANA was of great interest and surely substantiates the 
role of thiol groups and carbohydrates as a part of the cellu­
lar IBV receptor moitiés. The reversal of the serum IBV-
inhibitor with many simple sugars may eventually shed some 
light on which chemical groups function as attachment inhib­
itors. Receptors for IBV were shown to be similar to those of 
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NDV only in their sensitivity to neuraminidase and inhibition 
by NANA, while thiols, SH reagents, and serum did not alter 
NDV attachment. 
In regards to virus attachment, two previous reports 
(Cunningham and Spring, I965, and Lukert, 1965) had determined 
that maximum IBV attachment to CEK monolayers occurred by 
90 minutes. In light of the findings of this study, it can be 
more correctly said that for a given IBV-CEK cell culture 
system essentially all of the virus that will attach to a 
particular culture has attached by 90 minutes but by no means 
has all of the infective virus been removed from the inoculum. 
The attachment interference of a 2nd dose of IBV by a 
1st dose of homologous virus appears to resemble that described 
for enteroviruses by Crowell and Syverton (I96I). They initial­
ly found that HeLa cells continually carrying and producing 
coxsackievirus B3 interfered with coxsackievirus B1 and B5. 
Later reports by Crowell (I963 and I966) showed that exposure 
of HeLa cells to high levels of virus (200 FPU's or more/cell) 
for 1 hour could also induce this interference and it was 
felt that the mechanism was either destruction or blockade of 
cell receptors. 
The attachment interference stimulated in CEK cell mono­
layers by IBV was shown to become evident at around 1 hour 
at both ambient temperature and 37°- Two facts strongly indi­
cating that the homologous interference observed in this study 
is, indeed, an attachment interference are: (1) interference 
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develops at ambient temperature as rapidly and to the same 
extent as at 37°. and (2) a high portion of any inoculum re­
mains as unattached virus, readily detectable in a fresh virus-
cell system. Probably neither interferon production nor 
competition for intercellular sites essential for viral syn­
thesis plays a role in this interference because these 2 
mechanisms would require viral penetration and metabolically 
active cells. Since the penetration of IBV does not occur 
during a 90-minute attachment period as shown by its suscept­
ibility to antibody neutralization (Lukert, 1966a), the latter 
2 interference mechanisms are probably not a factor. 
There were 2 striking differences between the attachment 
interference described here and that for coxsackieviruses. One 
difference was that dosages required to establish interference 
with IBV were much lower. Crowell (I966) found that 20 FPU's/ 
cell did not cause interference, while in this study as few as 
50 to 100 PPU's of IBV/culture were sufficient to induce 
interference. The second difference was that UV-irradiated 
virus could establish interference in the coxsackievirus system 
but could not in the case of IBV. If saturation or blockade 
of receptors was the mechanism of attachment interference for 
IBV, then at least 3 possibilities exist to explain why such 
low dosages of virus are effective and they are as follows: 
(1) There is a high ratio of non-infective virions or viral 
subunits to infective virus which are capable of saturating 
receptors. (2) There exists only a few receptors per cell. 
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thus, they are readily saturated. (3) The presence of IBV-
inhibitors in the serum used for implantation of the cells 
may block most of the receptors thus making it possible to 
establish interference with low dosages of virus. It may well 
be that a combination of any 2 or all 3 of the above factors 
are responsible. 
The fact that UV-irradiated virus did not establish 
interference is disturbing and does not support the receptor 
blockade theory. While this study did not establish whether 
UV-irradiated IBV is capable of attaching to cells, care was 
taken to not irradiate the virus excessively so that denatura-
tion of the viral envelope material would be minimal. Baluda 
(1957) showed that UV-treated NDV could attach to erythrocytes 
and lung epithelial cells equally as well as active virus. 
It appears that many types of interference other than 
that mediated by interferon exists. Interference between 
enteroviruses has been described that is not attributed to 
interferon, nor to attachment interference but it does involve 
very early events of viral replication (Drake, 1958; Ledinko, 
1963; Cords and Holland 1964; and Pohjanpelto and Cooper, 
1965). Baluda (1957) demonstrated that homologous interfer­
ence with NDV was not attributable to the prevention of attach 
ment of a second virus exposure but did probably occur at the 
cell surface to block the eclipse of the second virus. 
Future studies on the mechanism of attachment inter­
ference with IBV should be done with cells implanted with 
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inhibitor-free serum. Virus should also be labelled with 
radioactive compounds to determine if UV-treated IBV will 
attach to cells. The attachment receptors of IBV may well 
be more susceptible to UV-irradiation than other virus types. 
While attachment of IBV to cell monolayers was shown to 
be relatively inefficient, it was the most efficient in mono­
layer cultures of CEK cells which are about 30-60 times more 
sensitive than CELi cells (Lukert, I965). Less IBV was shown 
to attach to CELi, WCEFi and CEPi cells which are susceptible 
but less sensitive cell types. The virus attached least 
effectively, or not at all, to the non-susceptible PK-I5 cell 
type, thus it appears that the susceptibility and sensitivity 
of different cell types can be explained in part by differences 
in the cell's ability to attach virus. The WCEFi and CEPi 
cell cultures only differ from one another in respect to the 
relative number of epithelial cells present. The WCEFi cells 
were prepared without removal of the viscera, thus, more 
epithelial type cells were evident than in CEPi cells. The 
requirement of epithelial cells for initial virus infection 
has been shown for IBV (Lukert, 1966). These findings are 
similar to those of Holland et (1959) in which poliovirus 
did not attach to non-susceptible cells because they lacked 
specific receptors for the virus. Holland (I96I) also showed 
that tissues refractory to polio vivo became susceptible 
in vitro and evidently gained receptors upon cultivation. It 
appears that the opposite may be true with IBV, because upon 
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subculture of CEK cells they become less sensitive thus indi­
cating a loss of receptors. Another possibility for the loss 
of sensitivity is that the susceptible epithelial cells fail 
to proliferate and cultures become predominately fibroblastic. 
Of great interest was the finding that the highest thiol 
group activity is found on the surface of primary CEK and CELi 
cell cultures as compared to primary fibroblastic cell cultures 
especially since thiol groups are a part of IBV-receptors. 
While these differences in thiol activity could not be directly 
related to the sensitivity of the cell types, there may be 
some correlation with the susceptibility of cells to IBV and 
also reflect basic differences between epithelial and fibro­
blastic cells. The epithelial PK-15 cell had surface thiol 
activity similar to fibroblasts and total thiol activity 
similar to primary chicken embryo epithelial cells. Whether 
primary swine kidney cells would demonstrate high surface 
thiol activity was not determined. It is interesting to 
speculate that surface thiol activity may be lost upon contin­
ued cultivation ^  vitro. 
Even though there was no correlation between the degree 
of sensitivity of cells to IBV and the relative amount of thiol 
activity associated with cell surface, it was clearly shown 
that thiol groups are intimately associated with IBV receptors 
on both the virus and cell. Thiol groups are active in many 
cellular components especially enzymes of all types and non­
enzyme proteins of the cytoplasm, plasma membrane, and those 
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involved in movement such as ciliary proteins (Webb, 1966, 
pp. 635-653). The recent reports of Hoorn and Tyrrell (I966) 
and Mcintosh ^  al,, I967, have described the isolation from 
humans of a new group of viruses, morphologically resembling 
IBV, using ciliated tracheal organ cultures. These viruses 
seem to have a fastidious requirement for ciliated epithelial 
cells and thus there may be a correlation between highly thiol 
active ciliary proteins and receptor substances for IBV-like 
viruses. 
The inhibition of IBV attachment by cysteine and other 
thiols is probably one of competitive inhibition in which the 
confound acts as a cellular receptor to prevent cell-virus 
binding. The forces involved are evidently weak because the 
cysteine does not form a stable complex with the virus and is 
readily removed by dialysis. Lerner et (1963) found the 
receptors of erythrocytes agglutinated by reoviruses were not 
altered by PHMB, thus thiol groups were not a part of the cell 
receptor. The IBV-receptors of CEK cells were altered by PHMB, 
indicating that thiol groups are an integral part of the cell 
receptor, thus it is probable that only viruses having thiol-
containing cell receptors would be inhibited by thiols such 
as cysteine. 
An inhibitor of poliovirus type 1 found in horse serum 
was described by Takemoto and Habel (1959) and was associated 
with the gamma globulin fraction. It, like the IBV-inhibitor 
of bovine serum, prevented poliovirus attachment and reduced 
plaque size when incorporated into agar-overlay medium. Pagano 
(1965) showed that the poliovirus inhibitor was found in bovine 
as well as horse serum and was associated with the 19S macro-
globulins. Thomssen et (I966) confirmed that the polio­
virus inhibitor of horse serum was I9S macroglobulin and they 
proposed that the inhibitor formed antibody-like complexes 
with the viral surface. Ackermann and Dinka (19^ 5) found that 
the poliovirus inhibitory activity of bovine serum was distrib­
uted over a variety of sizes of macroglobulins. The IBV-
inhibitor was found in sera from at least 4 species and all 
rabbit serums seem to contain high quantities of this inhibitor. 
While the bovine serum IBV-inhibitor resembles the poliovirus 
inhibitors, it differs from those characterized by Pagano 
(1965) and Thomssen et a2. (I966) in respect to size. The 
IBV-inhibitor is not solely a 198 macroglobulin and by both 
gel filtration and sucrose rate-zonal centrifugation was found 
to be associated with macroglobulins ranging from 78 to 198 
in size with most of the activity between these two extremes. 
The poliovirus inhibitor characterized by Ackermann and Dinka 
(1965) more closely resembles the heterogeneous size of the 
IBV-inhibitor. Takemoto and Habel (1959) found the horse 
serum poliovirus inhibitor to resist 15-minute heating at 70°, 
and the bovine serum IBV-inhibitor was almost completely de­
stroyed in 10 minutes at 65°. Because the Inhibitor of IBV 
was not affected by neuraminidase, kaolin adsorption, and 
acetone treatment, it is probably not similar to the serum 
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mucoprotein inhibitors of myxoviruses (Cohen et al., 19^ 5) 
or the serum lipoprotein inhibitors of arboviruses (Clarke 
and Casals, 1958). It is probably a polymer of 78 gamma 
globulin because of its large molecular size as shown by gel 
filtration and its susceptibility to DTT. 
The mode of action of serum IBV-inhibitor may well be 
from an ability to complex with the virus, however, it may also 
inhibit IBV by reacting with cellular receptors. The fact 
that its action can be prevented by the presence of simple 
sugars clearly differentiates this substance from antibody. 
Pagano (1965) found that dextran sulfate reversed the action 
of poliovirus inhibitor in horse serum and thus may be similar 
to the IBV-inhibitor in respect to reversal by saccharides. 
It would seem very plausible that the reversal of IBV-inhib­
itor by sugars may indicate that sugars, like thiol groups, 
are an integral part of viral and cellular receptors and may 
compete with virus and cells for the inhibitor substance. It 
is interesting to speculate that the spatial configuration 
around one carbon atom may be the determining factor as to 
whether a sugar will, reverse the IBV-inhibitor. With the 
exception of D-glucosamine the non-reversing sugars, lactose, 
D-galactose, and L-arabinose, differ from the reversing sugars 
by the configuration around the 4th carbon atom. 
Many of the sugars seemingly reversed the serum inhibitors 
completely (Table 31) and plaque counts were even significantly 
higher than in serum and sugar-free controls. These same 
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sugars alone, however, would not cause an increase in plaque 
counts. The explanation for this may be that the serum, no 
longer inhibitory due to the presence of sugar, protects virus 
from inactivation at 37° and more viable virus is able to 
attach to and infect cells. It is not known what the mode of 
action is for the methylated glucose derivatives which pro­
duced significantly higher plaque counts when virus was allowed 
to attach in its presence. One possible explanation might be 
that these compounds have a greater affinity for the serum 
IBV-inhibitor than other sugars and is capable of removing 
the inhibitor from the cell surface, thereby exposing more 
cellular IBV-receptors. 
The recent findings that simple sugars inhibited the 
hemagglutination of a number of enteroviruses (Lerner et , 
1965» Lerner et a2., I966; and Kunin, I967) would seem to 
clearly show that these compounds are active in the virus-cell 
union. Lerner et a2. (1966) proposed that the carbonyl 
groups of the sugars were the active groups involved in the 
inhibition of virus-erythrocyte attachment. Faust et al. 
(1967) reported that D-glucose binding to brush borders of 
intestinal epithelial cells is blocked by HgCl2 and proposed 
that thiol groups are Involved in the binding and transport 
of sugars. This would indicate that the mechanism of some 
virus-cell unions may be similar to that of a thiol-sugar 
interaction. The enterovirus group and IBV would be good 
candidates for an attachment mechanism such as this. 
The inhibition of IBV attachment by NANA and removal of 
cellular receptors by neuraminidase presented the only similar­
ity of IBV receptors with those of NDV. In fact, the IBV 
receptors appeared to be more sensitive to neuraminidase 
treatment and attachment of IBV was inhibited to a greater 
extent by NANA than was NDV attachment. This could be indica­
tive of the fact that there are fewer IBV than NDV receptors/ 
cell or that more cells, thus more receptors, are susceptible 
to NDV than IBV. 
The separation of a serum portion that enhances the cyto-
pathic effect and spread of IBV only illustrates the complexity 
of a biological fluid such as serum. This enhancing effect 
of the serum filtrate is evidently normally masked by the IBV-
inhibitor substances and other large molecular weight sub­
stances that tend to spare cells from the cytopathic altera­
tions caused by IBV. Further studies are needed as to the 
chemical nature of this enhancing substance, its mode of 
action, and to determine the range of viruses that are affected 
by it. The more rapid spread of virus and the increased plaque 
size in the presence of filtrate may be explained simply by the 
fact that virus is released more rapidly from infected cells. 
The increased plaquing efficiency in the presence of 
pancreatin is of great interest but the mechanism of its action 
can only be speculative because of the complex nature of a 
crude enzymatic preparation of this kind. Zajac and Growell 
(1965) reported that HeLa cells treated with pancreatin and 
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chymotrypsin were unable to attach group B coxsackieviruses 
and cells treated with trypsin failed to attach type 1 polio-
virus. Prom this evidence, they postulated that the receptors 
for these two enteroviruses differed. Wallis et a2. (1966a) 
reported that pancreatin and cysteine enhanced plaque numbers 
in monkey kidney cultures of many types of echoviruses and 
group A and B coxsackieviruses. The enzyme and cysteine were 
added to the agar overlay in the latter study and thus the 
results of the two studies may not be in conflict. Wallis 
et al. (1966b) also found that pancreatin enhanced the plaqu-
ing efficiency of reovirus by incorporation of the enzyme 
into the agar overlay. From these results, it can be seen 
that the effect of crude enzymes may be variable and in each 
case a different component may be acting and the action prob­
ably depends upon the time at which the virus or cell is ex­
posed to the enzyme preparation. In this study, the pancreatin 
may act to enhance IBV in at least two ways. It may remove 
the serum IBV-inhibitor from cellular receptor sites so that 
more receptors are available or the possibility exists that 
it is inhibiting the attachment interference mechanism, thus 
allowing a more efficient attachment. Further study would be 
required to determine what specific enzymes are active and 
their mode of action. 
While the attachment receptors of IBV resemble those of 
enteroviruses and reoviruses in many respects, there are 
several basic differences. One is the fact that thiol groups 
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of the reovirus erythrocyte receptors are not active in attach­
ment as in IBV (Lerner et al., 19^ 3). Another difference is 
that enterovirus receptors are not altered by neuraminidase 
treatment (Zajac and Crowell, I965)• Finally, it appears that 
the attachment of enteroviruses, at least their attachment to 
eruthrocytes, can be inhibited by simple sugars (Lerner et al., 
1965; and Kunin, 1967) while IBV attachment is not. 
The evidence presented in this study showed that condi­
tions or substances which altered IBV attachment seemed to 
have an effect on both cells and virus. One explanation for 
this could be that IBV has a lipoprotein envelope (Berry ^  
al., 1964) which is probably derived from the cell membrane. 
This fact may account for the complimentary nature of both 
the viral and cellular receptors as they may be similar chem­
ically. This would not be the case with the enterovirus system 
where the nucleocapsid is probably made ^  novo. 
The finding that lysosomes apparently play no role in 
IBV cytopathology confirms the results of Wolff and Bubel 
(1964) and Flanagan (I966) in which they demonstrated that not 
all viral cytopathology was a result of lysosome activation. 
Allison and Sandelin (1963) and Allison and Mallucci (1965) 
had proposed lysosome activation as a mechanism for all viral 
cytopathology. IBV infection did not alter the distribution 
of the enzyme nor the permeability of the lysosomal membrane 
of infected cells until very late in infection and these 
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alterations were considered to be secondary rather than primary 
responses to viral Infection. 
The observation that all liver cells in culture did not 
show the same acid phosphatase activity was in agreement 
with the 3^  vitro studies of Novikoff (1959)• He found that 
centrolobular hepatic cells exhibited much less acid phos­
phatase and acid esterase activity than did peripherolobular 
cells. Since both cells with high and low acid phosphatase 
were susceptible to IBV, it would appear that this particular 
enzyme has no bearing on the susceptibility of these cells to 
I 
IBV. 
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SUMMARY 
The attachment of IBV to cell monolayers was found to 
be very Inefficient even to CEK cells, the most sensitive of 
the cell culture systems studied. While the kinetics of attach­
ment were similar at 4°, 22°, and 37°» there was about 6 
times more virus attached at 37° than at either 4° or 22°. 
IBV attached very poorly or not at all to non-susceptible 
cells. IBV attachment was also less efficient to the cell 
culture types that were less sensitive than CEK cultures. 
During the period of attachment there was an interference that 
developed, starting at around 60 minutes, which prevented 
further attachment of virus after 90 minutes. There was also 
a significant inhibition of attachment of a second dose of 
homologous virus. This attachment interference developed at 
ambient temperature and 37° and could not be stimulated with 
either UV-irradiated IBV or heterologous NDV. 
Attachment receptors of both the virus and cell were 
shown to be sensitive to sulfhydryl reagents and attachment 
could be prevented with thiols such as cysteine and reduced 
glutathione. An IBV-inhibitor, which prevented viral attach­
ment was demonstrated in bovine, swine, chicken, and rabbit 
serums. The inhibitor was proteinaceous in nature and was 
associated with gamma globulins ranging from 7S to 198 in 
molecular size. This IBV-inhibitor was susceptible to DTT, 
65° for 10 minutes and its effect could be reversed using a 
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number of simple sugars. The inhibitor was shown to adsorb 
to cells and prevent virus attachment and when it was incor­
porated into the agar overlay, it reduced plaque size but not 
plaque numbers. The receptors for IBV were also shown to be 
neuraminidase-sensitive and the attachment of both IBV and 
NDV could be inhibited with NANA. This was the only similarity 
between NDV and IBV receptors as NDV was not sensitive to 
sulfhydryl reagents nor to the serum inhibitors. 
Alpha and beta methylated glucose not only reversed the 
action of IBV-inhibitors in serum but also effectively increas­
ed plaque numbers when used alone. Pancreatin was also effec­
tive in Increasing plaque counts significantly; however, 
neither the specific enzyme responsible nor the mode of action 
were determined. 
It was shown both histochemically and quantitatively that 
the distribution of acid phosphatase activity of IBV infected 
cells during the early hours of infection was the same as that 
observed in uninfected cells and release of this enzyme from 
lysosomes did not occur until very late in viral infection. 
The conclusion of this study was that lysosomes play no part 
in the cytopathology induced by IBV and that the late changes 
were secondary to infection rather than primary. 
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APPENDIX 
Table 40. Effect of time on attachment of IBV 
Time of 
Trial attachment Number of 
number (minutes) plaques 
Mean (-) Ratio of: 
number^ of PFU's at 240 min.  ^100% 
plaques PFU's at each time 
+ 28— 
— X 
60 46,40 43 + 6 56^  
90 48,41,36 42 + 7 55^  
120 44,44,36 41 + 5 53^  
150 55,61,48 51 + 9 66^  
180 69,52,78 66 + 15 86^  
210 78,74^ 73 75 + 3 98^  
240 71,77,83 77 + 7 100^  
30 5,13,10,7.10 9 + 3 20^  
60 16,30,16,24,16 22 + 6 49^  
90 39,25,34,30,31 32 + 5 71^  
120 28,44,38,30,33 36 + 6 80^  
150 25,44,46,61,40 43 + 12 96^  
180 35,21,29,30,34 30 + 5 67^  
210 49.38,35,37,40 42 + 5 93^  
240 58,43,36,50,37 45 + 8 100^  
200 
Table 41. Results of trials comparing plaque counts on singly 
and dually infected GEK cell monolayers at progres­
sively increasing attachment periods 
Trial 
number' a 
Time at which 
culture was 
dually infected 
Number of 
doses 
of virus 
Mean 
plaque 
county 
Percent increase 
in plaques in 
dually infected 
cultures 
15 1 46 + 3 
2 74 + 6 61$ 
30 1 75 + 12 
2 119 + 14 59$ 
45 1 68 ± 5 
2 
o
 
H
 ± 8 105$ 
60 1 95 ± 14 
2 194 + 8 104$ 
75 1 100 + 5 
2 169 + 7 69$ 
90 1 111 + 8 
2 175 + 12 53$ 
30 1 22 + 5 
2 41 + 3 86$ 
60 1 27 + 4 
2 38 + 4 41$ 
A^ttachment temperature was 37° in the 1st 3 trials and 
ambient temperature in the 4th and 5th. 
b 
Mean was determined from 5 counts. 
Table 4l. (Continued) 
Mean Percent increase 
Time at which Number of plaque in plaques in 
Trial culture was doses count dually infected 
number dually infected of virus + 28- cultures 
90 1 41 ± 5 
2 50 + 3 22^  
30 1 44 + 4 
2 71 + 10 68^  
60 1 56 + 6 
2 79 + 8 41^  
90 1 70 5 
2 114 + 12 63^  
30 54 + 6 
H
 
H
 + 9 110# 
60 86 + 9 
180 + 7 110# 
90 120 + 8 
200 + 10 67# 
30 29 + 7 
63 + 7 117# 
60 37 + 9 
54 + 12 45# 
90 57 + 9 
69 + 7 21# 
202 
Table 42. Results of dose response of L-cysteine to inhibi­
tion of IBV attachment 
Trial 
number 
Molar concentration Mean plague 
of L-cysteine x 10"^  count + 28-
— X 
% change in 
mean plaque 
count 
1^  
o
 
o
 
H
 22 + 3 -80# 
5.0 28 + 5 -74# 
2.5 54 + 9 
0
 1 
1.25 70 10 
0.625 80 + 10 -2k% 
0.3125 97 + 11 -11# 
Virus control — — — — 109 ± 5 — — — 
2^  10.0 38 ± 8 -62# 
5.0 63 ± 12 -38# 
2.5 88 ± 9 -23# 
1.25 94 ± 6 - 7# 
0.625 119 ± 12 +18# 
0.3125 111 ± 7 +10# 
Virus control M» mm mm 101 + 9 mm 
M^eans determined from 7 counts. 
M^eans determined from 5 counts. 
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Table 4-3. Effect of a non-thiol reducing agent (ascorbic acid) 
and two disulfide compounds (L-cystine and oxidized 
glutathione) on IBV attachment 
% change in 
Mean plaque mean plaque 
Concentration count count 
Ascorbic acid lO-^ M 129 ± 7 + 7^  
10-^ M +
1 H
 26 +16# 
H
 
O
 1 
H
 
O
 
1+
 15 +17# 
H
 
o
 1 126 + 14 + 5# 
H
 
O
 1 
123 ± 10 + 2# 
Virus control 120 + 7 — — — — 
L-cystine lO-^ M +
1 0
0 
12 -16# 
10"^ *% 00
 
o
 
1+
 
5 -14# 
1 o
 
H
 93 ± 7 0# 
10"^ * 91 ± 13 - 2# 
1 o
 
1—
1 
+
1 0
0 00 
10 
- 5# 
Virus control +
1 O
N 10 — — — — 
Oxidized glutathione 10-^ M 96 + 13 +16# 
10-% 104 + 9 +24# 
H
 
O
 1 
00
 
1+
 6 0# 
H
 
O
 1 
63 ± 6 -24# 
Virus control 83 ± 9 — — — — 
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Table 44. Kinetics of IBV Inactlvatlon with concentrations 
of 10-2, 10-3, 10-% PHMB 
Logio FPU's detected after reaction 
Time with PHMB at concentration of: 
of 
reaction 
In 
minutes 
lO-^ M Trial 1 
10-3M 
Trial 2 Trial 3 
1 o 
H
 
0 6.9 6. 5 6.9 6.9 6.9 
30 5.9 5.5 6.1 — — — 7.0 
60 5.2 5.0 5.8 5.6 6.6 
90 4.9 5.1 5.7 — — —  6.3 
120 4.8 5.0 5.5 5.4 6.0 
150 4.6 —  — —  5.4 —  —  —  6.0 
180 4.4 —  —  —  —  —  —  5.4 —  —  —  
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Table 45. Results of quantitation of 4 bovine serums for 
their IBV-inhibitory activity 
Serum and Concentration Mean plaque 
identification of serum count + 28-
% change 
in mean 
plaque count 
Bovine #681 
Bovine #1181 
Bovine #98 
0^  (control) o
o H
 + 8 — — — — 
1^  93 + 8 -33^  
2^  60 + 1 -56^  
38 + 5 -72* 
35 + 2 -75* 
24 + 3 -83* 
G% 17 + 3 -88* 
7)^  18 + 3 -87* 
8^  19 + 2 -86* 
9^  15 + 3 -89* 
10^  13 + 3 -91* 
0% (control) 70 + 8 — — 
1^  39 + 3 -44* 
3^  19 + 1 -73* 
20 + 1 -72* 
7^  9 + 1 -87* 
9^  11 + 6 -84* 
0^  (control) 48 + 6 — — — — 
\% 51 + 12 + 6* 
3^  44 + 10 - 8* 
5^  32 + 9 -33* 
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Table 45. (Continued) 
Serum and 
identification 
Concentration Mean plaque 
of serum count + 28-
% change 
in mean 
plaque count 
Bovine #5533 0% (control) 
3^  
5# 
10^  
2 2 + 9  
48 + 6 
56 + 13 
53 ± 5 
4? + 17 
3 5 + 9  
-54^  
+l6^  
+10^  
Table 4-6. Results of comparative titration of (NH/j,)2S0j^  pre­
cipitated /globulin and whole serum of bovine 
serum pool #681 
Material Concentration Mean plaque % inhibition 
tested of material count + 28- of mean 
 ^ plaque count 
7681 2^  22 + 11 86^  
13 ± 3 92^  
6^  1 0 + 5  94^  
8^  1 0 + 3  94^  
±0% +
1 CO 95^  
Whole serum 2^  18 + 13 88^  
4^  1 2 + 8  92^  
6% 1 0 + 5  94^  
8^  9 + 5  94^  
10% 5 ± 1 97^  
Virus control 156 + 12 — — — 
207b 
Table 47. Titration of bovine serum #681 heated at 56° for 
36 minutes and 65° for 20 minutes in comparison to 
unheated serum 
% change in 
Serum Concentration Mean plaque mean plaque 
treatment of serum counts + 23- count 
56° for 30 min. 39 ± 3 
3# 19 ± 1 -73# 
5# 2 0 + 1  -72# 
7# 9 ± 1 -87% 
9^  1 1 + 6  -8!j^  
65° for 20 min. 1# 6 7 + 2  - 4% 
3# 63 + 13 1 H
 
0
 
5^  7 0 + 9  0% 
7# 61 + 10 -13% 
9^  90 + 15 +29% 
Unheated serum 1^  2 0 + 8  1 ON
 
00
 
3^  8 + 3  -89% 
5# 7 + 1  -90% 
7# 6 + 0 -91% 
9^  2 + 2  -97% 
Virus control mm mm 7 0 + 5  — — " 
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Table 48. Inhibitory activity of the 10 fractions obtained 
from a sucrose rate-zonal centrlfugation of a gamma 
globulin fraction (125 mg protein/ml) of bovine . 
serum #681. Each fraction was tested at a concen­
tration of 10^ and 5-55% 
Fraction and Mean plaque  ^change in 
% sucrose represented count + 28- mean plaque 
by each fraction before count 
centrlfugation 10^  5-55% 10^  5-55% 
1 (sample) 37 + 5 54 + 11 -29 + 8 
2 (15^ 1 40 6 58 + 14 -23 +15 
3 (152) 30 + 11 4l + 13 -41 -17 
4 (20#) 15 + 7 38 + 5 -71 -23 
5 (20#) 18 + 6 30 + 7 -65 -39 
6 (25#) 19 + 5 32 + 5 -64 -35 
7 (25#) 15 + 4 30 + 6 -71 -39 
8 (30#) 17 + 3 35 + 5 -67 -29 
9 (30#) 27 + 6 39 + 13 -47 -21 
10 (59#) 56 + 9 47 ± 6 + 8 - 6 
Virus control 52 + 6 50 + 6 — — — — — — 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
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IBV-inhlbitory effect of samples collected from 
Sephadex G200 column. Each sample was tested at a 
level of 10^  
Number of Mean % change in 
plaques detected plaques mean count 
49,36 43 1 H
 
34,47 41 1 H 
33,38 36 -25^  
42,48 45 - 6^  
26,29 28 -42^  
30,22 26 -46# 
41,41 4l 
-152 
30,31 31 -35# 
31,33 32 -33^  
29,34 32 
-332 
43,33 38 -212 
37,35 36 -25^  
39,39 39 -192 
40,37 39 -192 
41,35 -212 
44,49 47 - 22 
28,29 29 -402 
38,52 46 -172 
43 43 -102 
48,49 49 + 22 
47,44 46 '- 42 
210 
Table ^9- (Continued) 
Sample Number of Mean % change in 
number plaques detected plaques mean count 
22 37,36 -23# 
23 47,45 46 - 4% 
24 41,47 44 - 8# 
25 41,46 44 - 8# 
26 33,39 36 -25$ 
Virus control 42,39,47,54, 48+6 
55,42,43,62 
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Table 50» Effect of acetyl salicylate, para-amlno salicylate, 
sodium salicylate, and amantadine hydrochloride on 
attachment of IBV to CEK cell monolayers 
Compound Concen- Mean plaque % change in 
tested tration count + 28- mean plaque 
 ^ count 
Acetyl salicylate 10"% Toxic to cells — — — 
10-^ M 116 + 12 + 7^  
10"% 130 + 17 +20^  
10-3.% 128 + 14 +18^  
p-amino salicylate 10"% 86 + 15 -20^  
10"% 112 + 17 + 
1 o H 112 + 5 + 4^  
10"3'% 117 + + 8^  
Virus control — — — 108 + 10 — — — 
Sodium salicylate 10"% Toxic to cells — 
10"% 59 + 8 - 2^  
H
 
o
 1 
57 + 11 -5^  
Virus control — — 60 + 11 — — — 
Amantadine HCl 100 45 ± 13 —16^  
50 >«g 49 + 14 - 9^  
46 + 6 -15# 
10 jug 55 ± 7 + 2^  
Virus control — — — 54 + 7 — — — 
